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There is epidemiological evidence that the benefits of dietary polyunsaturated fatty
acids (PUFA) derived from fish oil (n-3 PUFA) and plant seed oil (n-6 PUFA) in
cardiovascular disease include a reduction in blood pressure (BP). In man, intervention
studies have shown that dietary PUFA can affect vascular resistance, an important
determinant of BP. Animal experiments have suggested that n-3 PUFA may affect
vascular responses to a \ -adrenoceptor stimulation but differences between species, in
experimental diets and duration of feeding make interpretation of the results difficult.
The aim of this thesis was to use semisynthetic isocalorific experimental diets,
representative of what is or could be consumed by man, to investigate the effects of
dietary PUFA on cardiovascular responses to a i-adrenoceptor stimulation.
Generally, diets derived 40% of total calories from fat. The control diet had a
PUFA/saturated fat (P/S) ratio of 0.3. Dietary n-3 PUFA were given as a small daily
supplement (0.4% dietary calories) to the control diet and the n-6 PUFA diet had a
P/S ratio of 2.0, achieved by substituting 18:2, n-6 for saturated fat. In one series of
experiments, diets deriving 10% of total calories from fat, relatively rich in saturated
fat, n-3 PUFA or n-6 PUFA, were used. Throughout, diets were fed for eight weeks.
There were three experimental preparations: the buffer perfused rat hind-quarters, the
isolated rat femoral resistance artery and the isolated rat heart retrogradely perfused
with buffer through the aorta. Responses to a \ -adrenoceptor stimulation were elicited
by noradrenaline in the presence of P- and a2-adrenoceptor antagonists, where
appropriate. The effect of the diets on total and fractionated phospholipid (PL) FA
composition was monitored in cardiac tissue.
In the perfused hind-quarters and isolated resistance artery, n-3 PUFA, but not n-6
PUFA, significantly attenuated responses to a \ -adrenoceptor stimulation. A
supplementary study in the resistance artery did not reveal any effect of dietary PUFA
on relaxation to acetylcholine. In the isolated heart, a 10% fat n-3 PUFA diet, but not
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an n-6 PUFA diet, significantly attenuated peak left ventricular pressure (LVP)
responses to a \-adrenoceptor stimulation. The peak LVP effect of n-3 PUFA was
maintained after chemical denervation. At 40% fat, the n-6 PUFA significantly
attenuated peak LVP responses whereas the n-3 PUFA supplement did not.
LVdP.dt"!, heart rate and coronary flow were not affected by diet. Parenteral
flurbiprofen removed the effect of the 40% fat n-6 PUFA diet on peak LVP. Baseline
cardiac prostacyclin release decreased 75% with flurbiprofen and was not influenced
by diet.
Analysis of PL FA composition revealed numerous significant changes in relation
to diet. In phosphatidylcholine (PC) and phosphatidylethanolamine (PE), dietary n-3
PUFA reduced the proportion of 18:2, n-6 and 20:4, n-6 and increased that of 20:5,
n-3 and 22:6, n-3. The n-6:n-3 ratio fell and the double bond index rose. These effects
were more profound with the 10% than the 40% fat diets. Phosphatidylinositol (PI)
and phosphatidylserine (PS) were more resistant to dietary influence. Dietary n-6
PUFA led to modest increases in 18:2, n-6 and the n-6:n-3 ratio but the double bond
index was unaltered or decreased. The proportion of 20:4, n-6 was unaffected by
dietary n-6 PUFA at 40% fat and fell paradoxically at 10% fat. No correlation was
identified between PL FA composition and the responses ofpeak LVP.
The influence of the 40% fat diets on aortic versus cardiac PL FA composition was
investigated. Aortic PC incorporated less 20:4, n-6, and PE more, than the heart. All
aortic fractions incorporated more 20:5, n-3 and less 22:6, n-3 than the heart. Levels
of 18:2, n-6 were broadly similar. Higher n-6:n-3 ratios and lower double bond indices
were further evidence of lesser incorporation of longer chain PUFA in the aorta.
In conclusion, dietary PUFA reduced vascular and cardiac responses to
a i-adrenoceptor stimulation. Dietary PUFA altered cardiac PL FA composition but
no direct relationship could be demonstrated between FA composition and cardiac
responses. Dietary PUFA did not affect baseline cardiac prostacyclin release but the
attenuatory effect of dietary n-6 PUFA on cardiac peak LVP responses was removed
vii
by flurbiprofen. The influence of n-3 PUFA on vascular responses may help to explain
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Chapter 1
Introduction
^ ardiovascular disease continues to be the principal cause of death in the
developed world. In 1987, diseases of the heart and circulation accounted for one half
of all mortality [Lopez, 1990], a proportion which had altered little during the previous
decade [Balajaran, 1991, Kannel et al., 1984], Coronary heart disease alone is
responsible for a quarter of deaths. Hypertension, raised BP, is not associated with a
high incidence ofmortality, but is a major risk factor for other cardiovascular diseases.
Moreover, hypertension is eight times more prevalent than coronary heart disease
[Kannel et al., 1984] and is thus a substantial source of morbidity. Recognition of the
importance of detecting and treating hypertension is accompanied by increasing
interest in non-pharmacological means of management, including the use of PUFA
derived from plant seed oils (n-6 PUFA) and fish oils (n-3 PUFA). This Introduction
will begin by considering the epidemiological evidence that dietary PUFA are
associated with lower BP.
1.1 Dietary PUFA and blood pressure
§
1.1.1 Population studies
Evidence suggesting that dietary PUFA may be associated with lower BP can be found
in a number of epidemiological studies. These studies were commonly performed to
assess risk factors within populations who differed in their prevalence and incidence of
coronary heart disease. Thus, Scottish men were found to have higher systolic and
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diastolic BP, and lower adipose tissue 18:2, n-6, than Swedish men [Logan et al.,
1976], Likewise, Italian men were noted to have lower systolic and diastolic BP than
their Scandinavian counterparts [Riemersma et al., 1986, Olsson et al., 1988], The first
of these studies revealed that the Italians had a higher proportion of adipose tissue
18:2, n-6 and the proposal that this finding was consistent with a higher dietary P/S
ratio was confirmed in the second study. In an investigation of serum phospholipid
fatty acid composition in Finnish men sustaining a myocardial infarction, 18:2, n-6 was
negatively correlated with systolic and diastolic BP in the control group [Miettinen et
al., 1982], Weak, but significant, negative correlations were found between adipose
tissue 18:2, n-6 and platelet 20:5, n-3 in a control group of middle-aged Edinburgh
men [Wood et al., 1987], Reviewing several epidemiological studies, mostly
performed in Greenland Eskimos, Bonaa [1989] concluded that BP tended to be lower
in relation to increased consumption ofn-3 PUFA.
In response to these observations, a number of dietary intervention studies,
discussed in the following section, have been carried out to investigate further the
potential BP lowering effects of n-6 PUFA and n-3 PUFA in man.
1.1.2 Dietary intervention studies and BP in man.
Studies using dietary intervention to investigate the effect ofPUFA on BP do so in two
ways. The overall proportion of PUFA in the diet can be increased at the expense of
saturated fat or the diet can be supplemented with the required PUFA. The majority of
such studies concern n-3 PUFA and, curiously, have been performed relatively
infrequently in hypertensive subjects.
Systolic BP was reduced by a mackerel diet in individuals with mild essential
hypertension [Singer et al., 1985], Likewise, dietary supplements providing
approximately 5 g [Norris et al., 1986] or 15 g [Knapp and Fitzgerald, 1989] of n-3
PUFA daily led to small but significant falls in BP in mild hypertension. The
combination of a decrease in dietary fat intake (to 23% total calories) and an increase
in dietary n-6 PUFA (to a P/S ratio of 1.0) was found to reduce BP, more so for
hypertensives than normotensives, in Finnish men [Puska et al., 1983],
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In normotensive men, n-3 PUFA given as fish oil [Mortensen et al., 1983] and fish
paste [van Houwelingen et al., 1987] reduced systolic BP, although in the latter study,
BP also fell with meat paste containing a high proportion of 18:1, n-9. Studies
examining the effects of dietary n-6 PUFA on BP in healthy volunteers have not been
consistent. A low fat diet (24% total calories) with an increased proportion of n-6
PUFA (P/S ratio 1.2) lowered systolic and diastolic BP in normotensive Finns [Iacono
et al, 1983] and dietary supplementation with safflower seed oil (a source of 18:2,
n-6) reduced systolic BP in healthy males [Heagerty et al., 1986], However, diets with
a P/S ratio of 1.0 had no effect on BP in either 54 Australian or 58 Dutch volunteers
[Margetts et al., 1985, Mensink et al., 1990], There are no appreciable differences in
systolic or diastolic BP at the outset in these four n-6 PUFA studies.
Animal intervention studies, where diets can be tightly controlled, and BP
measured frequently under reproducible conditions, might be expected to confirm the
effects ofn-3 PUFA and clarify those ofn-6 PUFA. This area is discussed below.
1.1.3 Dietary intervention studies and BP in animals
In contrast to the general trend in man, the effects of dietary n-3 PUFA on BP in
various animal models have not been consistent. Dexamethasone-induced hypertension
was attenuated in rats fed a diet supplemented with cod liver oil (another source of n-3
PUFA) as opposed to saturated fat [Codde and Beilin, 1985], but the same research
group found that spontaneously hypertensive rats showed a non-sustained increase in
BP with fish oil treatment [Croft et al., 1988], Rats rendered hypertensive with oral
1.5% saline increased their BP less in relation to dietary cod liver oil than sunflower
seed oil (n-6 PUFA), and the rise in BP was less for both series ofPUFA compared to
a saturated fat diet [Ziemlanski etal., 1985],
In normotensive animals, reports of the effects of n-3 PUFA are equally conflicting.
Cod liver oil was associated with raised BP in rats after six weeks [Scherhag et al.,
1982] but, interestingly, 20:5, n-3 delivered by an osmotic pump blunted the increase
in BP in rats subjected to isolation stress [Mills and Ward, 1986],
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The few data regarding the effects of n-6 PUFA in animal models tend to agree, in
contrast to the human studies. In one-clip one-kidney (Goldblatt) hypertensive rats,
sunflower seed oil curtailed the rise in BP [Mahoney et al., 1983], The similar results
of Ziemlanski et al. [1985] with regard to sunflower seed oil and saline-induced
hypertension in the rat are mentioned above. Also, normotensive rats sustained lower
BP after feeding with sunflower seed oil compared to saturated fat [Charnock et al.,
1985],
An important observation when considering the effect of experimental diets on BP
in animal studies is that dietary 18:2, n-6 reverses the relative hypertension that occurs
with essential fatty acid deficiency [Cox et al., 1982], The reason for the inconsistent
nature of the results in n-3 PUFA dietary experiments may be that some of the diets
used in these studies were deficient in n-6 essential fatty acids.
A number of mechanisms have been proposed to underlie the effects of dietary
PUFA on BP in human and animal work and these are discussed below.
1.1.4 Putative mechanisms in the effect of dietary PUFA on BP: studies in man
Virtually all the mechanisms thought to account for the effects of dietary PUFA in
human studies are in relation to the effects of n-3 PUFA. Indeed, most concern factors
likely to influence peripheral vascular resistance, an important determinant ofBP. (BP
is the product of cardiac output and peripheral vascular resistance.)
The tendency for BP to fall with dietary n-3 PUFA is accompanied by either
unchanged [Mortensen et al., 1983] or increased [Singer et al., 1985, Jorgensen et al.,
1986] renin levels. If hypotensive effects of n-3 PUFA were associated with a decrease
in renal perfusion, renin levels would be expected to rise, but an alternative explanation
involves decreased sensitivity to the powerful vasoconstrictor angiotensin II, as was
found in volunteers given purified 20:5, n-3 [Yoshimura et al., 1987],
There are conflicting reports concerning the effects of dietary n-3 PUFA on
eicosanoids. Some authors describe decreases in PGI2 and TXA2 synthesis from 20:4,
n-6 with increases in PGI3 and TXA3 synthesis from 20:5, n-3 [Lorenz et al., 1983,
Fischer and Weber, 1983, Fischer and Weber, 1984, Knapp and Fitzgerald, 1989],
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Others describe a simple decrease in platelet cyclooxygenase/lipoxygenase products
[Driss et al., 1984], Even a paradoxical increase in PGI2 synthesis following dietary
n-3 PUFA has been reported [de Caterina et al., 1990], Generally, as TXA3 is a less
potent vasoconstrictor than TXA2, but PGI3 and PGI2 equipotent vasodilators,
dietary n-3 PUFA shift the balance in favour ofvasodilator prostanoids.
Perhaps the best known effects of n-3 PUFA are on blood rheology. Decreased
viscosity, increased erythrocyte deformability and decreased erythrocyte and platelet
aggregation have all been reported [Terano et al., 1983, Cartwright et al., 1985, Driss
et al., 1984, Ernst, 1989], A reduction in fibrinogen, an important determinant of
plasma viscosity, has also been found with n-3 PUFA [Hostmark et al., 1988], These
changes would contribute to a fall in BP.
There may be an effect of dietary n-3 PUFA on the mechanical characteristics of
conduit vessels. A decrease in aortic pulse wave velocity, measured indirectly by means
ofDoppler ultrasound, in a fish-eating population was proposed to reflect an increase
in vascular compliance [Hamazaki et al., 1988], Similar results were obtained in
non-insulin-dependent diabetics and healthy controls fed in excess of 100 g fish per
week [Wahlqvist etal., 1989],
Potential effects of dietary n-3 PUFA on vascular reactivity attract increasing
interest. Attenuated pressor responses to noradrenaline [Lorenz et al., 1983], to
angiotensin II [Yoshimura et al., 1987] and even mental stress [Singer et al., 1985]
have been reported, though clearly the last study may reflect a central effect of dietary
n-3 PUFA on sympathetic activation. Further, the systolic BP response to treadmill
exercise testing was reduced in angina sufferers treated with fish oil [Mehta et al.,
1988] and the onset of digital vasoconstriction in response to cold provocation was
delayed in patients with Raynaud's disease given fish oil. These data are consistent with
the concept that dietary n-3 PUFA can attenuate the increase in peripheral vascular
resistance brought about by catecholamines or other vasoactive agents.
The mechanisms responsible for hypotensive effects of dietary n-6 PUFA have
been little investigated. An increase in leukocyte total Na+ efflux was found in
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association with a fall in systolic BP in mild hypertensives given safflower oil
[Heagerty et al., 1986], suggesting that abnormal membrane Na+ transport in
hypertensives may respond to n-6 PUFA. Dietary n-6 PUFA may influence vascular
reactivity or sympathetic activation in a similar manner to n-3 PUFA. In healthy
volunteers, a diet rich in 20:4, n-6 attenuated the fall in forearm blood flow induced by
cold stimulation (ice applied superficial to the carotid bifurcation) [Butcher et al.,
1990],
In the following section, mechanisms suggested by animal studies are discussed.
1.1.5 Putative mechanisms in the effect of dietary PUFA on BP: animal studies
Data are sparse regarding the effects of dietary n-6 PUFA and, as in human studies,
many of the mechanisms suggested for dietary n-3 PUFA are linked to changes in
vascular resistance. Much of the evidence comes from in vitro work.
Decreases in circulating PGI2 and TXA2 [Codde and Beilin, 1985] and in their
synthesis by aortic tissue [Scherhag et al., 1982, Croft et al., 1988] have been found in
rats fed n-3 PUFA but in these studies, the effects of n-3 PUFA on BP were
inconsistent. The finding of Mills and Ward [1986] that BP responses to isolation
stress were attenuated in rats fed fish oil suggests a mechanism involving a decrease in
sympathetic activation or in vascular responses to catecholamines or other vasoactive
agents, as proposed in some of the human studies.
In animal work also, there is great interest in the potential effects of dietary n-3
PUFA on vascular reactivity. Aortic rings isolated from rats fed fish oil have been
shown by more than one research group to have diminished contractile responses to
noradrenaline [Lockette et al, 1982, Yin et al, 1991, Malis et al., 1991], Also, in
rabbits, highly purified 20:5, n-3 was associated with reduced pressor responses to
angiotensin II and noradrenaline, though the effect on noradrenaline responses did not
achieve significance. In marked contrast to these findings, oral dosing with fish oil for
one week led to enhanced BP responses to a\-adrenoceptor stimulation [Kenny et al.,
1990], However, the control animals were not orally dosed and the effect of this
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procedure was not examined. Generally, the data indicate a negative effect of dietary
n-3 PUFA on vasoconstriction.
The influence of dietary n-3 PUFA on vascular relaxation became clear in animal
studies. Coronary artery rings isolated from swine fed cod liver oil demonstrated
enhanced relaxation in response to bradykinin, serotonin and adenosine [Shimokawa et
al., 1987], The effect was dose- (of oil) dependent, endothelium-dependent and
removed by methylene blue, allowing the authors to conclude that the mechanism
involved endothelium-derived relaxing factor. There are similar data from rat studies.
Dietary fish oil enhanced the relaxation of aortic rings from spontaneously hypertensive
rats [Yin et al., 1988, Yin et al., 1991], an effect thought to have both endothelium-
dependent and endothelium-independent components [Malis et al., 1991], Thus, there
are other means by which dietary n-3 PUFA shift the balance in favour of
vasodilatation.
As mentioned, there are virtually no animal data concerning mechanisms in n-6
PUFA effects on BP. Reports of increased noradrenaline overflow following field
stimulation in the tails of rats fed sunflower seed oil [Panek et al., 1985, Semafuko et
al., 1989] are clearly inconsistent with the tendency for n-6 PUFA to reduce BP in
other studies.
1.2 Physiological roles of fatty acids and phospholipids
§
As the first part of this Introduction concerned the effects of dietary PUFA on BP, the
physiological roles of fatty acids will be reviewed.
1.2.1 Fatty acids as a source of energy
Our most important source of energy is fat, stored in adipose tissue as triacylglycerols.
Fatty acids are highly reduced compared to carbohydrates and yield a correspondingly
greater amount of energy on oxidation; 9 kcal.g"^ as opposed to 4 kcal.g'l for
carbohydrate and protein. Another important difference between fat and carbohydrate
as energy sources is the hydrophilic nature of glucose polymers. Glycogen binds
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approximately 2 g F^O.g"* whereas triacylglycerols are anhydrous. Accordingly,
intracellular fat contains six times the potential metabolic energy, weight for weight, of
intracellular glycogen. Thus a typical 70 kg man has fuel reserves approaching 10^ kcal
in body fat in contrast to some 600 kcal in total glycogen. In response to adrenaline
during stress and glucagon when fasting, for example, triacylglycerol is hydrolysed by
hormone-sensitive lipase (triacylglycerol lipase) to yield diacylglycerol and one
unesterified fatty acid. Diacylglycerol and monoacylglycerol are also hydrolysed by
specific lipases. Of the energy subsequently derived from complete oxidation, 95% is
from the acyl side chains, 5% from the glycerol backbone.
To undergo degradation, fatty acids in the cytosol are conjugated with coenzyme A
(CoA) and transferred onto the carrier, carnitine, to be transported into the
mitochondrion where P-oxidation takes place. The process of P-oxidation entails the
cyclic release of two-carbon fragments, in the form of acetyl-CoA, commencing at the
carboxyl terminal of the fatty acid. One P-oxidation cycle yields 5 molecules of
adenosine-fr/5-phosphate (ATP) from reduced electron carriers. The subsequent
oxidation of acetyl-CoA in the citric acid cycle yields a further 12 ATP.
The oxidation of unsaturated fatty acids necessitates the conversion of
c/'s-A^-enoyl-CoA fragments to trans-A^-enoyl-CoA by enoyl-CoA isomerase. After
hydration by 2,4-dienoyl reductase, P-oxidation can proceed. These additional steps
incur a slight reduction in the overall energy yield.
For more comprehensive details of fatty acid metabolism, the reader may refer to
the excellent text ofMathews and van Holde [1990],
1.2.2 Fatty acid synthesis and the essential fatty acids
Generally speaking, endogenous fatty acid synthesis is the reverse of degradation, but
the biochemical pathways are quite different. In the cytosol, synthesis commences with
acetyl-CoA and malonyl-CoA, both of which are then conjugated to an acyl carrier
protein (ACP) to provide acetyl-ACP and malonyl-ACP. Malonyl-ACP serves as an
acetyl donor. The condensation of acetyl-ACP and malonyl-ACP produces
3-ketoacyl-ACP which is reduced and dehydrated to butyryl-ACP. Thereafter,
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successive molecules of malonyl-ACP are used to lengthen the acyl chain, arriving
primarily at 16:0.
To obtain a variety of chain lengths and degrees of unsaturation, elongation and
desaturation must take place. In elongation, acyl-CoA receives an acetyl group from
malonyl-CoA (not malonyl-ACP) to form 3-ketoacyl-CoA, which is subsequently
reduced and dehydrated to a saturated acyl-CoA, two carbons longer than the original.
Desaturation requires microsomal enzyme systems; the fatty acyl-CoA desaturases.
Mammalian cells contain A^, A^, A^ and A9 desaturases but are unable to introduce
double bonds beyond carbon 9 in the fatty acid chain. Consequently, mammals cannot
synthesise either 18:2 cis-A9,A*2 (18:2, n-6 - linoleic acid) or 18:3 cA-A9,A^A^
(18:3, n-3 - linolenic acid). These are termed essential fatty acids because they must be
provided by the diet. Following ingestion, these essential fatty acids themselves
become substrates. One pathway ofparticular importance merits description.
By means of A^ desaturation,
, 18:2 c/s-A9,Al2
elongation and A-5 desaturation
"0 desaturation
(right), dietary 18:2, n-6 is used to
18:3 cis-A6,A9,Al2
derive 20:4, n-6. This fatty acid
-0- elongation
species is then preferentially
20:3 c/S-A8,AH,A14
incorporated to the sn-2 position in
-0- desaturation
cell membrane phospholipids, PC and
20:4 cz'S-A5,A8,AH,A14
PE for example, from where it can be
hydrolysed by phospholipase A2 to act as the precursor for series 2 prostanoid
synthesis.
At one time it was believed that the essential fatty acids were solely required to
generate substrate for prostanoid synthesis. However, incorporation of unsaturated
fatty acids into membrane phospholipids also causes greater separation of sn-1 and
sn-2 chains in the cell membrane lipid bilayer, rendering it more fluid. Consistent with a
direct membrane effect, essential fatty acid deficiency in the rat has been shown to
decrease myocardial adenylate cyclase activity [Alam et al., 1987] and increase
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erythrocyte Na+/K+ ATPase and Ca^+/Mg^+ ATPase activity [Holmes et al., 1983],
Further, as reviewed by Brenner [1984], there is evidence of negative feedback
between the degree of membrane phospholipid unsaturation and and desaturase
activity, suggesting a homeostatic mechanism. The role of fatty acids and
phospholipids in the cell membrane is discussed further in the following section.
1.2.3 Fatty acids and phospholipids in cell membranes
Cell membranes consist of a phospholipid bilayer, approximately 7 nm deep, in which
membrane proteins and cholesterol are embedded. The bilayer exists because
phospholipids have a polar, hydrophilic head group and apolar, hydrophobic fatty acyl
side-chains. A glycerol backbone carries the acyl side-chains at the sn-1 and sn-2
positions and the polar head group at the sn-3 position. The specific nature of the head
group distinguishes individual phospholipids (Table 1.1).
Table 1.1 Basic structure, head-groups and nomenclature ofmembrane phospholipids.













Rl and R^ denote acyl side chains
Cell membranes are asymmetrical in their phospholipid distribution. In rat liver tissue,
for example, PC tends to occupy the outer leaflet of the bilayer whereas PE, PI and PS
are more likely to lie in the inner leaflet. This is clearly not a state of equilibrium, as
these different components are unequally distributed, and emphasises the dynamic
nature of the cell membrane. Current concepts in membrane structure and biochemistry
are reviewed in detail elsewhere [Katz, 1992, Hazen and Gross, 1992],
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The acyl side chains vary. Commonly, 18:0 or 18:1, n-9 is found at the sn-\
position, and 18:2, n-6, or a longer more unsaturated fatty acid species such as 20:4,
n-6, at the sn-2 position. The orientation of the sn-2 chain is such that the first -CH2
group lies parallel to the membrane while the distal chain is perpendicular. It is possible
that this arrangement facilitates enzymatic cleavage. The acyl chains at the sw-1 and sn-
2 positions may be cleaved by phospholipase Aj and A2 respectively. From the sn-2
position, substrate for prostanoid synthesis may be released, as mentioned above, but
this is also the means of exchanging one fatty acid species for another.
The influence of dietary PUFA, and of certain other factors such as
catecholamines, on phospholipid fatty acid composition has attracted considerable
interest because of the links between diet and coronary heart disease, and between cell
membrane fatty acid composition and physical properties. Section 1.2.4 discusses this
topic.
1.2.4 Dietary PUFA, phospholipid fatty acid composition, and catecholamines
Many of the studies in this area have been performed in the rat and there are several
observations germane to this thesis.
Data based on the analysis of tissue total phospholipid fatty acid composition may
be misleading, as they can obscure important changes, or lack of change, in
fractionated phospholipid fatty acid composition [Egwin and Kummerow, 1972,
Chapkin and Carmichael, 1990], This is particularly true for the less abundant
phospholipid fractions, PI and PS. Diet does not appear to affect the distribution of
individual phospholipid fractions within total phospholipid [Swanson and Kinsella,
1986, Benediktsdottir and Gudbjarnason, 1988a] or the phospholipid P/S ratio, which
is relatively fixed [McMurchie et al., 1983, Sargent, 1990], Diet instead alters the
phospholipid PUFA balance and there are interactions between PUFA of the n-3 and
n-6 series. At the level of desaturase, the rate limiting step in fatty acid
elongation/desaturation, 18:3, n-3 competes advantageously with 18:2, n-6 [Egwin and
Kummerow, 1972, Roshanai and Sanders, 1985], Also, n-3 series PUFA in general
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compete with 20:4, n-6 for esterification at the sn-2 position [Iritani and Fujikawa,
1982, Montfoort etal., 1986],
Although 22:6, n-3 is the predominant n-3 PUFA in cardiac and skeletal muscle
[Sprecher, 1989, Stubbs and Kisielewski, 1990], it is suggested that these tissues do
not synthesis 22:6, n-3 but obtain it from an extracellular source, such as the liver. In
cultured myocyte studies, 22:6, n-3 is avidly incorporated but levels are not increased
by 20:5, n-3, which can be elongated to 22:5, n-3 but not subsequently (A^)
desaturated [Meij etal., 1990, Mohammed etal., 1990],
Significant changes in phospholipid fatty acid composition can occur rapidly with
diet. In rats fed fish oil, serum total phospholipid 20:4, n-6 was decreased 23% after 48
hours [Croft et al., 1985], The fatty acid composition of rat cardiac mitochondria
changed in 11 days, and was reversible in the same period, in a soya bean oil/rapeseed
oil crossover study [Innis and Clandinin, 1981], In another study, rat subcellular
membranes did not alter further in fatty acid composition beyond three weeks of
feeding [Tahinef al., 1981],
Interesting effects of catecholamines on phospholipid fatty acid composition have
been described. Chronic treatment of rats with increasing doses of noradrenaline (1-5
mg.kg-1 subcutaneously for 2 weeks) brought about reversible decreases in 18:2, n-6
and 20:4, n-6, and increases in 22:6, n-3, in cardiac PC and PE [Emilsson and
Gudbjarnason, 1983, Montfoort et al., 1986], Similar findings with adrenaline
occurred regardless of diet (saturated fat, n-6 PUFA or n-3 PUFA) [Benediktsdottir
and Gudbjarnason, 19886], In cultured cardiomyocytes, the fatty acid composition of
PI was not affected by exposure of the cells to phenylephrine, but effects on PC and
PE were confirmed [Meij et al., 1990],
1.2.5 Specialised roles of fatty acids: the eicosanoids
The term "eicosanoid" encompasses the prostanoids and leukotrienes. These autacoid
families are synthesised from the 20-carbon fatty acids 20:3, n-6, 20:4, n-6 and 20:5,
n-3, giving rise respectively to the 1, 2 and 3 series of prostanoids. All three potential
substrates must be derived from the essential fatty acids 18:2, n-6 and 18:3, n-3 or
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consumed in the diet. Biosynthesis of the prostanoids and leukotrienes is dependent
upon the hydrolysis by phospholipase A2 of fatty acid substrate from the sn-2 position
of membrane phospholipids, referred to in section 1.2.2. In man, 20:4, n-6
predominates but 20:5, n-3 may be important in relation to n-3 PUFA consumption.
The prostanoids, including prostacyclin (PGI) and thromboxane (TXA), contain
ring structures and are derived following the actions of cyclooxygenase on the
20-carbon substrate. Taking the example of 20:4, n-6, the unesterified fatty acid
precursor is oxygenated and cyclized to form the unstable cyclic endoperoxide
products PGG2 and PGH2 (ty2 5 minutes at 37°C, pH 7.5). Isomerisation of PGH2
produces PGD2, PGE2 and PGF2a. PGH2 is also metabolised to two biologically very
active compounds, PGI2 and TXA2. PGI2, a powerful vasodilator, is characteristically
formed in vascular tissue by prostacyclin synthetase, has a ty2 of 3 minutes (at 37°C,
pH 7.5) and is hydrolysed to a stable product, 6-oxo-PGFia. TXA2, a vasoconstrictor
and aggregating agent, is typically formed in platelets by thromboxane synthetase, has
a very short ty2 of 30 seconds (at 37°C, pH 7.5) and degrades to the stable TXB2. The
metabolism and functions of prostanoids are reviewed in detail by Moncada and Vane
[1979],
Two hydroxylated straight-chain fatty acid products, 12-hydroperoxy-
eicosatetraenoic acid (HPETE) and 12-hydroxyeicosatetraenoic acid (HETE), result
from the actions of 12-lipoxygenase on 20:4, n-6. The epoxide derivative ofHPETE is
leukotriene A4 (LTA4), from which LTB4 and a glutathionyl derivative LTC4 are
derived. Removal of y-glutamic acid from LTC4 produces LTD4 and it is now
accepted that a combination of these two leukotrienes is the mediator originally termed
"slow reacting substance of anaphylaxis". The leukotrienes, which are not of direct
relevance to this thesis, are discussed in greater detail in the review ofPiper [1983],
PGI2 accounts for approximately 70% of prostanoid release from buffer-perfused
rat hearts [de Deckere et al., 1977], PGE2 contributes about 15%, PGD2 and
PGF2a less than 10%. A small amount of TXA2 is released from perfused hearts,
perhaps from adherent platelets. In blood vessels, PGI2 is released in amounts
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approximately 5- and 10-fold greater than PGF2a and PGE2, respectively [Moncada
and Vane, 1979, Pipili and Poyser, 1981],
1.2.6 Specialised roles of phospholipids: cell signalling
A variety of hormones and transmitters, including a \ -adrenoceptor agonists, evoke a
rise in cytosolic Ca^+ levels. It is now widely accepted that PI is an important link in
receptor-mediated mobilisation of intracellular Ca^+ stores [Michell, 1975], PI is
unusual in that it exists in two more phosphorylated forms. These are
phosphatidylinositol-4-monophosphate and phosphatidylinositol-4,5-Z)A-phosphate;
PIP and PIP2 respectively. PIP and PIP2 constitute less than 2% of total cell inositol
phospholipid but this proportion may be 10-fold higher in cell membranes [Augert et
al., 1989], Stimulation of the oq-adrenoceptor, for example, activates membrane-
bound phospholipase C which hydrolyses PIP2 to release inositol-1,4,5-/rA-phosphate
(IP3) and diacylglycerol (DAG) [Berridge, 1983], IP3 functions as a cytosolic second
messenger for the release of intracellular Ca^+ [Berridge and Irvine, 1984] and DAG
operates within the plane of the cell membrane to activate protein kinase C [Nishizuka,
1984],
Recognition of the pivotal role of inositol phospholipids in cell signalling has
encouraged other lines of investigation. Recent reports suggest that the more abundant
phospholipid PC may be another source of second messengers. In response to diverse
agonists, phospholipase C can release DAG from PC [Exton, 1990], It is also possible
that phosphatidic acid, derived from PC by the actions of phospholipase D, may be an
alternative second messenger involved in sustained Ca^+ release [Ohanian et al.,
1990],
The following sections relate to a\ -adrenoceptors in blood vessels and the heart
and the exciting topic of phospholipid-dependent signal transduction will be further
discussed.
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1.3 The oq-adrenoceptor in the cardiovascular system
§
1.3.1 History and classification of a-adrenoceptors
Establishing the principle that receptors should be characterised by their capacity to
recognise and respond to certain agents, rather than according to their site and the
tissue response elicited, Ahlquist [1948] proposed that adrenoceptors be divided into
two separate categories; a and p. In a similar way, the different susceptibilities of
a-adrenoceptor populations in the cat spleen to phenoxybenzamine led to the concept
of post-junctional a j-adrenoceptors mediating contraction, and pre-junctional oq-
adrenoceptors exerting negative feedback on neuronal noradrenaline release [Langer,
1974], However, it has since become clear that the ot2-adrenoceptor exists beyond the
confines of the sympathetic neuromuscular junction, at post-junctional sites where it
activates smooth muscle cell contraction [Drew and Whiting, 1982, Gardiner and
Peters, 1982, McGrath, 1982], Indeed, the oq-adrenoceptor may be more important
than the a j-adrenoceptor in vasoconstriction at the level of the pre-capillary arteriole
[Faber, 1988], There is also evidence to suggest a pre-junctional, negative feedback
regulatory role for the a\-adrenoceptor [Kobinger and Pichler, 1982, Docherty, 1983,
Story et al., 1985], Thus, we have pre- and post-junctional a\-adrenoceptors, and pre-
and post-junctional oq-adrenoceptors.
The cq- and a,2-adrenoceptors are further distinguished by their signal
transduction mechanisms. Generally, signalling for the a j-adrenoceptor involves the
breakdown of inositol phospholipids, mentioned above (section 1.2.6) and discussed
further below, whereas a.2-adrenoceptor activation inhibits adenylate cyclase and
decreases intracellular cyclic AMP levels [Fain and Garcia-Sainz, 1980],
On the basis of heterogeneous affinity for imidazolines and phenylethylamines, the
uniform aj -adrenoceptor classification has been questioned. It is proposed that
oqa-receptors; activated by imidazolines and low concentrations of phenylethylamines
and often sensitive to Ca^+ antagonists, operate by opening Ca^+ channels. In
contrast, a^-receptors; activated by high concentrations of phenylethylamines,
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provoke the inositol phospholipid-dependent release of intracellular Ca^+ stores. The
topic of a i -adrenoceptor sub-classification, still a source of debate, is thoroughly
reviewed by Minneman [1988], An alternative explanation, in view ofmany exceptions
to the oiia/aib definitions, is that a \ -adrenoceptors share a common recognition site
but have diverse agonist affinities [Bevan et al., 1988] or perhaps signalling
mechanisms [McGrath and Wilson, 1988],
1.3.2 aj-adrenergic signal transmission
The a i-adrenoceptor is an integral membrane protein, or glycoprotein, comprising a
single polypeptide chain of approximately 80 kDaltons [Leeb-Lundberg et al., 1984],
The receptor is coupled to a toxin-insensitive G protein (GTP-binding protein) which
may be Gq, a 42 kDalton protein [Pappano et al., 1988, Pang and Sternweis, 1990], G
proteins are heterotrimers, consisting of a, (3 and y subunits. Following agonist-
receptor binding, GTP is exchanged for the GDP attached to the inactive a subunit and
the p/y subunits together dissociate from the G protein complex. The now active a
subunit in turn activates membrane-bound phospholipase C. During deactivation of the
G protein, the intrinsic GTPase activity of the a subunit restores a-GTP to a-GDP
which reassociates with the p/y subunits. Current concepts of G proteins have been
reviewed recently [Holmer and Homey, 1991, Fleming et al., 1992],
Phospholipase C releases IP3 and DAG from PIP2 as described above (section
1.2.6) and PIP2 hydrolysis in relation to oq-adrenoceptor stimulation has been
demonstrated in the rat aorta and heart [Jenkin et al., 1991, Otani et al., 1988], IP3
mobilises intracellular Ca^+ [Berridge and Irvine, 1984] which can exert small direct
positive inotropic effects in the myocardium [Otani et al., 1988], and influence trans¬
membrane ion flux such as Na+/Ca^+ exchange [Gilbert et al., 1991], IP3 can be
phosphorylated to inositol-1,3,4,5-tetrakis-phosphate, another putative intracellular
second messenger. Inositol is regenerated for fresh PI synthesis by a series of
phosphatases. Two of these phosphatases are inhibited by Li+, inositol
polyphosphate-1-phosphatase and inositol monophosphatase. The phosphoinositide
cycle has been succinctly summarised by Nahorski et al. [1991],
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The role ofDAG is twofold; it is an activator of protein kinase C and, through the
actions of phospholipase A2, a source of 20:4, n-6 [Berridge, 1984, Nishizuka, 1986],
It is possible that unsaturated fatty acids, such as 20:4, n-6, can also activate protein
kinase C [McPhail et al., 1984, Murakami and Routtenberg, 1985]. Protein kinase C is
a phospholipid- (PS) dependent enzyme [Nishizuka, 1983, Nishizuka, 1984] which is
thought to travel in a Ca^+-dependent manner from the cytosol to the cell membrane
at the time of activation [Khalil and Morgan, 1991]. Once activated, protein kinase C
is involved in the phosphorylation of regulatory proteins, likely to be a mechanism in
a1-adrenergic effects on the slow inward Ca^+ current [Lindemann, 1986], on
Na+/H+ exchange [Otani et al., 1990] and cardiac contractility [Talosi and Kranias,
1992], Protein kinase C may also render the a \ -adrenoceptor inactive by
phosphorylation, thus exerting a negative feedback effect [Lefkowitz and Caron,
1986],
1.3.3 Aspects of vascular ai-adrenoceptor function
Co-transmission and synergism in oq-adrenergic effects continue to attract a great deal
of interest, partly because of therapeutic implications. Work with rat and guinea-pig
vas deferens preparations first suggested that neuronal noradrenaline release might be
associated with the release of another transmitter [Blakely et al., 1981] This putative
second transmitter was identified as ATP, which occupies a specific purinergic
receptor (P2x) on the smooth muscle cell and elicits excitatory junction potentials
[Sneddon and Burnstock, 1984], ATP co-transmission was subsequently demonstrated
in the isolated rabbit saphenous artery [Burnstock and Warland, 1987], As a
consequence of the ATP-induced excitatory potentials, dihydropyridine-sensitive slow
Ca^+ channels are activated, explaining the finding of Blakely et al. [1981] that a
component of the vas deferens response was sensitive to nifedipine. This effect of
dihydropyridines has also been shown for a \ -adrenoceptor responses to exogenous
noradrenaline [Dunn et al., 1991c].
The synergistic relationship of angiotensin II with adrenergic responses was
uncovered by the effects of captopril, an angiotensin converting enzyme (ACE)
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inhibitor, which reduced responses to sympathetic nerve stimulation and to
a i-adrenoceptor agonists in pithed rats [Hatton and Clough, 1982, Richer et al.,
1984], The effect was abolished by prior nephrectomy. The relationship between
angiotensin II and sympathetically mediated haemodynamic responses in the pithed rat
was further investigated by Kaufmann and Vollmer [1985], These authors
distinguished the actions of angiotensin II on peripheral vascular resistance in the
context of endogenous and exogenous sympathetic stimulation from those in
unstimulated preparations, where angiotensin II appears to support BP by maintaining
cardiac output, probably through a reduction in venous capacitance. Recent evidence
suggests that the facilitatory effects of angiotensin II, whether in relation to
sympathetic nerve stimulation or the application of exogenous agonist, may be
relatively selective for the ct2- rather than the a\-adrenoceptor [Dunn et al., 1991a,
Dunn etal., 19916],
The existence of post-junctional ot2-adrenoceptors capable of causing
vasoconstriction has provoked much research into the roles of oq- and 012-
adrenoceptors in vasoregulation. The greater effects of prazosin on pressor responses
to nerve stimulation, as opposed to exogenous noradrenaline, gave rise to the concept
that a1-adrenoceptors were innervated, whereas ot2-adrenoceptors were not [Langer
etal., 1980, Docherty and McGrath, 1980, Langer et al., 1981], In pithed rats injected
with DMPP (l,l-dimethyl-4-phenylpiperazine), which releases catecholamines from
sympathetic neurones and the adrenal medulla, bilateral adrenalectomy abolished
pressor responses mediated by the 012-adrenoceptor [Wilffert et al., 1982], The
authors concluded that circulating adrenaline, rather than neuronal noradrenaline, was
the normal source of ot2-adrenoceptor stimulation. However, against these findings,
ot2-adrenoceptor antagonists augmented the effect of prazosin on pressor responses to
nerve stimulation in perfused hind limb preparations [Madjar et al., 1980, Gardiner and
Peters, 1982, Eisner et al, 1984, Hamed et al, 1986], Interestingly, reflex vascular
responses to exercise and cold were preserved in men given sufficient prazosin to
lower BP [Mancia et al., 1980], suggesting that 012-adrenoceptors have some function
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in sympathetic autoregulation. The relative contribution of oq- and a2-adrenoceptors
to resting vascular tone is more difficult to ascertain. Although the effects of
a J-adrenoceptor antagonists are readily interpreted, those of a2-adrenoceptor
antagonists are usually complicated by their pre-synaptic actions. Nevertheless, the
(^-adrenoceptor antagonist yohimbine has been reported to cause a dose-dependent
increase in resting forearm blood flow in normal volunteers [van Brummelen et al.,
1983],
In attempts to establish the physiological roles of oq- and ot2-adrenoceptors, it has
been proposed that their distribution is heterogeneous. In canine coronary arteries, the
proximal (conduit) vessels and distal (resistance) vessels appeared to be subserved
respectively by oq- and ot2-adrenoceptors [Heusch et al, 1984] with the dominant
effect on coronary vasoconstriction being mediated by a2-adrenoceptors [Da Huang
Chen et al., 1988], However, others have found that oq- and o(2-adrenoceptors exert
equivalent effects in the coronary vascular bed [Woodman and Vatner, 1987,
Miyamoto et al., 1991], In skeletal muscle, adrenergic effects on large arterioles and
venules were mediated by cq- and a2-adrenoceptors, but a2-adrenoceptors were
more important in pre-capillary arterioles [Faber, 1988], Experimental conditions are
important in these studies as environmental effects on a-adrenoceptors must be
considered. McGrath et al. [1982] demonstrated in the pithed rat that alkalosis favours
a i -adrenoceptor activation and acidosis, a2-adrenoceptor activation. Consistent with
this observation, sympathetic vasoconstriction distal to a severe coronary stenosis was
dependent on a2~adrenoceptors [Heusch and Deussen, 1983] and coronary
hypoperfusion was necessary to demonstrate an effect of the (^-adrenoceptor agonist
BHT-933 on vessels less than 100 pm in diameter [Chilian, 1991], In contrast, low
flow and metabolic acidosis diminished constrictor responses to (^-adrenoceptor
stimulation in rat arterioles [McGillivray-Anderson and Faber, 1991, Anderson and
Faber, 1991], The influence of altered regional flow and acid-base balance on
a-adrenoceptor function remains incompletely understood.
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Other factors may affect the a-adrenoceptor. Cooling suppresses oq-adrenoceptor
responses and enhances a2-adrenoceptor responses [Freedman et al., 1992], similar
effects to age [Nielsen et al., 1992], Oestrogens are associated with greater
a-adrenoceptor affinity for noradrenaline and adrenaline [Colucci et al., 1982], In
dogs, pacing-induced heart failure was found to enhance peripheral vascular
a\-adrenoceptor responses [Forster and Armstrong, 1992], Curiously, in this last
study, there was no investigation of the likely contribution of elevated renin and
angiotensin levels to the observed effects.
Effects of a J-adrenoceptor stimulation in vivo are readily demonstrated in vitro.
This is not so for the a2-adrenoceptor. The difficulty in eliciting responses to selective
a2~adrenoceptor agonists in isolated vessels has led authors to conclude that various
arterial and venous preparations are devoid of functional a2-adrenoceptors [Langer
and Hicks, 1984, Nielsen et al., 1991], These conclusions may be erroneous. Dunn et
al. [1991c] (referred to above) have elegantly demonstrated that a2-adrenoceptor
responses can be revealed by, and may indeed be dependent upon, a degree of vascular
smooth muscle stimulation conferred by angiotensin II or a \ -adrenoceptor activation.
1.3.4 Aspects of cardiac aj-adrenoceptor function
Controversy regarding the cardiac a-adrenoceptor has been sufficient to provoke the
question, "Are there a-adrenoceptors in the mammalian heart?" [Schumann, 1980], In
fact , inotropic actions of phenylephrine (an a j-adrenoceptor agonist), which were
abolished by phentolamine (an a-adrenoceptor antagonist), were demonstrated in rat
ventricular strips nearly thirty years ago [Wenzel and Su, 1966], It has since been
shown that responses of the rat heart to the physiological agonists noradrenaline and
adrenaline are readily unmasked by P-adrenoceptor blockade [Ask and Stene-Larsen,
1984], There are important species differences in cardiac a j -adrenoceptor density
[Steinfath et al, 1992] in that the rat has a density 5 to 8-fold greater than the guinea-
pig, rabbit or man, for example. Although the presence and function of
a2-adrenoceptors is easily shown in the coronary arteries (see previous section), this
adrenoceptor subtype seems to be almost non-existent in the myocardium [Williams et
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al., 1981], The physiological role of myocardial a\-adrenoceptors remains uncertain
but their function in pathophysiological circumstances, such as myocardial ischaemia
and heart failure, has attracted considerable attention. Broadly speaking, research
efforts have followed three directions; first, the behaviour of the a j-adrenoceptor
during and after myocardial ischaemia, second, a\ -adrenoceptor effects on cardiac
contractility and, third, the effects of a j-adrenoceptor stimulation and blockade on
cardiac dysrhythmogenesis.
Approximately 30 minutes following coronary artery ligation in vivo, an increase in
cardiac a \ -adrenoceptor density, assessed by radio-ligand binding, has been observed
in the dog [Mukheijee et al., 1980], the cat [Corr et al., 1981], the guinea-pig [Maisel
et al., 1986] and the rat [Allely and Brown, 1988], It has been suggested that, in the
rat, this is a reflex phenomenon dependent upon intact autonomic innervation [Dillon
et al., 1988], However, an increase in a\-adrenoceptor density has also been shown in
isolated rat cardiomyocytes subjected to temporary hypoxia [Matsuo et al., 1986],
Evidence from isolated canine cardiomyocytes and rat hearts in vivo suggests that the
ischaemia-induced increase in oq-adrenoceptor density may be dependent upon long-
chain acyl carnitines [Heathers et al., 1987, Allely and Brown, 1988], Regional
ischaemia has also been associated with enhanced chronotropic responses to the
ai-agonist methoxamine [Sheridan etal., 1980],
As a consequence of downregulation, the Pj-adrenoceptor reserve declines in heart
failure [Brown et al., 1992] and cardiac responses to pj-adrenoceptor stimulation may
be further impaired by Gs protein dysfunction [Longabaugh et al., 1988, Kessler et al.,
1989, Feldman et al., 1990], The oq-adrenoceptor does not appear to be similarly
affected. In the cardiomyocytes of genetically cardiomyopathy hamsters [Sen et al.,
1990], and in ventricular tissue from patients suffering severe heart failure (NYHA
Grade IV) due to idiopathic dilated cardiomyopathy [Bohm etal., 1988], the density of
a i -adrenoceptors, reflected by ^H-prazosin binding sites, was preserved and responses
to a J-adrenoceptor stimulation maintained or enhanced. There were similar findings
with respect to adrenoceptor density in relation to supraphysiological pacing-induced
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failure in healthy dogs, but responses to both oq- and (3 \-adrenoceptor stimulation
decreased [Calderone et al., 1991], Diabetic cardiomyopathy induced by
streptozotocin in rats was associated with a decrease in both ^H-dihydroergocriptine
and -^H-dihydroalprenolol binding sites [Heyliger et al., 1982], but inotropic responses
to methoxamine in the presence of practolol were found increased in lambs with
alloxan-induced diabetes mellitus [Downing et al., 1983],
Although there is considerable interest in the apparent susceptibility of the
adrenoceptors, particularly the P-adrenoceptor, to these diverse pathophysiological
states, the important effects of increased circulating catecholamines, associated with
adrenoceptor down-regulation, should not be overlooked. The elevated levels of
noradrenaline and adrenaline found in heart failure would also be expected in relation
to myocardial ischaemia in vivo and experimental diabetes. Further, it is possible that
enhanced a i-adrenoceptor reponsiveness reflects a synergistic effect of angiotensin II
(referred to in section 1.3.3), levels of which are likely to be increased in the above
conditions.
The maintenance of myocardial a \ -adrenoceptor function, in circumstances
adversely affecting the Pi -adrenoceptor, suggests that the a i-adrenoceptor is part of a
reserve mechanism when Pi-adrenoceptor function is perturbed. Aside from beneficial
effects on contractility, ai-adrenoceptor stimulation may confer metabolic advantages.
It was proposed recently that the protective effect of a i-adrenoceptor stimulation in
the context of myocardial stunning was in part due to the increased release and
availability of adenosine [Kitazake et al., 1991], Unfortunately, peripheral and
pulmonary arterial and venous effects of a i-adrenoceptor stimulation tend to have
adverse effects on cardiac preload and afterload [Leier et al., 1990],
The positive inotropic effects of oq- and Pi-adrenoceptor stimulation differ. In
isolated papillary muscles, selective a i-adrenoceptor stimulation lengthens the action
potential, thus increasing and delaying peak tension, and prolonging the duration of
contraction [Dukes and Vaughan Williams, 1984, Bruckner et al., 1984], This is quite
distinct from the characteristic Pi-adrenoceptor effects of accelerating both the
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development and relaxation of tension. As a corollary, a \ -adrenoceptor stimulation
has been shown to have minimal effects on LVdP.dt"! in the perfused heart [Aoyagi et
ah, 1991], Indeed, the effects on LVdP.dt'l in this study may be partly explained by
residual Pi-adrenoceptor stimulation; up to 10 pM phenylephrine was used in the
presence of 1 pM propranolol. It is curious that studies in different species have
nevertheless used LVdP.dt"^^ as the preferred end-point of oq-adrenoceptor
stimulation [Downing et al., 1983, Reibel et al., 1988],
It was quickly appreciated that the effect of a j -adrenoceptor stimulation was
independent of cyclic AMP (adenosine-3',5'-monophosphate) [Osnes et al., 1973,
Osnes, 1976, Scholz, 1980], and unaffected or enhanced by adenosine [Endoh and
Yamashito, 1980] and acetylcholine [Inui et al., 1982], both of which diminish cyclic
AMP-mediated effects. Recognition of the roles of IP3 and DAG in cell signalling
(discussed above) was followed by the demonstration of PIP2 hydrolysis following
a1-adrenoceptor stimulation in cardiomyocytes [Brown et al., 1985], Others have
since reported that IP3 is responsible for the initial phases of the inotropic response,
and DAG-activated protein kinase C for the sustained response [Otani et al., 1988,
Otani et al., 1990], Indeed, although IP3 generation (measured by LP] accumulation)
approximately parallelled the inotropic response to epinephrine in the presence of P-
adrenoceptor blockade in the rat, this was not so in the rabbit, suggesting that this
product of PIP2 hydrolysis does not account for all the effects of a j -adrenoceptor
stimulation [Endoh et al., 1991], Recent studies using inhibitors ofNa+/H+ exchange,
such as hexamethylamiloride, demonstrate that these agents can partly abolish the
inotropic effects of oq-adrenoceptor stimulation [Otani et ah, 1990, Terzic and Vogel,
1991], Activation of Na+/H+ exchange, possibly by protein kinase C, raises
intracellular pH which facilitates myofibrillar Ca^+ binding [Blanchard and Solaro,
1984]; presumably the explanation for the finding ofEndoh and Blinks [1988] that oq-
adrenoceptor stimulation was linked to changes in myofibrillar Ca^+ responsiveness.
Another putative mechanism in the positive inotropic effects of a 1 -adrenoceptor
stimulation has been highlighted by Fedida and Bouchard [1992], They showed that in
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rat cardiomyocytes, the inward Ca^+ current was sustained, but not increased, by
prolongation of the action potential in association with a \ -adrenoceptor stimulation.
The prolongation of the action potential was demonstrated to be due to a decrease in
outward K+ current, an effect previously attributed to the oq-adrenoceptor [Apkon
and Nerbonne, 1988, Ravens et al., 1989, Fedida et al., 1990], Detailed
electrophysiological studies such as these are necessary to unravel the complex cellular
effects ofa \ -adrenoceptor stimulation.
In addition to the effects of the a \ -adrenoceptor on cardiac contractility are effects
on cardiac rhythm and dysrhythmogenesis. The chronotropic actions of oq-
adrenoceptor stimulation are complex and remain a source of confusion. In isolated
human and rat atria, a negative chronotropic effect was associated with, respectively,
delayed phase IV depolarization and delayed repolarization [Mary-Rabine et al., 1978,
Dukes and Vaughan Williams, 1984], Conversely, studies in the pithed rat revealed a
positive chronotropic effect of both exogenous and endogenous catecholamines
[Flavahan and McGrath, 1981], In a subsequent study, these authors uncovered
biphasic effects ofoq-adrenoceptor stimulation on heart rate in the same preparation; a
transient negative chronotropic effect was detected within the overall positive
chronotropic effect. The negative chronotropic effect was removed by atropine and
hexamethonium, and enhanced by neostigmine, indicating that a positive feedback
effect on parasympathetic nerves at a pre-ganglionic level had taken place. It has also
been claimed that a \ -adrenoceptor stimulation exerts a negative feedback effect on
parasympathetic outflow; phenylephrine antagonised the bradycardic effects of vagal
stimulation in rats [McGrattan et al., 1987], However, the latter study did not exclude
the likely effects of this particular agonist on post-junctional oq- and Pj-
adrenoceptors. There is evidence that the incidence of ventricular dysrhythmia
precipitated by myocardial ischaemia may be reduced by oq-adrenoceptor antagonists,
and increased by a i -adrenoceptor agonists. Prazosin was protective against
reperfiision ventricular fibrillation induced by regional ischaemia in cats and rats
[Sheridan et al., 1980, Thandroyen et al., 1983], Also, prazosin reduced the incidence
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ofventricular fibrillation in response to post-infarction ischaemia in dogs [Wilber et al.,
1987], In the study of Sheridan et al. [1980], a secondary finding was that the adverse
effects of left stellate ganglion stimulation during reperfusion could be inhibited by
phentolamine, and partly reproduced by intracoronary methoxamine. Following
chemical denervation with 6-hydroxydopamine, methoxamine increased the incidence
of ischaemic and reperfusion ventricular tachycardia and fibrillation in perfused guinea-
pig hearts [Culling et al., 1987], Difficult to dissect from the results in studies of this
nature is whether the favourable effect of oq-adrenoceptor antagonism is due to an
electrophysiological effect or to a beneficial redistribution of coronary flow. Although
caesium-induced afterdepolarizations and ventricular dysrhythmias were aggravated by
phenylephrine (in the presence of propranolol) and alleviated by prazosin in dogs
[Ben-David and Zipes, 1990], another recent study found both pro- and anti¬
arrhythmic effects of a i-adrenoceptor stimulation on oscillatory afterpotentials and
triggered automaticity in isolated rabbit Purkinje tissue, depending on the means of
induction (strophanthin or high [Ca^+]0) [Han and Ferrier, 1990], Thus, pure
electrophysiological studies are equally difficult to interpret. It has been suggested that
contrasting effects of traditional oq-adrenoceptor agonists on dysrhythmogenesis
might be explained by the presence in conducting tissue of oqa- and a^-
adrenoceptors, respectively increasing and decreasing automaticity [del Balzo et al.,
1990, Molina-Viamonte et al., 1991] but it is probably unwise to assume that this
subclassification is widely applicable, as was alluded to above (section 1.3.1). For a
helpful overview of the general role of a-adrenoceptors in arrhythmogenesis, the
reader may refer to McGrath [1989],
The final sections of this Introduction deal with established and proposed links
between PUFA and adrenergic events.
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1.4 Interactions: PUFA and adrenergic mechanisms
§
Several of the reports cited in previous sections either reveal or imply effects ofPUFA
on adrenergic mechanisms. These are briefly highlighted together with other relevant
literature.
1.4.1 Dietary PUFA and adrenoceptor responses
Studies performed in isolated rat aortic tissue have consistently shown that dietary n-3
PUFA are associated with attenuated responses to exogenous noradrenaline [Lockette
et al., 1982, Yin et al., 1991, Malis et al., 1991], In the isolated rat heart also,
inotropic responses to selective a \ -adrenoceptor stimulation were reduced by n-3
PUFA [Reibel et al., 1988], These results imply an effect of n-3 PUFA on the
a i-adrenoceptor or on the intracellular events which follow a \ -adrenoceptor
stimulation. In contrast to these data, the effects of dietary PUFA, commonly n-6
PUFA, on the responses of cardiac tissue to 3 \ -adrenoceptor stimulation vary widely.
Enhancement [Hoffman et al., 1982, Charnock et al., 1987], attenuation [Wince and
Rutledge, 1981, Wince et al., 1987] and a lack of effect [Reibel et al, 1988] of diet on
P \-adrenoceptor responses have all been demonstrated. These inconsistencies raise the
possibility that dietary effects on adrenoceptors may be relatively selective for the cq-
adrenoceptor.
Noticeable in the above studies is the lack of information regarding the effects of
the various experimental diets on tissue fatty acid composition; only Lockette et al.
[1982] and Reibel et al. [1988] provide such data and it is limited to total phospholipid
fatty acid composition.
1.4.2 Dietary PUFA and the regulation of noradrenaline release
There is much evidence for the role of certain prostanoids in the control of neuronal
noradrenaline release. PGE2 appears to exert a negative feedback effect while PGF2a
may do the opposite [Hedqvist, 1977], The ability of dietary n-3 PUFA to alter the
balance of dienoic and trienoic prostanoids may thus have consequences for
sympathetic regulation. PGI2, the principal prostanoid released by vascular and cardiac
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tissues, does not appear to have any pre-junctional effects [Hedqvist, 1977, Armstrong
and Thirsk, 1979].
The group of Dixon and co-workers has performed a series of investigations
examining the effect of diet on tissue noradrenaline content and release, focusing on
n-6 PUFA versus saturated fatty acids. In relation to n-6 PUFA, they repeatedly show
a decrease in noradrenaline release measured during field stimulation in isolated rat tail
[Panek et al., 1985, Semafuko et al., 1989] and heart [Semafuko et al., 1987]
preparations. The results for tissue noradrenaline content were less consistent, being
increased in the first report, unchanged in the second, and decreased in the third,
following dietary n-6 PUFA. Although the same experimental diets were administered
in each of these studies, the authors offer no data regarding the effects of these diets on
tissue fatty acid composition. Such data might aid interpretation of the variable effects
of diet on noradrenaline content. It is difficult to marry these results with those of
dietary intervention studies in animals where n-6 PUFA are generally associated with a
fall in BP (see section 1.1.3).
Pressor responses to various forms of stress in rats (see section 1.1.5) and man (see
section 1.1.4) have been blunted by both n-3 PUFA [Mills and Ward, 1986, Singer et
al., 1985, di Giacomo et al., 1989] and n-6 PUFA [Butcher et al., 1990], These
interesting findings reflect reduced sympathetic activation and are obviously consistent
with a number ofmechanisms, including neuronal and central effects.
1.4.3 Dietary PUFA, signalling and Ca^+ channels.
Dietary PUFA affect the fatty acid composition of cell membrane phospholipids,
principally by altering the nature of the fatty acid species esterified at the sn-2 position,
where n-3 and n-6 series PUFA compete (see section 1.2.4). Increased incorporation
of unsaturated fatty acids renders the cell membrane more fluid and this is thought to
influence the activity of enzymes associated with the membrane, such as protein kinase
C [Epand and Lester, 1990], Phospholipase A2 activity has been altered by PUFA in
the diet [Malis et al., 1990] and in cell culture medium [Nalbone et al., 1990],
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The conformational changes brought about by the presence of longer-chain
unsaturated fatty acid species in PI might be expected to have implications for the
generation of intracellular second messengers from PIP2 (see section 1.2.6). This has
been shown to be the case. In a variety of studies, n-3 PUFA in the diet [Medini et al.,
1990], and in cell culture media [Locher et al., 1988, Bordoni et al., 1990], have
attenuated the synthesis or release of IP3. Evidence for direct effects of n-6 PUFA on
adrenoceptors and signalling is more limited, but reductions in P-adrenoceptor density
and affinity, and adenylate cyclase activity, were found in the isolated atria of rats fed
an n-6 PUFA diet [Wince and Rutledge, 1981],
Cell membrane ion channels may also be influenced by dietary PUFA. In a series of
investigations, dietary n-6 and n-3 PUFA attenuated the responses of rat papillary
muscles to external Ca^+ [Charnock et al., 1985, McLennan et al., 1987]. However,
the same was not true of dietary n-6 PUFA in the marmoset [McLennan et al., 19876],
Unfortunately, none of these studies provides data on tissue fatty acid composition
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Throughout the project, weaned male Sprague-Dawley rats (Banting and Kingman,
The Field Station, Grimston, Hull, England) or weaned male Lew rats (Harland Olac,
Shaws Farm, Blackthorn, Bicester, Oxfordshire, England) were used. For dietary
studies, rats six weeks of age were obtained. For smaller scale experiments performed
in order to define aspects of methodology, rats were purchased by weight at
300-400 g, typical of the final weight achieved with the experimental diets. Animals
were housed, no more than four in a cage, under standard conditions of a twelve hour
light/dark cycle and ambient temperatures of 20-21° C. Routinely, cages were changed




2.2.1 Ingredients of experimental diets
Semisynthetic experimental diets were used throughout the project. These were
prepared from the basic ingredients of casein, cellulose, cornflour, edible fats and oils,
salt mixture and vitamin mixture. Diets compared in individual experiments were
designed to be isocalorific. The diet most used as a control derived 40% of total
dietary calories from fat, 37% from carbohydrate and 23% from protein. Low fat diets
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obtaining 10% of total calories from fat had the contribution from carbohydrate
increased appropriately (Appendix 1). The required balance of fatty acids was obtained
by using different edible fats and oils (beef dripping, olive oil, safflower oil and
sunflower oil) of which the fatty acid composition had been determined. Published
food tables [McCance and Widdowson, 1978] were used to estimate the amounts of
vitamin E provided by these sources. Different experimental diets were rendered
equivalent in vitamin E content (80 mg.kg~l) by the addition of J-a-tocopherol
acetate as required. The quantities of salts and vitamins appropriate to the diets were
derived from the work ofUnilever Research, Vlaardingen, The Netherlands.
2.2.2 Preparation and storage of experimental diets
Drystuffs for the diets, including the bulk salt and vitamin mixes, and complete diet
mixtures were prepared in the departmental diet kitchen using a "Robot Coupe"
commercial food mixer (capacity 2-3 kg). Dry ingredients, casein, cellulose and
cornflour, were combined as batches sufficient for 2 kg of complete diet and stored in
sealed polythene bags at room temperature. Fat mixtures (Appendix 2) were made by
combining oils with melted solid fats so as to be sufficient for several 2 kg quantities of
complete diet. Vitamin E, if required, was added to the fat mixture which was then
stored in sealed plastic tubs for less than two weeks at -10° C. Dietary salt
components (Appendix 3) were combined and mixed for 2-5 minutes in the Robot
Coupe. Thereafter, 46 g lots of salt mixture, sufficient for 2 kg of complete diet, were
dispensed into sealed plastic cups before being stored at room temperature. Fresh
vitamin mix (Appendix 4) was prepared as required and 8 g quantities were weighed
into screw-top plastic vials, kept at -10° C.
Complete diets were prepared weekly by blending together the above classes of
ingredient in the Robot Coupe. Drystuffs, salts and vitamins were combined at slow
speed and the correct volume of molten fat mix gradually poured in. The ingredients
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were then mixed at high speed for 2 minutes. Water was not added and the food was
not pelleted. To safeguard against peroxidation, diets were stored under argon in
sealed polythene containers at -10° C. Diets containing large proportions of fish oil
(Chapter 5) were assumed to be more prone to peroxidation and were therefore
prepared freshly every 48 hours. Halfwas used immediately and the remainder kept at
-10° C, under argon, in glass jars sealed with screw-on lids and clingfilm, for less than
24 hours.
2.2.3 Feeding of experimental diets
Fresh supplies of experimental control and n-6 PUFA diet were provided thrice weekly
when the animal cages were changed. When the diets containing fish oil were in use,
these were provided daily and cages were also changed daily to ensure the removal of
spilled diet at risk of peroxidation.
2.2.4 Preparation and administration of dietary supplements
Certain experiments (Chapters 3, 4, 6 and 7) required the use of small amounts of n-3
PUFA which added only 0.4% to the total dietary calories i.e. less than 0.1 ml fish oil
per day. Volumes of this order could not be mixed into a complete diet, the dilution
being too great to allow even distribution. The sole means of ensuring the
consumption of these volumes of fish oil, and of being certain that there was no
opportunity for peroxidation, was oral administration. Accordingly, rats were dosed
transoesophageally with fish oil diluted in olive oil (total volume 0.5-0.7 ml) using a
short plastic cannula (initially an Argyle® 5G Infant Feeding Catheter, later a similar
device fashioned from a 16GMedicut® Intravenous cannula and the tip of an Argyle®
6G Infant Endotracheal Suction Catheter, all Sherwood Medical, Tullamore, Eire).
The olive oil used to dilute the fish oil was not supplementary as it had been withheld
from the original olive oil content of the diet. Similarly, olive oil withheld from the fat
content of the control and n-6 PUFA diets provided control oral doses, to which fish
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oil was not added, for these other animals. The mixtures of fish oil and olive oil were
prepared in advance, placed in 20 ml universal containers under argon and kept at
-20° C for less than one week until the day of use, being allowed to thaw just prior to
administration. A fresh container was used each day and any excess was discarded.
Olive oil for control doses, at less risk of peroxidation, was simply refrigerated in
sealed containers.
2.2.5 Monitoring the effect of experimental diets: tissue fatty acid composition
To assess the consumption of the n-6 PUFA experimental diets, adipose tissue was
sampled for fatty acid analysis as part of the surgical procedures of the various
experiments. Approximately 1 g perinephric adipose tissue was placed in an
Eppendorff tube and stored at -40° C pending assay. The influence of the diets on the
fatty acid composition of total and fractionated phospholipid was assessed using
cardiac tissue. Where the experiments concerned vascular tissue (Chapters 3 and 4),
analysis of the fatty acid composition of the target tissue could not be performed due
to the amount of tissue required. Hearts were excised carefully after the
commencement of hind-quarters perfusions (Chapter 3), before isolated resistance
artery studies (Chapter 4) or retained after isolated heart perfusions (Chapters 5,6 and
7). The hearts were trimmed of atria and great vessels, opened, rinsed free of blood in
ice-cold buffer if necessary, blotted dry and placed in Nunc tubes stored at -70° C
pending assay.
2.3 Preparation of drugs
§
For all experiments, solutions of drugs were prepared freshly on the day of
administration. During a series of experiments, agents in frequent use, e.g.
noradrenaline and timolol, were first prepared as concentrated stock solutions
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(1-5 mM in 0.01 M HC1) and refrigerated in dark brown semi-opaque flasks for less
than five days. Fresh solutions of noradrenaline for infusion (thus diluted a final
1:30-60 on infusion) were made every 3-4 hours during an experimental day,
contained ascorbic acid 1 mg.mH and were kept in the dark on ice.
In one experiment, 6-hydroxy-dopamine was required (section 2.6.6 and Chapter
5). The chloride salt was kept frozen with dessicant at -20° C and the appropriate drug
concentration, in sterile 0.9% saline containing 1 mg.mH ascorbic acid, was only
prepared immediately prior to dosage.
2.4 Hind-quarters perfusion studies
§
2.4.1 Perfusion apparatus
The method for the perfusion of the rat hind-quarters was modified from Folkow et al.
[1970], The apparatus used for these experiments is displayed diagrammatically in
Figure 2.1. Gassed buffer warmed to 37° C was drawn through gas-impermeable
tubing from a 5 L flask by a Watson-Marlow roller pump and fed through rigid
manometer tubing incorporating a 5 pm filter to a glass heat exchanger. A further
short length of manometer tubing carried buffer to a grooved perfusion cannula
(fashioned from the needle of a 16G Medicut® Intravenous cannula). Two three-way
taps provided ports for drug infusion and measurement of perfusion pressure. A two-
channel infusion pump (Harvard Apparatus Co. Inc., Dover, Mass., USA) delivered
drug through small-bore silicone tubing and short lengths ofmanometer tubing led to
Model EM751 pressure transducers (Elcomatic, Glasgow, Scotland, UK). The
transducers were linked to a hot-pen recorder (Devices Ltd., Welwyn Garden City,
England, UK) which was calibrated by means of an aneroid sphygmomanometer
connected to a pressure bottle.
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Figure 2.1 Diagrammatic representation ofthe hind-quarters perfusion apparatus.
2.4.2 Perfusate
In these experiments, the perfusate was a modified Tyrode's buffer of the following
ionic composition (mM) : Na+ 148, K+ 4.0, Ca^+ 1.84, Mg2+ 1.05, CI" 110, PO^"
0.5, HCO3" 25 with glucose 11, pyruvate 1.8 and EDTA 0.027. The solution was
gassed continuously with 95% 02:5% CO2 to produce a pH of 7.4±0.01 with the
following gas tensions (mm Hg) : PO2 571±8, PCO2 36±0.7. The perfusate contained
3% high molecular weight Dextran (Mol. wt. approximately 90,000).
2.4.3 Surgical procedures
Rats were anaesthetised with intra-peritoneal sodium pentobarbitone (60 mg.kg body
weight"*). Both hind limbs were ligated firmly with a 2/0 silk suture placed just above
the paw. The animal was taped in place on a heating pad and the abdominal cavity
opened through a transverse incision. The abdominal aorta and inferior vena cava were
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identified, gently dissected free of each other and a 4/0 silk suture placed loosely
around the aorta proximal to the iliac bifurcation. Sodium heparin (250 IU.kg body
weight"1) was administered via the inferior vena cava or left renal vein. The proximal
abdominal aorta was occluded with a bulldog clip and the flushed perfusion cannula
quickly introduced into the aorta via an arteriotomy. The cannula was secured by
tightening the loose 4/0 suture, the inferior vena cava was opened to permit free
drainage and the animal was exsanguinated by severing the proximal abdominal aorta.
2.4.4 Protocol
Hind-quarters preparations were perfused in pairs. Perfusion was commenced at low
flow (approximately 5 ml.100 g perfused tissue" l.min'l) to achieve maximal metabolic
vasodilatation. The weight of perfused tissue was approximated by taking 40% of the
total body weight. We confirmed this approximation to be reasonable in early
experiments by comparing the dissected hind-quarters weight with body weight. After
10 minutes of low flow perfusion, the flow was gradually increased to reach a rate of
approximately 10 ml.100 g perfused tissue"l.min"! at 20 minutes. This flow rate was
maintained for the duration of the experiment. Mean perfusion pressure was recorded.
Preparations with a baseline perfusion pressure exceeding 50 mmHg were rejected.
During the dose-response study, drug infusion (maximum infusion rate 0.4 ml.min'l,
< 3% of the hind-quarters perfusion rate) was interrupted after each response plateau
in order that perfusion pressure could be seen to decline satisfactorily to baseline levels
before a further increment in dose was given. Plateaux were used to plot dose
response curves. Preparations with a rising baseline, or where the baseline was
elevated at the end of the protocol, were rejected.
2.4.5 Preliminary experiments
A number of preliminary experiments were performed to establish the range of
concentrations of agonist and to examine the effects of selected antagonists. The
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physiological neurotransmitter noradrenaline was used as the agonist in this and
subsequent experimental models. Rauwolscine was used as an ot2-adrenoceptor
antagonist and timolol as a non-selective (3-adrenoceptor antagonist free of local
anaesthetic effect with minimal intrinsic sympathomimetic activity. In Figure 2.2, the
upper two dose-response relationships illustrate the effect of stimulation of the
perfused rat hind-quarters with noradrenaline (0.5-10 pM) in the absence (n=10) and
presence (n=10) of the two antagonists. In a third group of 6 rats, pre-perfusion with
phenoxybenzamine 1 pM was seen to abolish the responses to noradrenaline in the
presence of rauwolscine and timolol (Fig. 2.2, lowermost curve), thus indicating that
these had been mediated by a \ -adrenoceptors. Body weights were similar in these
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Figure 2.2 The effect ofrauwolscine
(1 pM) and timolol (10 pM), and of
these agents following phenoxy¬
benzamine (PBA, 1 pM), on
responses to noradrenaline (0.5-











In a small number ofpreparations vasoconstricted with noradrenaline to 60-75% of the
maximum response, prompt relaxation (-50%) to acetylcholine 10 nM-1 mM was
demonstrated, indicating endothelial integrity. This procedure was repeated
Methods 37
intermittently throughout the perfused hind-quarters experiments and remained
satisfactory.
2.5 Isolated resistance artery studies
§
2.5.1 Experimental apparatus
The studies were carried out using an isometric myograph as described by Mulvany
and Halpern [1977], The apparatus contains a 10 ml organ chamber in which lie two
pairs of jaws. The fixed medial jaws are attached to strain gauge transducers and the
movable lateral jaws are adjusted with micrometer gauge handles. Each jaw has two
screw heads which serve as anchoring points for a length of fine stainless steel wire
(40 pm diameter). A pair is displayed diagrammatically in Figure 2.3.
Figure 2.3 Diagrammatic representation ofa vessel mounted in the isometric myograph.
Jaw attached
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Removal of a perspex cover allows addition of buffer and drug to the organ chamber
into which gas is bubbled continuously. The chamber is drained by suction and the
apparatus maintained at the desired temperature by a water circulating system. The
transducers were linked to a Grass Model 7D polygraph and were calibrated by
measuring the pen deflection produced when a known mass on a small pivot was set to
pull against a wire mounted on the transducer jaw.
2.5.2 Perfusate
The buffer used in these experiments was a physiological salt solution (PSS) of the
following composition (mM) : NaCl 119, KC1 4.7, CaCl2 2.5, MgSC>4 1.17, NaHC03
25, KH2PO4 1.18, glucose 5 and EDTA 0.026. K-PSS (see 2.5.4) had the same
composition but with an equimolar substitution of KC1 for NaCl. Shortly before use,
solutions were brought to 37° C in a water bath and were bubbled with
95% 02:5% CO2 to achieve a pH of 7.4.
2.5.3 Surgical procedures
Rats were sacrificed by stunning and cervical dislocation. Both hind limbs were rapidly
removed by excision through the hip joint and care taken to preserve the inguinal area.
The limbs were placed immediately in ice-cold buffer. One hind-limb at a time was
pinned in a petri dish and repeatedly irrigated with ice-cold buffer whilst a section of a
second order branch of the superficial femoral artery was dissected out with the aid of
a binocular Nikon microscope. A 2-3 mm segment, free of side branches, was then
separated from any accompanying vein and cleared of adventitia before being mounted
as a ring in the myograph (Figure 2.3). The procedure was repeated to dissect and
mount a second vessel.
2.5.4 Protocol
The vessels were allowed to equilibrate gradually to 37° C. Thereafter,
resting tension - internal circumference relationships were determined in order to
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calculate Z<100> the internal circumference the vessel would maintain relaxed under a
transmural pressure of 100 mmHg, using a Hewlett-Packard programmeable
calculator. The effective transmural pressure was calculated after Laplace from:
P = T * (L / 2tc)
(P: pressure, kPa; T: tension, mN.mm"!; L. internal circumference, mm)
The vessels were then set to normalised internal circumferences Lq, where
Lq = 0.9 Lioo> at which setting maximum contractile force can be achieved. Vessels
were then activated by thrice stimulating with 10 pM noradrenaline in K-PSS. It has
been shown that 10 pM noradrenaline induces maximal contractions in vessels of this
calibre [Mulvany et al., 1980], Any vessel found to have an effective internal diameter
(L\qq/k) in excess of 300 pm, or unable to contract against an effective transmural
pressure of 100 mmHg, was discarded. Following activation, dose-response
relationships were determined. Vessels were exposed to increasing concentrations of
agonist for three minutes at each concentration. The response plateau at the end of
each three minute period was used to plot dose response curves. Where oscillatory
changes were observed, the mean tension for the last 20 seconds was used. In the
second part of the resistance artery studies, vessels were constricted to 60% of the
maximum tension recorded during the preceding dose response study and relaxation
brought about by acetylcholine was examined. Vessels demonstrating a contractile
response to low doses of acetylcholine were considered to have been de-
endothelialised by the mounting process and were accordingly rejected.
2.5.5 Preliminary experiments
To assess the appropriate dose range of agonist and to examine the effect of selected
antagonists, a number of preliminary experiments were performed. As in the hind¬
quarters model, the agonist was noradrenaline. Timolol was used a non-selective
P-adrenoceptor antagonist and yohimbine as an ct2-adrenoceptor antagonist. The
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effect of stimulation of resistance arteries isolated from control rats with noradrenaline
in the absence and presence of these antagonists is illustrated in Figure 2.4. Although
the dose response relationships did not differ significantly, subsequent studies were
nevertheless performed in the presence of 012- and P-adrenoceptor antagonists.












FIGURE 2.4 Changes in active
tension (mN.mm'l) in response to
noradrenaline (3 nM-10 pM), in the
absence and presence ofyohimbine
(1 pM) and timolol (1 pM), of
femoral resistance arteries isolated
from the rat.
loglQ [noradrenaline] M
The resistance artery experiments were performed in collaboration with Dr T.S.
Lawal, Commonwealth Research Fellow, Department of Medicine, Leicester
University, Leicester, England under the supervision of Dr A.M. Heagerty, Senior




The method of perfusion of the isolated rat heart was modified from Langendorff
[1895], Apparatus was designed to reproduce the conditions described by Reibel et al.
[1988] and is displayed diagrammatically in Figure 2.5. By means of a roller pump
(Watson Marlow Ltd., Falmouth, Cornwall, England), buffer was circulated
continuously between a 5 L flask and a 500 ml capacity gassing reservoir. A second
roller pump drew oxygenated buffer of pH 7.4 from the reservoir and fed it in parallel
through gas-impermeable tubing to a pair of glass heat exchangers. Buffer then passed
via three-way taps, where drug could be infused, into 60 cm glass columns, open at the
top and bearing a three-way tap and a grooved 3.5 mm metal cannula at the lower end.
Figure 2.5 Diagrammatic representation ofthe isolated heartperfusion apparatus.
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Once cannulated, the hearts were surrounded by a small chamber with a drainage hole.
The gassing reservoir, heat exchangers, columns and heart chambers were all water-
jacketted and in series with a hot water circulator which maintained the perfusate at
37° C. The rate of circulation of buffer to and from the gassing reservoir exceeded the
rate of withdrawal for perfusion. The perfusion rate was held constant and always
exceeded the maximum coronary flow rate. This strategy permitted the use of drug
solutions of fixed concentration, delivered through fine bore silicone tubing by a two-
channel infusion pump (Harvard Apparatus Co. Inc., Dover, Mass., USA). LVP was
transmitted via fine-gauge manometer tubing to Model EM751 pressure transducers
from 1 mm bore grooved stainless steel cannulae inserted at the apices of the hearts.
Calibration was carried out as described in section 2.4.1. The signals from the
transducers were fed to a Mingograph 34B four-channel ECG recorder (Siemens
Elema, Stockholm, Sweden) through a purpose-built pre-amplifier/signal differentiator
(Department ofMedical Physics and Engineering, University ofEdinburgh).
2.6.2 Perfusate
A modified Krebs-Henseleit buffer of the following composition (mM) was used for
the perfusion of the isolated heart: Na+ 140, K+ 5.5, Ca^4" 2.4, Mg^+ 1.0, CI" 120,
PO^" 0.4, HCC>3" 25, glucose 5.0. The buffer was continually gassed with
95% O2: 5% CO2 to achieve a pH of 7.37±0.00 and gas tensions (mm Hg) of P02
576±5 and PC02 38.6±0.2.
2.6.3 Surgical procedures
Rats were anaesthetised with intra-peritoneal sodium pentobarbitone (60 mg.kg~l).
The abdominal cavity was opened transversely to expose the diaphragm and sodium
heparin (250 IU.kg'l) was administered via the inferior vena cava or left renal vein. In
rapid sequence; the diaphragm was slit, the rib cage opened and the heart with the
proximal great vessels still attached removed and placed in ice-cold buffer to effect
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cardioplegia. As soon as beating ceased, the aortic root was drawn swiftly over the
perfusion cannula and secured firmly with a 2/0 silk suture as perfusion commenced.
The elapsed time between opening the diaphragm and the aortic perfusion was
approximately 90 seconds. After gentle removal of pericardial fat and connective
tissue and separation of any attached lung tissue from the pulmonary vessels, the
cardiac apex was punctured with fine dissecting forceps and the 1 mm pressure
cannula introduced to the left ventricle. Spent buffer dripping from the heart was taken
as coronary venous effluent for the purposes of estimating coronary flow rates and
lactate assay.
2.6.4 Protocol
Hearts were hung in pairs. In the dietary studies, the sequence of paired perfusions
was such that the perfusion channel (left/right) was alternated for hearts from the same
dietary group (e.g. control/n-3 PUFA *=> n-6 PUFA/control ■=> n-3 PUFA/n-6 PUFA
etc.). After stabilising for 15-20 minutes from the time of aortic cannulation, the
coronary venous effluent was collected into 10 ml tubes of known weight. Baseline
peak LVP, LVdP.dt'l and heart rate were recorded. Hearts were then exposed to
increasing concentrations of agonist and cumulative dose response curves were
constructed with pressure and heart rate data recorded three minutes after each dose
increment. Following the final dose, pressures were observed for a decline to baseline
values. This protocol was completed within 35-40 minutes. Hearts which developed
ventricular fibrillation, sustained ventricular tachycardia or excessive bradycardia were
rejected as were those which did not recover baseline pressure following the
administration of agonist. If baseline lactate production was subsequently found to




A small number ofpreliminary experiments were performed to confirm the appropriate
range of agonist and to examine the nature of the responses elicited. The hearts of 6
Sprague-Dawley rats were perfused with buffer containing timolol 10 pM and
prazosin 1 pM. The infusion of noradrenaline 0.1-2.5 pM failed to elicit any increase
in peak LVP (Fig. 2.6). A further 6 hearts were perfused and responses to
noradrenaline 2.5 pM, the maximum dose used in subsequent experiments, in the
presence of timolol 10 pM, were obtained. Increasing the concentration of timolol ten¬
fold to 0.1 mM had no effect on the increment in peak LVP in response to
noradrenaline (Fig. 2.6, inset).
Figure2.6Response ofpeak LVP to
noradrenaline (0.1-2.5 pM), in the
presence of timolol 10 pM and
prazosin 1 pM and (inset) to
noradrenaline 2.5 pM in the
presence of timolol 10 pM and





























It was concluded from these preliminary studies that the responses of the isolated
perfused heart to noradrenaline in the presence of timolol 10 pM were mediated by
aJ-adrenoceptors
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2.6.6 Chemical denervation protocol
One set of perfusions was performed with hearts isolated from chemically denervated
rats fed experimental diets (Chapter 5). After six weeks of the eight week feeding
period, 6-hydroxy-dopamine chloride was administered intraperitoneally according to
the following regimen, adapted from Allely [1983],
The efficacy of this regimen has been carefully established by means of histochemistry.
Allely [1983] used an autofluorescence microscopy/sucrose-phosphate-glyoxylic acid
method [de la Torre and Surgeon, 1976] to demonstrate the absence of sympathetic
neuronal vesicles in the hearts of treated animals.
The 6-hydroxy-dopamine was prepared as described in section 2.3. The perfusion
studies took place 11 days after the last dose of 6-hydroxy-dopamine.
2.7.1 Analysis of adipose fatty acid composition
Approximately 10 mg of adipose tissue was homogenised in 5 ml isopropanol/heptane
(4:1, v/v) using an Elvjehem-Potter glass homogeniser. Phospholipids and free fatty
acids were separated by back-extraction from heptane into 0.05% KOH (1:1
potassium hydroxide/heptane, v/v). The triglyceride-containing heptane layer was
washed with 8 ml isopropanol/0.05% KOH (4:1, v/v, previously washed in heptane,
4:1:3, v/v/v) before being transferred to Quickfit tubes and evaporated to dryness on a












initiated by adding 1 ml toluene with 2 ml 0.5 M sodium methoxide and incubating at
50° C for 10 minutes. After washing with 11 ml glacial acetic acid/water/hexane
(1/5/5, v/v/v), the organic phase was evaporated to dryness and the methylesters were
redissolved in 40 ml chloroform with 0.01% butylated hydroxytoluene. The solutions
were transferred to GLC vials and stored at -20° C prior to analysis.
2.7.2 Analysis of cardiac total and fractionated phospholipids
Hearts were ffeeze-dried for 48 hours on an Edwards-Modulyo freeze dryer before
being crushed to a fine powder with a mortar and pestle. Approximately 150 mg of the
powder from each heart was weighed out and placed in a Quickfit tube (20 x
125 mm). Phospholipids were extracted according to Folch [1957] using 21 ml
chloroform/methanol (2:1, v/v) which was filtered into a second Quickfit tube (20 x
150 mm) before rinsing with a further 9 ml 2:1 chloroform/methanol. Then, 7 ml
0.88% KC1 was added and the aqueous phase was removed. The organic phase was
subsequently dried down under vacuum in a 1 L Buchi flask on the Buchi R rotary
evaporator. The lipid extract was dissolved in 6 ml 2:1 chloroform/methanol, placed in
a Quickfit tube, dried under vacuum once more and redissolved in 1 ml 2:1
chloroform/methanol using a Hamilton syringe.
Total phospholipid was separated into PC, PE, PI and PS by thin layer
chromatography. Aliquots of extract (100 pi) were streaked across Whatman LK5
plates (20 x 20 cm, preadsorptive area) which had been pre-developed with
chloroform/methanol (1:1, v/v), impregnated with 1% boric acid and activated at
100° C for 60 minutes. Plates were developed in chloroform/methanol/water/ammonia
(120:75:6:2, v/v/v/v) in a paper-lined tank for 60 minutes and dried with a commercial
hair-dryer. The plates were then sprayed with 0.1% dichlorofluoroscein to allow
individual phospholipid bands to be identified under ultraviolet light (365 nm). The
bands for the five phospholipid fractions were scraped off and placed in Quickfit tubes
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before the addition of internal standard. For PC and PE fractions, 70 pg
phosphatidylcholine C17:0 was added and for PS and PI, 2 pg was added.
Transmethylation and extraction of methylesters was carried out as described in
section 2.7.1.
2.7.3 Gas liquid chromatography
The system used was a Pye Unicam Series 204 gas chromatograph (Philips Analytical,
Cambridge, England) fitted with a PU4700 autoinjector. A gas column (1.5 m, 2 mm
internal diameter) packed with a stationary phase of 10% SP2330 on 100/120 mesh
chromosorb WHW (Supelco) was used for all separations. GLC vials containing
solutions of methyl esters were allowed to equilibrate to room temperature before
being placed on the autoinjector. Samples ofPS and PI (5 pi) were injected on to the
column with a 10 pi syringe and samples ofPC and PE (1 pi) with a 1 pi syringe. The
system settings and temperature programme were as follows.
Injector temperature 220° C
Detector temperature 300° C
Column temperature 180° C
Hydrogen gas flow 50 l.min"1
Carrier gas flow 50 l.min"1
Air flow 550 l.min"1




Initially, the system was linked to a Trilab Model II integrator (Trivector) but early in
the course of this project new chromatography software was introduced (Perkin Elmer
Nelson Systems Inc., Cupertino, CA 95014, USA) run on an IBM PS/1 Model 30/286
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computing system. Fatty acid methyl ester peaks had been identified originally using
authentic standards and thereafter retention times with respect to the 17:0 methyl
esters were used. Chromatograms were inspected on screen prior to saving on disk
and printing.
2.7.4 Fatty acid nomenclature, data and description of results
Fatty acids are described using a numbered abbreviation according to the following
convention. The first number is the carbon chain length after which a dotted colon
precedes the number of carbonxarbon double bonds. An n- designation indicates the
number of carbon atoms from the methyl terminal to the first double bond. Thus,
linoleic acid (cis.cis, 9,12-octadecadienoic acid) is abbreviated to 18:2, n-6 and
timnodonic acid (more commonly known as all cis, 5,8,11,14,17-eicosapentaenoic
acid) to 20:5, n-3.
Routinely, 19 individual fatty acid species, ranging from 14:0 to 22:6, n-3, were
reported. Values for 14 of these were used to calculate double bond indices, and for
10 to calculate n-6:n-3 fatty acid ratios, with respect to the experimental diets. For
clarity, the results which are later described are restricted to the double bond indices,
the n-6:n-3 ratios and data for four fatty acid species of particular interest. These are
the following. First, linoleic acid (18:2, n-6), as this is the principal n-6 fatty acid
offered by the n-6 PUFA enriched diets. Second, arachidonic acid (20:4, n-6), as this
elongation/desaturation product of 18:2, n-6 has considerable biological importance as
the substrate for prostanoid synthesis. Third, eicosapentaenoic acid (20:5, n-3), as this
species is not present in plant oils but was provided by the diets containing fish oil.
Fourth, docosahexaenoic acid (22:6, n-3), as this was also provided by the fish oil
diets and is an important n-3 fatty acid in cardiac total and fractionated phospholipids.
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2.7.5 Measurement of coronary venous lactate
Coronary venous lactate concentrations were measured using a commercial kit
(Boehringer) on a Cobas Bio centrifugal analyser (Roche Diagnostica, F. Hoffman-La
Roche and Co., Basle, Switzerland). In this assay, lactate concentration is directly
proportional to NADH (measured spectrophotometrically: 340 nm at 37° C) produced
during the conversion of lactate to pyruvate in the presence of excess NAD+, as
shown; reaction B. is effectively lactate
dehydrogenase
unidirectional and reaction A. is lactate —^ pyruvate
pulled to completion. As the NAD*" 9 NADH + H*"
assay kit was designed for giutamate-pyruvate
aminotransferase
clinical use, where lactate levels g. pyruvate ^ alanine
+ glutamate + oxoglutarate
can be considerably higher, it
was possible to use NAD+ at 40% of the recommended concentration.
A 1 mM lactate solution was assayed in triplicate in each run as an internal
standard and quality control was provided by the repeated assay of Precinorm-S
(Boehringer, mean concentration 880 pM). The interassay coefficient of variation was
10%.
2.7.6 Measurement of cardiac noradrenaline content
The noradrenaline content of cardiac tissue was measured by a radioenzymatic method
modified from Da Prada and Zurcher [1976], Hearts for analysis were ffeeze-dried and
crushed as described in section 2.7.2. Approximately 10 mg of the powdered tissue
was weighed into a Beckman tube to which 1 ml 0.3 M HCIO4 was added. The
sample was whirlimixed before centrifiiging at 15,000 rpm for 5 minutes. The
supernatant was removed and stored at -40° C pending assay. Noradrenaline in the
samples was converted to the 3-O-methylated derivative normetanephrine using rat
liver catechol-O-methyl transferase in the presence of the tritiated methyl donor
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3H-methyl-S-adenosyl methionine. The reaction product, ^H-normetanephrine, was
purified by selective ion pair extraction with tetraphenylborate, separated by thin layer
chromatography and subsequently oxidised to ^H-vanillin which was counted in a
liquid scintillation counter. The coefficient ofvariation of the assay was 7%.
2.7.7 Assay of coronary venous 6-axo-PGFia
Coronary venous 6-oxo-PGFia concentrations were measured by radioimmunoassay.
On stabilisation of the perfused hearts, timed samples of coronary venous effluent
were collected into 10 ml tubes of known weight which were weighed immediately
and frozen by placing in dry ice. Pending analysis, tubes were stored at -40° C.
A standard curve was constructed by using known concentrations of 6-oxo-PGF]a
(0.01-5.12 ng.mH) in diluent composed of 0.05 M tris buffer (pH 6.8) containing
gelatin (1 g.H). Aliquots of 500 pi were placed in tubes in triplicate. From the
coronary venous samples, 100 pi and 200 pi aliquots were taken, placed in tubes in
duplicate and made up to 500 pi with diluent. Tritiated 6-oxo-PGFja (50 pi, specific
activity 0.125 pCi.mH) was added to the standard curve tubes and coronary venous
sample tubes, to eight tubes containing diluent alone; four for zero standards and four
for counting standards, and to four tubes containing 10 ng.mH 6-oxo-PGFja to
assess non-specific binding of the tracer. An empty tube was used for machine
background. Rabbit antibody to 6-oxo-PGFia (50 pi) was then added to all but the
counting standard and machine background tubes and the tubes were whirlimixed
before incubating at room temperature for 1 hour. Normal rabbit serum (50 pi, 1:100)
and donkey anti-rabbit serum (50 pi, 1:10) were added to the tubes containing
antibody and all tubes were incubated overnight at 4° C. Thereafter, tubes containing
antibody + serum were centrifuged at 2,500 rpm, 4° C, for 30 minutes and the
supernatant carefully discarded. Scintillant (2.5 ml), composed of 10.5 g 2,5-
diphenyloxazole + 900 ml 2-ethoxyethanol + 1.5 1 toluene, was added to all tubes.
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After whirlimixing, the tubes were placed in a scintillation counter and counted for 4
minutes each, commencing with machine background and counting standards tubes.
The percentage of tracer bound was calculated according to:
The standard curve was plotted and the concentrations of 6-oxo-PGFja in the
coronary venous samples were obtained by extrapolation.
The cross reactivity of the 6-oxo-PGFia antibody was 4.2% for PGE2 1.1%
for PGEj and 0.43% for PGF|a. For other prostanoids and thromboxane, the cross
reactivity was < 0.1%.
This assay was performed courtesy of Dr N. Poyser, Senior Lecturer,
Department ofPharmacology, University ofEdinburgh.
Statistical analyses were carried out using commercial software (Release 7, Minitab
Inc., State College, PA16801, USA) run on an IBM PS/2 Model 55SX computing
system. All data are expressed as mean ± standard error of the mean (s.e.m.).
Continuous variables, for example animal weight, coronary flow and lactate
measurement, were normally distributed and were compared with a two sample t test.
The effect of the experimental diets on adipose tissue and tissue phospholipid fatty
acid composition was screened by one-way analysis of variance using a digital code
(levels) for diet. Where significant variation was apparent, a two sample t test
corrected for multiple comparisons was applied for individual fatty acid species,
double bond indices and n-6:n-3 ratios. A Mann-Whitney test was used to corroborate
significant differences in double bond indices and n-6:n-3 ratios, as these derived
parameters might not be normally distributed.




Several means of analysing the dose-response data, with or without
transformation, were tested and found to be unsatisfactory. Hand drawn curves might
not be consistent, single and double reciprocal plots fitted the data poorly and a more
complex unconstrained four-parameter logistic regression model fitted some
experimental data well but other equally sound data not at all. Consequently, dose-
response data, displayed as absolute response versus logjo concentration of agonist,
were simply interpolated and the relationships so defined were interrogated by analysis
ofvariance for repeated measures using a three factor design which included diet, dose
and (random) rat effects. This analysis also indicated whether significant variation
between dose-response relationships was associated with non-parallelism, reflecting an
effect of diet on the "rate" at which maxima were achieved. Where significant variation
was evident, the points corresponding to specific concentrations of agonist were
subjected to a two sample t test corrected for multiple comparisons.
A similar analysis of variance for repeated measures, taking account of the random
effects of time and potential changes in the rat population, was used to assess whether
fractionated phospholipid fatty acid composition related to a given experimental diet
varied between experiments.
It was clearly important to attempt to correlate any changes in pharmacological
response with respect to diet with the changes in fatty acid composition brought about
by the diet. A best subsets regression analysis was used to canvas for possible
relationships between the four fatty acid species of particular interest, the double bond
indices and the n-6:n-3 ratios, singly and in multiple combination, and the tissue
responses.




All materials were of at least analytical grade.
Aldrich Chemical Company, Gillingham, Dorset, England
CH3ONa
BDH (Chemicals) Ltd., Poole, Dorset, England
CaC03, FeCgH^Oy, KI03, NaCl, NaHC03, ZnCl2, perchloric acid.
Boehringer Corporation Ltd., Lewes, E. Sussex, England
Enzymatic kit for lactate
Leo Laboratories Ltd., Aylesbury, England.
Sodium heparin
May and Baker Ltd., Dagenham, England
Sodium pentobarbitone
Merck, Burnfield Avenue, Thornliebank, Glasgow, Scotland
CHC13, CH3OH, glacial acetic acid, heptane, isopropanol, KOH, NH3, toluene
Carl Roth, Karlsruhe, Germany
Rauwolscine hydrochloride
Sigma Chemical Co., Poole, Dorset, England
Butylated hydroxytoluene, CaCl2-2H20, CUCI2.2H2O, dichlorofluorescein, KC1,
KHC03, KH2P04, MgCl2 6H20, MgHP04.3H20, MnS04, Na3C6H507.2H20,
NaH2P04.H20, C17:0-phosphatidylcholine, ^H-methyl-S-adenosylmethionine.
Acetylcholine HC1, dextran (mol. wt. 60k-90k), 6-hydroxydopamine HC1, isoprenaline
HC1, noradrenaline bitartrate, noradrenaline HC1, prazosin HC1, timolol maleate,
yohimbine HC1







In man, vascular responses to noradrenaline and to cold provocation in Raynaud's
disease can be attenuated by n-3 PUFA [Lorenz et al., 1983, di Giacomo et al, 1989]
and diets with a high content of 20:4, n-6 reduced forearm vasoconstrictor responses
to a cold pressor test [Butcher et al., 1990], Animal studies of vascular reactivity have
focused on the effects of n-3 PUFA and there are inconsistencies. Vascular responses
to catecholamines and to angiotensin II have been reduced, not altered and even
increased by n-3 PUFA [Lockette et al., 1982, Yin et al., 1988, Yin et al., 1991,
Yoshimura et al., 1986, Kenny et al., 1990],
Interpretation of conflicting animal results is made difficult by differences in
experimental diets. The amount of n-3 PUFA administered in these studies varied
widely and doses equivalent to at least 40 g.day'l in the average man were given,
more than five times the daily n-3 PUFA intake of Greenland Eskimos [Bang and
Dyerberg, 1985], This degree of n-3 PUFA supplementation is poorly tolerated by
man and is clearly not realistic. Control diets are often laboratory chow which is of
low fat content, 5% to 10% of dietary calories, and disproportionately rich in
18:2, n-6, thus not relevant to man. Commonly, the effects of different fatty acids are
assessed by simply adding the source fat or oil to laboratory chow, but this practice is
not without risk. The use of highly saturated fats may precipitate essential fatty acid
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deficiency, which is associated with raised BP [Cox et al., 1982]. Also, addition of fats
or oils to laboratory chow compromises mineral and vitamin content. Dietary intake of
Na+ and K+, for example, is likely to be reduced. These problems can be avoided by
the use of semi-synthetic diets with an adequate 18:2, n-6 content (approximately 3%
of dietary calories).
Our intention was to investigate the effects of PUFA in diets representative of
what is, or might be, consumed by man on vasoconstriction in the peripheral vascular
bed. In the first of two studies, we examined the effect of a moderate dietary
supplement of n-3 PUFA (+ 0.4% dietary calories, equivalent to 3-4 g daily in the
average man) on the responses to aj-adrenoceptor stimulation in the rat hind quarters
perfused at constant flow. In the second study, we examined the effect of increasing
the dietary proportion of n-6 PUFA (to a P/S ratio of 2.0) in the same experimental
model. For the control in these two experiments, we used a semi-synthetic diet
deriving 40% of dietary calories from fat (P/S ratio 0.3), typical of the fat intake of
middle-aged Scottish men [Thomson, 1984].
3.2 Methods
§
3.2.1 Dietary n-3 PUFA
Thirty-six Lew rats were assigned at random to two groups, both of which were fed
the P/S 0.3 diet. Half of the animals received a daily oral dose of fish oil and half
received a control oral dose of olive oil. As discussed in section 2.2.4, the olive oil was
not supplementary to the diet. The feeding period was eight weeks. The composition
of the two final diets is shown in Table 3.1. At the end of the feeding period, the
surgical procedures and protocol of sections 2.4.3 and 2.4.4 were followed. Control
and n-3 PUFA rats were paired for the perfusions and the respective perfusion
channel, right or left, was alternated run to run. Increments in perfusion pressure in
response to noradrenaline 2-10 pM in the presence of timolol 10 pM and rauwolscine
1 pM were recorded. There was one preparation failure (n-3 PUFA group) and one
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preparation was excluded from further analysis on the basis of a rising baseline
pressure (control group).
Table 3.1 Calculatedfat composition (%) ofthe control and n-3 PUFA experimental diets.
Diet
Fatty acid classes Control n-3 PUFA
Saturates 20% 20%
Monoenes 14% 14%
n-6 PUFA 6% 6%
n-3 PUFA _ 0.4%
Total 40% 40,4%
Values represent the proportion of dietary calories supplied by
different classes of fatty acid.
3.2.2 Dietary n-6 PUFA
In a separate study, 24 Sprague-Dawley rats were randomly assigned to two groups
and fed either the control diet or a diet ofP/S ratio 2.0. These animals were not orally
dosed. The composition of the diets is shown in Table 3.2.
Table 3.2 Calculatedfat composition (%) ofthe control and n-6 PUFA experimental diets.
Diet
Fatty acid classes Control n-6 PUFA
Saturates 20% 8%
Monoenes 14% 14%
n-6 PUFA 6% 18%
n-3 PUFA - -
Total 40% 40%
Values represent the proportion of dietary calories supplied by
different classes of fatty acid.
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At the end of the feeding period, the surgical procedures and protocol of sections
2.4.3 and 2.4.4 were followed. The perfusions were performed as described for the n-3
PUFA experiment.
The n-3 PUFA experiments were performed in association with Dr Carol Sargent
of the Cardiovascular Research Unit who was investigating the effect of diet on
ventricular arrhythmia in the isolated perfused rat heart [Sargent, 1990],
3.3.1 Dietary n-3 PUFA and perfusion pressure
Noradrenaline, in the presence of rauwolscine and timolol, brought about a substantial
rise in perfusion pressure (Fig. 3.1). Increments in pressure were significantly
attenuated in relation to the n-3 PUFA supplemented diet compared to the control diet
(p< 0.05, ANOVA-RM). At any specific concentration of noradrenaline, there was no
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Baseline perfusion pressure was not altered by n-3 PUFA supplementation (n-3 PUFA:
42±1 mm Hg versus control: 41±1 mm Hg).
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3.3.2 Dietary n-6 PUFA and perfusion pressure
In contrast to the findings of the n-3 PUFA experiment, increasing the n-6 PUFA
content of the diet to achieve a P/S ratio of 2.0 had no significant effect on the rise in



















Figure 3.2 Increments in perfusion
pressure (mm Hg) in response to
noradrenaline (2-10 pM), in the
presence of rauwolscine (1 pM) and
timolol (10 pM), in the perfused
hind-quarters of rats fed
experimental diets: n-6 PUFA.
Baseline perfusion pressure prior to stimulation was unaffected by diet (n-6 PUFA:
41±2 mm Hg versus control: 44±1 mm Hg, NS).
3.3.3 Dietary n-3 PUFA: body weights and estimated hind-quarters flow rates
Final body weights and estimated hind-quarters perfusion flow rates (see section 2.4.4)
were in close agreement for the n-3 PUFA supplemented and control diets (Table 3.3).
Table 3.3 Final body weights (g) and estimated hind-quarters flow rates (ml.min~l.100g
tissue weight'1) for rats fed experimental diets: n-3 PUFA.
Diet Body weight Flow
Control 387±5 10.4±0.1
n-3 PUFA 386±7 10.4±0.2
Values: mean ± s.e.m., n=17 per group. There were no significant
differences.
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3.3.4 Dietary n-6 PUFA: body weights and estimated hind-quarters flow rates
Although there was a tendency toward greater body weights in the n-6 PUFA group,
this was not significant (Table 3.4). Body weights were more widely distributed in this
experiment but this did not lead to any significant difference in estimated hind-quarters
perfusion flow rates.
Table 3.4 Final body weights (g) and estimated hind-quarters flow rates (ml.min~l.100g
body weight'1) for ratsfed experimental diets: n-6 PUFA.
Diet Body weight Flow
Control 379±16 10.7±0.4
n-6 PUFA 413± 9 9.7±0.2
Values: mean ± s.e.m., n=12 per group. There were no significant
differences.
3.3.5 Dietary n-3 PUFA and the fatty acid composition of adipose tissue
Supplementation of the diet with n-3 PUFA did not affect the principal fatty acid 18:2,
n-6 in adipose tissue, or the very small proportion of 20:4, n-6 (Table 3.5). The n-3
fatty acid species were not detected (< 0.1%).
Table 3.5 Fatty acid composition of adipose tissue from rats fed experimental diets : n-3
PUFA.
Diet
Fatty acid species Control n-3 PUFA
18:2, n-6 12.2±0.4 10.8±0.5
20:4, n-6 0.1±0.0 0.1±0.0
20:5, n-3
22:6, n-3 - -
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid
species, n=8 per dietary group. There were no significant differences.
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3.3.6 Dietary n-6 PUFA and the fatty acid composition of adipose tissue
The n-6 PUFA diet brought about significant increases in the content of 18:2, n-6 and
in the small proportion of 20:4, n-6 (Table 3.6). The n-3 species were not detected
(< 0.1%).





18:2, n-6 15.1±0.9a 30.9±0.4a
20:4, n-6 0.2±0.0b 0.4±0.1b
20:5, n-3 - -
22:6, n-3 - -
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid
species, n=8 per dietary group. Superscript characters denote significant
differences (p< 0.01) between individual fatty acid species.
3.3.7 Dietary n-3 PUFA and the fatty acid composition of cardiac total and
fractionated phospholipid
Supplementation of the diet with n-3 PUFA did not alter the cardiac tissue content of
total phospholipid or of separate phospholipid fractions compared to the control diet
(Table 3.7). In total phospholipid, the proportion of 18:2, n-6 was not affected by n-3
PUFA supplementation but 20:4, n-6 was significantly decreased (Table 3.8). Levels
of the n-3 species were significantly increased although 20:5, n-3 was barely
detectable. The n-6:n-3 ratio was halved and the double bond index increased
significantly.
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Table 3.7 Total phospholipid and phospholipid fractions in the hearts of rats fed
experimental diets: n-3 PUFA.
Diets






Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet heart weight"1,
n=8 per dietary group. There were no significant differences.
Table 3.8 Fatty acid composition, including the n-6:n-3 ratio and double bond index (DB1),
oftotal phospholipid in the hearts ofratsfed experimental diets: n-3 PUFA.
Fatty acid species, Diet
n-6:n-3 ratio and DBI Control n-3 PUFA
18:2, n-6 18.3±0.7 17.7±0.7
20:4, n-6 27.6±2.2a 22.3±l.la
20:5, n-3 0.1±0.0b 0.2±0.0b
22:6, n-3 10.6±0.5C 13.3±0.5C
n-6:n-3 ratio 3.9±0.5d 2.0±0.2d
DBI 225±3e 234±2e
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids represent the
percentage weight of total fatty acid species. Superscript characters denote significant
differences (p< 0.001) between individual fatty acid species and parameters in
relation to diet.
The fatty acid composition of fractionated phospholipid is shown in Table 3.9. In none
of the fractions was 18:2, n-6 influenced by dietary n-3 PUFA supplementation. In PC,
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PE and PS, but not in PI, the proportion of 20:4, n-6 was significantly decreased in
relation to n-3 PUFA. Only in PC and PE was 20:5, n-3 detected where it was
increased by supplementation which also significantly increased the relative amounts of
22:6, n-3 in all fractions.
Table 3.9 Fatty acid composition of phospholipid fractions in the hearts of rats fed
experimental diets: n-3 PUFA.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA
PC 18:2, n-6 8.6±0.7 8.9±0.8
20:4, n-6 28.3±0.7a 24.7±0.6a
20:5, n-3 0.1±0.0b 0.2±0.2b
22:6, n-3 3.6±0.4C 5.9±0.5C
PE 18:2,n-6 4.7±0.4 4.7±0.3
20:4, n-6 27.5±2.8d 22.6±1.0d
20:5, n-3 - 0.3±0.2
22:6, n-3 19.1±0.4e 31.2±0.7e
PI 18:2, n-6 4.1±0.3 4.0±0.5
20:4, n-6 35.1±0.5 34.7±0.6
20:5, n-3 - -
22:6, n-3 2.5±0.4f 4.2±0.5f
PS 18:2, n-6 2.1±0.3 2.3±0.5
20:4, n-6 8.2±0.5g 6.6±0.7S
20:5, n-3 - -
22:6, n-3 13.4±0.8h 19.1±1.0h
Values (mean ± s.e.m.) represent the percentage of total fatty acid
species within each phospholipid fraction, n=8 per dietary group.
Superscript characters denote significant differences (0.001< p< 0.05)
between individual fatty acid species within phospholipid fractions in
relation to diet.
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In association with the above changes, the n-6:n-3 ratios fell, most strikingly so in PE
where the decrease was threefold (Table 3.10). Double bond indices rose significantly
in PC and PE with n-3 PUFA supplementation, but not in PI or PS.
Table 3.10 Phospholipid fraction n-6:n-3 ratios and double bond indices (DBI) in the
hearts ofratsfed experimental diets: n-3 PUFA.
Phospholipid fraction Diet
n-6:n-3 ratios and DBI Control n-3 PUFA
n-6:n-3 ratio 7.6±0.4a 3.0±0.5a
DBI 190±lb 198±2b
PE n-6:n-3 ratio 1.8±0.1c 0.6±0.2C
DBI 278±2d 290±2d
PI n-6:n-3 ratio 21.6±0.9e 8.4±0.7e
DBI 187±4 188±2
PS n-6:n-3 ratio 1.3±0.1f 0.6±0.1f
DBI 190±3 196±3
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters
denote significant differences (0.001< p< 0.05) between parameters for
individual phospholipid fractions in relation to diet.
3.3.8 Dietary n-6 PUFA and the fatty acid composition of cardiac total and
fractionated phospholipid
Increasing the dietary content of n-6 PUFA did not alter the cardiac tissue
concentrations of total phospholipid or of the separate phospholipid fractions (Table
3.11). The proportion of 18:2, n-6 was significantly increased in total phospholipid in
relation to the n-6 PUFA rich diet whereas that of 20:4, n-6 was not (Table 3.12).
There was a small but significant decrease in 22:6, n-3 and 20:5, n-3 was not detected.
A 50% increase was apparent in the n-6:n-3 ratio and the double bond index fell
significantly.
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Table 3.11 Total phospholipid and phospholipid fractions in the hearts of rats fed
experimental diets: n-6 PUFA.
Diets






Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet heart weight^
n=8 per dietary group. There were no significant differences.
Table 3.12 Fatty acid composition, including the n-6:n-3 ratio and double bond index
(DB1), oftotal phospholipid in the hearts ofratsfed experimental diets: n-6 PUFA.
Fatty acid species, Diet
n-6:n-3 ratio and DBI Control n-6 PUFA
18:2, n-6 16.4±0.4a 21.3±0.5a
20:4, n-6 25.2±0.3 24.4±0.4
20:5, n-3 - -
22:6, n-3 9.6±0.3b 8.7±0.2b
n-6:n-3 ratio 4.1±0.7C 6.4±0.3C
DBI 228±ld 222±2d
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids
represent the percentage weight of total fatty acid species.
Superscript characters denote significant differences between
individual fatty acid species and parameters in relation to diet
(0.00 l<p< 0.05).
The fatty acid composition of cardiac fractionated phospholipid with respect to dietary
n-6 PUFA is shown in Table 3.13. The proportion of 18:2, n-6 rose significantly in all
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fractions. However, not only was 20:4, n-6 unaffected in PC, PI and PS but it fell in
PE. A 20% decrease was seen in 22:6, n-3 in all fractions and 20:5, n-3 was not
detected (< 0.1%).
Table 3.13 Fatty acid composition of phospholipid fractions in the hearts of rats fed
experimental diets: n-6 PUFA.
Phospholipid fraction and Diet
fatty acid species Control n-6 PUFA
PC 18:2, n-6 6.5±0.6a 8.0±0.5a
20:4, n-6 29.8±0.7 30.2±0.6
20:5, n-3 - -
22:6, n-3 3.9±0.3b 3.0±0.4b
PE 18:2,n-6 4.5±0.4C 6.7±0.5C
20:4, n-6 25.7±0.6d 23.1±0.3d
20:5, n-3 - -
22:6, n-3 19.6±0.5 15.2±0.7
PI 18:2, n-6 4.2±0.2e 6.9±0.2e
20:4, n-6 35.1±0.4 35.8±0.3
20:5, n-3 - -
22:6, n-3 1.3±0.3f 1.0±0.4f
PS 18:2, n-6 2.2±0.38 3.6±0.5g
20:4, n-6 7.7±0.4 7.5±0.8
20:5, n-3 - -
22:6, n-3 14.1±0.7 12.1±0.3
Values (mean ± s.e.m.) represent the percentage of total fatty acid
species within each phospholipid fraction, n=8 per dietary group.
Superscript characters denote significant differences (0.001< p< 0.05)
between individual fatty acid species within phospholipid fractions in
relation to diet.
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The n-6:n-3 ratios in fractionated phospholipid increased by 50%, as in total
phospholipid, with dietary n-6 PUFA and the double bond indices fell, though not
significantly (Table 3.14).
TABLE 3.14 Phospholipid fraction n-6:n-3 ratios and double bond indices (DBI) in the
hearts ofratsfed experimental diets: n-6 PUFA.
Phospholipid fraction Diet
n-6:n-3 ratios and DBI Control n-6 PUFA
PC n-6:n-3 ratio 7.7±0.5a 11.9±0.6a
DBI 188±2 185±3
PE n-6:n-3 ratio 1.7±0.1b 2.3±0.1b
DBI 274±3 270±4
PI n-6:n-3 ratio 20.5±0.8C 31.3±l.lc
DBI 189±4 187±3
PS n-6:n-3 ratio 1.4±0.1d 2.1±0.2d
DBI 194±5 190±4
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters
denote significant differences (0.001< p< 0.05) between parameters for
individual phospholipid fractions in relation to diet.
3.4 Discussion
§
In the first of these two studies, supplementation of a 40% fat calorie diet of P/S ratio
0.3 with n-3 PUFA was found to attenuate responses to noradrenaline in the hind¬
quarters of Lew rats perfused at constant flow. The responses to noradrenaline,
recorded as increases in hind-quarters perfusion pressure, were obtained in the
presence of rauwolscine and timolol and were previously shown to be abolished by
phenoxybenzamine. Thus, we infer that these responses were mediated by
a)-adrenoceptors. The fatty acid composition of the perfused arterial bed could not be
determined due to the volume of tissue required, but analysis of cardiac fractionated
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phospholipid fatty acid composition revealed numerous statistically significant changes
in relation to dietary n-3 PUFA.
In the second study, an n-6 PUFA diet, P/S ratio 2.0, was not associated with any
difference in response to a \ -adrenoceptor stimulation in the perfused hind-quarters of
Sprague Dawley rats. An increase in adipose tissue 18:2, n-6 confirmed the
consumption of the P/S 2.0 diet which also brought about significant changes in
cardiac fractionated phospholipid fatty acid composition.
The results with respect to n-3 PUFA are in agreement with the findings of
previous studies in rat vessels [Lockette et al., 1982, Yin et al., 1991, Malis et al.,
1991] where considerably higher doses of n-3 PUFA (10- to 15-fold) were used.
However, neither our study nor these others reveals the mechanism by which
supplementation of the diet with n-3 PUFA brings about attenuation of vascular
responses to a \ -adrenoceptor stimulation. Curiously, despite much speculation
regarding potential mechanisms in these published reports, only Lockette et al. [1982]
present data on the changes in tissue fatty acid composition following their highly n-3
PUFA enriched experimental diet. These data are limited to total lipid analysis of
aortic tissue where 5- to 7-fold increases in n-3 PUFA species were observed. We
documented numerous changes of lesser degree in cardiac fractionated phospholipid
fatty acid composition but the extrapolation of our cardiac data to vascular tissue must
be cautious. Few studies have compared the effects of dietary PUFA on cardiac and
vascular tissue but it has been shown that following long term feeding of a fish oil diet
to marmosets, cardiac and aortic total lipid fatty acid composition differed only with
respect to 22:6, n-3 which was relatively higher in cardiac tissue [Charnock et al.,
1992], In the same study, enrichment of the diet with sunflower seed oil (a source of
n-6 PUFA) was associated with a greater proportion of 18:2, n-6 in cardiac than aortic
tissue but other fatty acid species were similar.
If the changes in cardiac tissue phospholipid fatty acid composition we describe in
relation to n-3 PUFA supplementation also occurred in the peripheral arterial bed,
vasoconstriction following a\ -adrenoceptor stimulation could be affected directly or
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indirectly. The incorporation of n-3 PUFA in the PC and PE fractions, which together
represent approximately 70% of cell membrane phospholipid, was associated with
significantly greater unsaturation and reduced levels of 20:4, n-6. Unsaturation may
render the cell membrane more fluid, affecting events such as agonist-receptor
coupling, for example. Reductions in 20:4, n-6 may compromise the availability of
substrate for the synthesis of vasoconstrictor prostanoids. Interestingly, in the PI
fraction, linked with a \ -adrenoceptor signal transduction, although 22:6, n-3 was
increased and the n-6:n-3 ratio decreased, the proportion of 20:4, n-6 did not fall with
dietary n-3 PUFA, as it is commonly assumed to do on the basis of total phospholipid
data, and the double bond index did not rise. Our data indicate that the PI fraction is
relatively resistant to dietary influence.
Despite the large increase in dietary n-6 PUFA in the P/S ratio 2.0 diet, the
associated changes in phospholipid fatty acid composition were essentially limited to
modest increases in 18:2, n-6 and in the n-6:n-3 ratios. Levels of 20:4, n-6 were
unaltered in relation to the n-6 PUFA diet, indeed in PE there was a small decrease in
this fatty acid species. It may therefore be suggested that the n-6 PUFA provided by
this diet was insufficient to influence fatty acid composition and perhaps vascular
responses. However, although we did not examine the effects of diets containing pure
sunflower seed oil or safflower seed oil (sources of n-6 PUFA), a P/S ratio of 2.0 in a
40% fat calorie diet is the maximum that can be achieved without resorting to liquid
formulation and we wished to adhere to diets that could be consumed by man.
The significant change in response to a j-adrenoceptor stimulation following
dietary n-3 PUFA took the form of an almost parallel depression of the rise in
perfusion pressure. This phenomenon suggests that, although baseline pressure was
not influenced by diet, some enhancement of vascular relaxation may have contributed
to the observed effects. It is recognised that dietary n-3 PUFA can facilitate
endothelium-dependent vascular relaxation [Shimokawa et al., 1987] and this has been
shown to apply to acetylcholine mediated relaxation of isolated rat aortic tissue [Yin et
al., 1988, Yin et al., 1991, Malis et al., 1991], In our study, the vasoconstricted hind-
Dietary PUFA andperipheral vasoconstriction 69
quarters was seen to vasodilate to acetylcholine as a qualitative means of assessing
endothelial integrity but it was not part of the study to document this response in a
controlled quantitative manner. Accordingly, an effect of our n-3 PUFA diet on the
relaxant state of the perfused vessels cannot be excluded.
We emphasise that two separate studies were performed in two separate strains at
different times. Seasonal influences on the animals are not relevant under controlled
environmental conditions but nevertheless, differences between the control groups
might have contributed to the apparently contrasting effects of n-3 and n-6 PUFA.
Although the n-3 and n-6 PUFA studies were not contemporaneous, comparison of
the perfusion pressure responses of the two control groups did not reveal any
significant differences. However, analysis of variance applied to the phospholipid fatty
acid composition of the two control groups confirmed that they varied, notably so for
n-6 fatty acid species in PC and 22:6, n-3 in PI. Whether these differences could have
influenced the results needs to be clarified by experiments designed around the
simultaneous administration of the three diets.
To summarise, supplementation of a 40% fat calorie diet with a small amount of
n-3 PUFA was found to attenuate vascular responses to a \ -adrenoceptor stimulation
in the rat hind-quarters perfused at constant flow. In the following chapter, the
possibility that dietary n-3 PUFA alters both vascular contraction and relaxation is
pursued in an isometric myograph model, and the problem of differing control groups




the contraction and relaxation ofresistance arteries
4.1 Introduction
§
In the hind-quarters of the rat perfused at constant flow, we demonstrated that
supplementation of the diet with a small dose of n-3 PUFA brought about the
attenuation of responses to a j-adrenoceptor stimulation. Changes in phospholipid
fatty acid composition in relation to dietary n-3 PUFA suggested a number of potential
mechanisms. It was also possible that differences in vascular relaxant state between the
control and n-3 PUFA groups could have contributed to the findings. A second
separate study did not reveal any significant effect of dietary n-6 PUFA on
a i -adrenoceptor mediated responses. These two dietary PUFA studies were
performed with different strains of rats. Although the two control groups did not differ
in vascular responses, they did differ in phospholipid fatty acid composition, further
precluding true comparison of the n-3 PUFA and n-6 PUFA effects.
The principal effectors of the vasoconstrictor response to cq-adrenoceptor
stimulation in the peripheral vascular bed are distal resistance arteries rather than
proximal conduit vessels. In order to clarify the effects of n-3 PUFA on vascular
reactivity and to facilitate the investigation of the possible effects of dietary PUFA on
vascular relaxation, we decided to direct our attention to the isolated resistance artery.
Using an isometric myograph, which allows different vessels to be maintained at
physiologically equivalent degrees of tension, we studied the effect of dietary PUFA
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on contraction and relaxation in second order femoral artery branches isolated from
the rat. Once again, the control diet derived 40% of dietary calories from fat and had a
P/S ratio of 0.3. Supplementation of this diet with 0.4% calories fish oil provided the




Thirty Sprague-Dawley rats were separated at random into three groups under the
conditions described in section 2.1. Semisynthetic experimental diets were fed for eight
weeks. The n-3 PUFA group received a daily oral dose of fish oil in olive oil and the
control and n-6 PUFA groups received daily oral doses of olive oil alone. As described
in section 2.2.4, the olive oil administered to the three groups was not supplementary
to dietary requirement. The overall dietary composition is shown in Table 4.1. At the
end of the feeding period, the animals were sacrificed and the surgical procedures and
protocol of sections 2.5.3 and 2.5.4 were carried out.
Table 4.1 Calculatedfat composition (%) ofthe experimental diets.
Fatty acid classes Control
Diet
n-3 PUFA n-6 PUFA
Saturates 20% 20% 8.7%
Monoenes 14% 14% 14%
n-6 PUFA 6% 6% 17.3%
n-3 PUFA _ 0.4% _
Total 40% 40.4% 40%
Values represent the proportion of dietary calories supplied by different classes of fatty acid.
Of the 60 vessels dissected and mounted, 8 were excluded on the basis of either an
effective internal diameter exceeding 300 pm or the inability to contract against a
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tension equivalent to a transmural pressure of 100 mm Hg (control group: 1, n-3
PUFA group: 4, n-6 PUFA group: 3). Contractions to noradrenaline 3 nM-10 pM
were elicited in the presence of yohimbine 1 pM and timolol 1 pM. Subsequently, we
recorded the relaxation to acetylcholine 1 nM-0.1 mM of vessels pre-constricted (with
noradrenaline 0.3 pM or 1 pM) to approximately 60% of their previous maximum
contraction. One vessel from the control group was found to contract further (+ 20%)
to low doses of acetylcholine, was presumed de-endothelialised and was excluded
from further analysis. Subsequently, for statistical purposes, 3 vessels (control group:
2, n-6 PUFA group: 1) were excluded at random to provide balanced groups of 16
vessels. Analysis of the data by rat (3 groups of 8) did not provide different results.
The final groups did not differ with respect to ZjoO values (see section 2.5.4) or vessel
segment length (Table 4.2).
Table 4.2 Ljqq values (pm) and vessel segment length (mm) offemoral resistance arteries
isolatedfrom ratsfed experimental diets.
Diet Ljqo Segment lengths
Control 243±9 2.10±0.07
n-3 PUFA 257±8 2.10±0.06
n-6 PUFA 245±7 2.00±0.10
Values: mean ± s.e.m., n=16 per dietary group. There were no significant
differences between the groups.
4.3 Results
§
4.3.1 Dietary n-3 PUFA and contractile responses of the resistance artery
Noradrenaline in the presence of yohimbine and timolol evoked considerable increases
in active tension. Vessels isolated from rats fed the n-3 PUFA diet demonstrated
significantly attenuated responses compared to control (p< 0.01, ANOVA-RM, Fig.
4.1). The effect was evident at higher concentrations of agonist and involved a
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depression of gradient and maximal response. At any specific concentration of
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Figure 4.1 Changes in active
tension (mN.mm'^J in response to
noradrenaline (3 nM-10 pM), in the
presence of yohimbine (1 pM) and
timolol (1 pM), in resistance arteries
isolated from rats fed experimental
diets: n-3 PUFA.
-5
4.3.2 Dietary n-6 PUFA and contractile responses of the resistance artery
Vessels isolated from rats fed the n-6 PUFA diet showed a downward trend in
contractile response compared to control throughout most of the dose response
relationship but this did not achieve statistical significance (Fig. 4.2).
Control diet-i n.s.







figure 4.2 Changes in active
tension (mN.mm'*) in response to
noradrenaline (3 nM-10 pM), in the
presence of yohimbine (1 pM) and
timolol (1 pM), in resistance arteries
isolated from rats fed experimental
diets: n-6 PUFA.
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4.3.3 Dietary PUFA and relaxation of the resistance artery
Neither the n-3 PUFA diet nor the n-6 PUFA diet exerted any significant effect on the
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Figure 4.3 Relaxation (%) of pre-
constricted isolated resistance
arteries in response to acetylcholine
(I nm-0.1 mM).
Prior to relaxation, the vessels of the three dietary groups were constricted to the same
degree (Table 4.3).
Table 4.3 Active tension (mN.mm'l) of isolated resistance arteries pre-constricted with





Values: mean ± s.e.m., n=16 per dietary group.
There were no significant differences between the
groups.
4.3.4 Body weights
The final body weights for animals fed the n-6 PUFA diet were significantly greater
than those of animals fed the n-3 PUFA diet but neither differed significantly from
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control. Inspection of the weights at arrival confirmed that the groups had varied at
the outset and, although weight gain tended to be greater in the n-3 PUFA group,
there were no significant differences (Table 4.4).
Table 4.4 Body weights (g) and weight gain (g) ofrats fed experimental diets.
Diet Initial weight Final weight Weight gain
Control 220±9a 379±8 159±5
n-3 PUFA 189±2a'b 363±6C 174±8
n-6 PUFA 240±3b 394±8C 154±7
Values: mean ± s.e.m., n=16 per dietary group. Superscript characters denote
significant differences (0.001< p < 0.05) with respect to diet.
4.3.5 Fatty acid composition of adipose tissue
The n-3 PUFA diet, as expected, did not influence adipose tissue 18:2, n-6 or 20:4,
n-6. The n-3 fatty acid species 20:5, n-3 was not detected (< 0.1%) and 22:6, n-3 was
only detected in relation to n-3 PUFA supplementation. Highly significant increases in
18:2, n-6 and in the small proportion of 20:4, n-6 were seen in relation to the P/S 2.0
diet, confirming consumption (Table 4.4).
Table 4.5 Fatty acid composition ofadipose tissue from ratsfed experimental diets.
Fatty acid species Control
Diet
n-3 PUFA n-6 PUFA
18:2,n-6 10.6±0.5a 11.6±0.5b 32.3±0.4a>b
20:4, n-6 0.1±0.0C 0.2±0.0d 0.5±0.1c'd
20:5, n-3 - - -
22:6, n-3 - O.liO.O -
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=8
per dietary group. Superscript characters denote significant differences (p< 0.01)
between individual fatty acid species with respect to diet.
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4.3.6 Fatty acid composition of cardiac total and fractionated phospholipid
The absolute amounts of total phospholipid and of the individual fractions (Table 4.6)
were lower than is usually found with these 40% fat calorie diets in our laboratory (see
Tables 3.7, 3.11, 6.9, 7.8 and 8.2) but the relative proportions of the individual
phospholipid fractions were similar to these other studies. There was no significant
dietary effect.





n-3 PUFA n-6 PUFA
PC 3757±227 3872±205 4428±276
PE 2951±366 2908±205 2773±275
PI 408±38 401±21 463±23
PS 257±8 237±13 237±21
Total 8384±861 9548±752 10022±371
Values (mean ± s.e.m.) are expressed as (j.g.g wet heart weight" n=8 per dietary
group. There were no significant differences between the groups.
The analysis of the fatty acid composition of total and fractionated phospholipid again
revealed numerous statistically significant differences with respect to diet. In total
phospholipid (Table 4.7), supplementation of the diet with n-3 PUFA led to small
reductions in the proportions of 18:2, n-6 and 20:4, n-6 and to an increase in the minor
proportion of 20:5, n-3. There was a marked increase in 22:6, n-3. The n-6:n-3 ratio
was halved and the double bond index rose significantly. The P/S ratio 2.0 diet was
associated with a limited increase in 18:2, n-6 and did not affect 20:4, n-6. With a
reduction of a third in the level of 22:6, n-3, the n-6:n-3 ratio was increased 50% but
the double bond index fell.
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Table 4.7 Fatty acid composition of total phospholipid, including the n-6:n-3 ratio and
double bond index (DBI), in the hearts ofratsfed experimental diets.
Fatty acid species,
n-6:n-3 ratio and DBI Control
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 18.4±1.4a 16.4±2.7b 21.0±1.3a'b
20:4, n-6 23.9±1.0C 20.0±1.0c>d 23.3±1.4d
20:5, n-3 0.1±0.1e 0.5±0.2e -
22:6, n-3 9.9±0.5f'g 17.5±2.4f>h 6.9±0.8&h
n-6:n-3 ratio 4.2±0.5iJ 1.9±0.5i>k 6.4±l.Q)'k
DBI 230±2,'m 240±l1'n 224±lm,n
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids represent the
percentage weight of total fatty acid species. Superscript characters denote significant
differences (0.001< p <0.05) between individual fatty acid species and parameters with
respect to diet.
The fatty acid composition of fractionated phospholipid (Table 4.8) revealed that the
decreases in 18:2, n-6 and 20:4, n-6 brought about by the n-3 PUFA diet were
confined to PC and PE, being especially marked in the latter. There was a small
increase in the minor proportion of 20:5, n-3 in PE and this fatty acid species was only
detected in PC in relation to n-3 PUFA supplementation; 20:5, n-3 was not detected in
PI or PS (< 0.1%). Increases in 22:6, n-3 ranged from 30% in PS to 200% in PE. The
n-6 PUFA diet led to modest increases in 18:2, n-6 in all fractions bar PS, but failed to
influence levels of 20:4, n-6, except in PE where, as noted in the previous chapter,
there was a small but significant decrease. The proportion of 22:6, n-3 fell by 25% in
PC, PE and PS in relation to n-6 PUFA feeding but was not affected in PI. The most
striking finding in the analysis of fractionated phospholipid fatty acid composition was
the close conservation of20:4, n-6 in PI regardless of diet.
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Table 4.8 Fatty acid composition of phospholipid fractions in the hearts of rats fed
experimental diets.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6c 9.1±0.4 7.4±0.7 10.3±0.5
20:4, n-6a>c 29.7±0.6 25.8±0.4 30.2±0.5
20:5, n-3 - 0.6±0.1 -
22:6, n-3a>b>c 4.1±0.1 9.6±0.8 2.9±0.2
PE 18:2, n-6b>c 4.6±0.1 3.8±0.3 6.5±0.3
20:4, n-6a'b'c 25.9±0.4 18.5±1.0 23.2±0.5
20:5, n-3a'b'c 0.2±0.0 0.5±0.1 O.liO.O
22:6, n-3a'b>c 20.2±0.2 32.9±1.5 15.2±0.7
PI 18:2, n-6b'c 4.2±0.2 4.2±0.2 7.5±0.4
20:4, n-6 35.5±0.9 34.8±1.0 33.6±1.1
20:5, n-3 - - -
22:6, n-3a>c 1.5±0.1 4.0±0.3 1.4±0.4
PS 18:2, n-6 2.6±0.3 1.9±0.2 2.8±0.1
20:4, n-6 10.3±0.6 9.0±0.5 11.4±0.3
20:5, n-3 - - -
22:6, n-3a>b'c 19.0±0.9 25.1±1.3 13.6±0.3
Values are means ± s.e.m. and represent the percentage weight of total fatty acid
species within each phospholipid fraction, n=8 hearts per dietary group. Significant
differences (0.001< p <0.05) between individual fatty acid species with respect to diet
are denoted by superscript characters. a control vs n-3 PUFA, b control vs n-6 PUFA,
c n-3 PUFA vs n-6 PUFA.
In response to n-3 PUFA supplementation, the n-6:n-3 ratios in all fractions were
halved and the double bond index increased significantly in PC and PE, though not in
PI and PS (Table 4.9). The n-6 PUFA diet increased the n-6:n-3 ratios by
approximately 50% but did not significantly affect the double bond indices.
Dietary PUFA and resistance arteries 79
TABLE 4.9 Phospholipidfraction n-6:n-3 ratios and double bond indices (DBI) in the hearts
ofratsfed experimental diets.
Phospholipid fraction, Diet
n-6:n-3 ratio and DBI Control n-3 PUFA n-6 PUFA
PC n-6:n-3 ratioa'b>c 7.7±0.3 2.9±0.4 11.8±0.9
DBIa>c 187±1 197±2 186±2
PE n-6:n-3 ratioa'b>c 1.6±0.0 0.7±0.1 2.5±0.1
DBIa>c 280±2 296±2 276±2
PI n-6:n-3 ratioa>c 1.5±0.1 4.0±0.3 1.4±0.4
DBI 184±3 186±4 184±4
PS n-6:n-3 ratioa>'3>c 1.1±0.1 0.6±0.0 2.1±0.0
DBI 188±4 186±5 182±4
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters denote
significant differences (0.000K p< 0.05) between parameters for individual
phospholipid fractions in relation to diet. a control vs n-3 PUFA, ^ control vs n-6
PUFA, c n-3 PUFA vs n-6 PUFA.
4.4 Discussion
§
The contractile responses of isolated rat femoral resistance arteries were attenuated by
supplementation of a 40% fat calorie diet of P/S ratio 0.3 with a small daily dose of
n-3 PUFA. Increasing the n-6 PUFA content of the diet to a P/S ratio of 2.0 did not
significantly affect contractile responses although a downward trend was evident. In
this experimental model, contractions were elicited by noradrenaline in the presence of
yohimbine and timolol, thus we infer that these responses were mediated by
a i -adrenoceptors. Neither of the PUFA diets had any influence on the acetylcholine
induced relaxation of pre-constricted vessels. The fatty acid composition of these small
vessels could not be determined due to the amounts of tissue required for analysis. The
effect of the diets was therefore monitored in cardiac tissue. Both PUFA diets were
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associated with significant changes in cardiac fractionated phospholipid fatty acid
composition, changes which were more extensive in relation to dietary n-3 PUFA.
The effect of dietary n-3 PUFA on the contractile responses of isolated resistance
arteries is consistent with our observations in the perfused hind-quarters of the rat
(Chapter 3). In the present study, the effect was apparent at higher doses of agonist, a
phenomenon also reported in rat aortic rings [Yin et al., 1991], The findings are also
consistent with other results obtained in the rat aorta following higher doses of n-3
PUFA [Lockette et al., 1982, Malis et al., 1991] to which we referred in Chapter 3.
The changes observed in cardiac fractionated phospholipid fatty acid composition
in relation to the n-3 PUFA diet were very similar to those described in Chapter 3.
Once again, if these changes occurred in the resistance arteries, the increased n-3 fatty
acid species content, increased unsaturation and decreased 20:4, n-6 content of PC
and PE may have led to the attenuation of contraction. It was again evident that the
fatty acid composition of the important PI fraction was relatively resistant to the
influence of dietary n-3 PUFA, particularly with respect to 20:4, n-6.
The diet rich in n-6 PUFA did not exert any significant effect on the contractile
responses of the isolated resistance arteries but, in contrast to the results in the
perfused rat hind-quarters, there was an obvious trend toward attenuation. This trend
might be important but potential mechanisms are obscure. There were some
statistically significant changes in fractionated phospholipid fatty acid composition in
relation to the n-6 PUFA diet but these were limited. Further, although n-6:n-3 ratios
rose, the double bond indices did not differ from control and were significantly lower
than for dietary n-3 PUFA in PC and PE. Increased release of prostacyclin or other
vasodilator prostaglandins, not investigated in our study, would be an attractive
explanation for an attenuatory effect of n-6 PUFA on contractile responses. However,
a mechanism of this nature is difficult to support as levels of precursor 20:4, n-6 were
unaltered in PC, PI and PS and actually fell in PE following the n-6 PUFA diet.
The lack of any obvious potential mechanism underlying the n-6 PUFA trend
renders the whole study less easy to interpret. Whereas the n-3 and n-6 PUFA effects
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on contraction were in the same direction; significant attenuation for the former and
non-significant attenuation for the latter, this was not true for their effects on fatty acid
composition. The significant effects of dietary n-6 PUFA on fatty acid composition
were generally opposite in direction to those of n-3 PUFA. Accordingly, the
mechanisms suggested above for n-3 PUFA are unlikely to be direct or linear.
In Chapter 3, we suggested that enhanced relaxation of the perfused vessels in the
n-3 PUFA group could have contributed to the findings. In the present study, the
normalisation procedure of the isometric myograph technique (section 2.5.4), which
sets different vessels to physiologically equivalent degrees of stretch, should minimise
baseline variations in relaxation state [Dainty et al, 1990]. It is interesting therefore
that the contractile responses of resistance arteries in the n-3 PUFA group overlap
those of the control group during the initial part of the dose response relationship
whereas the effect of n-3 PUFA was present throughout in the perfused hind-quarters.
This would be consistent with a baseline effect of n-3 PUFA in the hind-quarters
model which was not seen following normalisation in the myograph model. However,
it would follow that the vessels from the n-3 PUFA group would require a greater
degree of stretch to bring them to the same level as control and n-6 PUFA vessels and
this was not so; L\qq was not affected by diet. Thus, although the pattern of n-3
PUFA effect in the two preparations varies, this is unlikely to be due to removal of an
important baseline effect of n-3 PUFA in the isolated resistance artery.
Neither PUFA diet affected relaxation of the pre-constricted vessels to
acetylcholine. With regard to n-3 PUFA, this contradicts reports of enhanced
acetylcholine induced relaxation of aortic rings isolated from rats fed fish oil [Yin et
al, 1988, Malis et al, 1991] and is inconsistent with the enhanced endothelium-
dependent relaxation of coronary artery rings from swine fed fish oil [Shimokawa et
al, 1987], There are two points. First, we used a small dose of fish oil,The effect of
fish oil on the swine coronaries was shown to be dose dependent and relaxation was
much more pronounced with doses of n-3 PUFA 2 to 3-fold greater than in our study.
Second, there is recent evidence of regional variation in vascular relaxation responses
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in the rat. Enhanced acetylcholine induced relaxation of rat aortic rings in relation to
dietary n-3 PUFA was not apparent in mesenteric resistance arteries isolated from the
same animals, arteries which had nevertheless demonstrated an attenuated response to
noradrenaline [Yin etal., 1991], Nagao et al. [1992] have proposed that endothelium-
dependent relaxations in vessels of small calibre differ from those of large calibre.
In summary, a small dose of dietary n-3 PUFA attenuated the contractile responses
of isolated resistance arteries to oq-adrenoceptor stimulation. Associated changes in
the fatty acid composition of fractionated phospholipid suggested certain mechanisms
but there were contradictions in the effects of dietary n-6 PUFA. The following
chapter describes our initial studies of the effects of dietary PUFA on
a J-adrenoceptor stimulated responses in the isolated heart.
Chapter 5
Polyunsaturatedfatty acids in




The effects of dietary PUFA on the heart are the focus of much attention, particularly
with regard to n-3 PUFA. However, relatively few reports concern dietary PUFA and
aspects of cardiac physiology. Of these reports, the majority disagree over whether n-6
PUFA exert positive or negative inotropic effects in various experimental models.
Recently, it was reported that dietary menhaden oil (relatively rich in n-3 PUFA), but
not corn oil (rich in n-6 PUFA), attenuated the response of dP.dt"^wax; to
a i -adrenoceptor stimulation in retrogradely perfused isolated rat hearts [Reibel et al.,
1988], These n-3 and n-6 PUFA diets derived 12% of total calories from fat. In the
same study, responses to isoprenaline were not affected. We found this report
particularly interesting in view of our findings in the perfused rat hind-quarters
(Chapter 3) and isolated rat resistance artery (Chapter 4) but felt that certain questions
should be addressed. First, the n-3 PUFA diet used was probably deficient in n-6
essential fatty acids and the control diet was actually a laboratory chow, low in fat (5%
dietary calories). Second, work with isolated rabbit papillary muscles [Dukes and
VaughanWilliams, 1984] and isolated rabbit hearts [Aoyagi et al., 1991] suggests that
changes in peak LVP rather than LVdP.dt"! would better reflect oq-adrenoceptor
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stimulation in the isolated heart. Third, there was the possibility that dietary PUFA
might have influenced neuronal noradrenaline content and release [Wince et al., 1981,
Semafuko et al., 1987, Semafuko et al., 1989] and thus could have affected the
results.
We therefore decided to examine LV responses to a j -adrenoceptor stimulation
(noradrenaline in the presence of timolol) in rats fed isocalorific semisynthetic diets
deriving 10% of dietary calories from fat. The control diet had a P/S ratio of 0.3. To
prevent essential fatty acid deficiency, the n-3 PUFA diet contained sufficient 18:2,
n-6. This was also the predominant fatty acid in the n-6 PUFA diet. In a second related
study, we investigated the effect of chemical denervation on the responses of hearts
from rats fed the two PUFA diets.
5.2 Methods
§
5.2.1 Dietary PUFA and cardiac aj-adrenoceptor responses
Thirty-six Sprague-Dawley rats were separated at random into three groups of 12
under the conditions described in section 2.1. The precautions discussed in sections
2.2.2. and 2.2.3 were taken in the administration of the 10% fat calorie diets (Table
5.1). After an eight week feeding period, the surgical procedures of section 2.6.3 were
performed. Hearts were perfused according to the protocol of section 2.6.4. After
stabilising, the responses of the isolated perfused hearts to noradrenaline
0.1-2.4 pM in the presence of timolol 10 pM were recorded. Five hearts (control: 2,
n-3 PUFA: 1, and n-6 PUFA: 2) were excluded according to the criteria given in the
protocol.
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Table 5.1 Calculated fatty acid composition (%) of the control, n-3 PUFA and n-6 PUFA
experimental diets.
Fatty acid classes Control
Diet
n-3 PUFA n-6 PUFA
Saturates 5.0% 2.3% 1.5%
Monoenes 3.5% 2.2% 3.3%
n-6 PUFA 1.5% 2.5% 5.2%
n-3 PUFA _ 3.0% _
Total 10% 10% 10%
Percentage values reflect the proportion of dietary calories supplied by
different classes of fatty acid.
5.2.2 Influence of chemical denervation
For the second study, 30 Sprague-Dawley rats were separated at random into two
groups of 15. One group received the n-3 PUFA 10% fat calorie diet and the other the
n-6 PUFA diet. After five weeks feeding, the animals began the intraperitoneal
6-hydroxy-dopamine regimen of section 2.6.6. At the end of eight weeks feeding, an
experiment identical to the above was performed. No experimental exclusions were
indicated. In order to assess the effect of the 6-hydroxy-dopamine regimen, denervated
and non-denervated hearts (from the previous experiment) were assayed for
noradrenaline content (section 2.7.6).
5.3 Results
§
5.3.1 Dietary PUFA and LVP
An effect of dietary PUFA on peak LVP in the absence of noradrenaline infusion was
evident. The hearts from the n-3 PUFA group maintained significantly lower tensions
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than hearts from the control and n-6 PUFA groups, which were identical to one
another (Table 5.1).
Table 5.2 Peak LVP (mmHg) prior to noradrenaline infusion, in the presence of timolol





Values: mean ± s.e.m., n=10 per dietary group.
Superscript characters denote significant
differences (p< 0.05).
A similar pattern was seen in the dose response relationships to noradrenaline where
the n-3 PUFA diet was associated with significant parallel attenuation of the peak LVP
responses to cq-adrenoceptor stimulation compared to the control diet (p< 0.05,
ANOVA-RM, Fig. 5.1). As indicated, secondary analysis identified significant
differences at the lower three concentrations of agonist (p< 0.05, t test).
Figure 5.1 Response of peak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence of timolol
(10 pM), in hearts isolated from rats
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The n-6 PUFA diet was associated with slightly increased responses which did not
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Figure 5.2 Response of peak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence of timolol
(10 pM), in hearts isolatedfrom rats
fed experimental diets: n-6 PUFA.
Comparison of the two PUFA groups confirmed that they differed overall (p< 0.05,
ANOVA-RM, Fig. 5.3) and at the lower four concentrations of noradrenaline
(p< 0.05, / test).
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figure 5.3 Response of peak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence of timolol
(10 pM), in hearts isolated from rats
fed experimental diets: n-3 PUFA
and n-6 PUFA.
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5.3.2 Dietary PUFA and LVdP.dt"!
Table 5.3 LVdP.dt'^max (mmHg.sec'^) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence of timolol (10 pM), in hearts isolated from rats fed
experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 3060±180 2840±180 3380±420
0.10 pM 3220±240 3310±270 3640±340
0.19 pM 3420±220 3520±250 4280±450
0.52 pM 3840±220 4080±280 4500±350
1.22 pM 4080±250 4160±280 4580±330
2.37 pM 3960±240 4140±300 4640±330
Values: mean ± s.e.m., n=
between dietary groups.
=10 per dietary group. There were no significant differences
Table 5.4 LVdP.dr1min (mmHg.sec'l) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence of timolol (10 pM), in hearts isolated from rats fed
experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 1733±210 1475±427 1771±150
0.10 pM 1967±240 1675±170 2143±310
0.19 pM 2267±290 1850±160 2514±300
0.52 pM 2667±260 2150±180 2971±340
1.22 pM 2700±300 2275±190 3029±280
2.37 pM 2533±240 2350±210 2914±340
Values: mean ± s.e.m., n=10 per dietary group. There were no significant differences
between dietary groups.
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LVdP.dt"! increased in all three dietary groups with a\-adrenoceptor stimulation.
Neither the responses of dP.dt"1,^ (Table 5.2) nor dP.dt"1^ (Table 5.3) were
significantly influenced by diet (ANOVA-RM, N.S.).
5.3.3 Dietary PUFA and heart rate
Resting heart rates were in close agreement. There was a tendency toward initial
bradycardia in all three groups but this was not significant (Table 5.6). Neither n-3 nor
n-6 PUFA significantly affected the heart rate responses to a j-adrenoceptor
stimulation (ANOVA-RM, N.S.).
Table 5.6 Rates (bpm) at rest and in response to noradrenaline (0.1-2.4 pM), in the




n-3 PUFA n-6 PUFA
Baseline 269±10 279±10 275±9
0.10 pM 260±7 256±9 256±4
0.19 pM 251±5 245±7 260±8
0.52 pM 255±4 252±4 255±4
1.22 pM 264±5 255±6 263±7
2.37 pM 278±7 254±7 270±5
Values: mean ± s.e.m., n=10 per dietary group. There were no significant
differences between dietary groups.
5.3.4 Dietary PUFA: coronary flow and lactate production
Neither baseline coronary flow nor lactate production varied with respect to diet
(Table 5.7, overleaf).
PUFA in 10% fat diets and the heart 90
Table 5.7 Resting coronary flow (ml.min'Kg wet heart weight'^) and lactate production
(jumol.min'l .g wet heart weight'*) ofhearts isolatedfrom ratsfed experimental diets.
Diet Flow Lactate
Control 9.4±0.5 0.41±0.08
n-3 PUFA 9.6±0.3 0.41±0.06
n-6 PUFA 9.2±0.2 0.52±0.07
Values: mean ± s.e.m., n=10 per dietary group. There were no
significant differences between dietary groups.
5.3.5 Dietary PUFA: body and heart weights
The final body weights and wet heart weights were similar in the three dietary groups
(Table 5.8).
Table 5.8 Final body weights (g) and wet heart weights (g) ofratsfed experimental diets.
Diet Body weight Heart weight
Control 350±9 1.06±0.02
n-3 PUFA 354±8 1.09±0.03
n-6 PUFA 360±8 1.08±0.03
Values: mean ± s.e.m., n=10 per dietary group. There were no
significant differences between the groups.
5.3.6 Fatty acid composition of adipose tissue
Both the n-3 PUFA and n-6 PUFA diets brought about statistically significant changes
in adipose fatty acid composition (Table 5.9). The greater proportion of 18:2, n-6 and
a small but significant increase in the minor proportion of 20:4, n-6 in relation to the
n-3 PUFA diet compared to control reflected the composition of the diets (see Table
5.1). The n-3 fatty acid species 20:5, n-3 and 22:6, n-3 were only detectable in animals
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fed the n-3 PUFA diet. The n-6 PUFA diet led to 4-fold increases in 18:2, n-6 and
20:4, n-6.
Table 5.9 Fatty acid composition ofadipose tissue from ratsfed experimental diets.
Diet
Fatty acid species Control n-3 PUFA n-6 PUFA
18:2, n-6 6.6±0.4a>b 14.0±0.7a>c 27.1±0.9b>c
20:4, n-6 0.1±0.0d>e 0.3±0.0d 0.4±0.0e
20:5, n-3 - 1.6±0.1
22:6, n-3 - 1.9±0.1 -
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=8
per dietary group. Superscript characters denote significant differences
(p< 0.001) between individual fatty acid species in relation to diet.
5.3.7 Fatty acid composition of cardiac total and fractionated phospholipid
The PUFA diets did not affect the amount of total phospholipid or the contribution of
the individual phospholipid fractions (Table 5.10). Analysis of the fatty acid
composition of cardiac total and fractionated phospholipid revealed numerous
statistically significant differences. The n-3 PUFA diet brought about moderate
increases in 18:2, n-6 in total phospholipid (Table 5.11) compared to the control diet
but 20:4, n-6 was more than halved. There was a substantial increase in the small
proportion of20:5, n-3 with this diet and 22:6, n-3 tripled. The n-6:n-3 ratio fell 4-fold
and the double bond index increased significantly. Although the n-6 PUFA diet raised
the level of 18:2, n-6 relative to control, it did not exceed that of the n-3 PUFA diet.
Paradoxically, 20:4, n-6 was lower in relation to the n-6 PUFA diet than to control. Of
the n-3 fatty acid species, 20:5, n-3 was not detected (< 0.1%) and 22:6, n-3 was 60%
that of control and 20% that of the n-3 PUFA diet. The n-6:n-3 ratios nearly doubled
with n-6 PUFA but there was no significant change in the double bond index.
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n-3 PUFA n-6 PUFA
PC 3987±181 4276±249 4101±207
PE 3364±156 3178±141 3248±179
PI 450±20 443±17 421±19
PS 251±11 238±14 245±17
Total 9974±236 10093±210 11162±244
Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet heart weight"1, n=8
per dietary group. There were no significant differences between the groups.
Table 5.11 Fatty acid composition of total phospholipid, including the n-6:n-3 ratio and
double bond index (DBI), in hearts isolatedfrom ratsfed experimental diets.
Fatty acid species,
n-6:n-3 ratio and DBI Control
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 20.8±1.3a>b 24.5±0.6a 25.5±1.0b
20:4, n-6 21.8±0.4c'd 10.1±0.2c'e 18.5±0.5d>e
20:5, n-3 0.2±0.0f 1.7±0.1f -
22:6, n-3 5.2±0.4g>h ls.eiO^g'i 3.0±0.3h4
n-6:n-3 ratio 8.0±0.7)'k 1.8±0.1.M lS^il^k'1
DBI 200±3m 216±2m'n 195±2n
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids represent the percentage
weight of total fatty acid species. Superscript characters denote significant differences
(0.001< p < 0.05) between individual fatty acid species and parameters in relation to diet.
In the phospholipid fractions (Table 5.12), the n-3 PUFA diet was associated with
slightly higher levels of 18:2, n-6 than control but there were decreases in 20:4, n-6
ranging from 30% in PC and PI to 70% in PE. Of the n-3 fatty acids, 20:5, n-3 was
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present in small amounts in all fractions and marked increases in 22:6, n-3 were
confined to PC, PE and PI.
Table 5.12 Fatty acid composition ofphospholipidfractions in hearts isolatedfrom rats fed
experimental diets.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6a>b 10.8±0.4 14.4±0.8 13.8±0.7
20:4, n-6a>c 22.4±0.7 13.5±0.3 22.5±0.8
20:5, n-3 - 2.2±0.1 -
22:6, n-3a'b'c 2.1±0.4 9.0±0.4 1.2±0.1
PE 18:2, n-6a'b'c 4.8±0.2 6.5±0.3 8.8±0.6
20:4, n-6a>b'c 30.8±0.9 9.0±0.3 22.0±1.1
20:5, n-3a 0.1±0.0 1.3±0.4 -
22:6, n-3a'b'c 12.1±0.9 33.2±0.7 6.3±0.9
PI 18:2, n-6a>b 2.6±0.5 5.9±0.3 6.1±0.3
20:4, n-6a>b»c 29.8±1.01 20.1±0.7 24.2±1.3
20:5, n-3a 0.1±0.1 1.0±0.1 -
22:6, n-3a'c 0.1±0.1 2.7±0.3 0.3±0.0
PS 18:2, n-6a>b 2.3±0.2 3.4±0.4 3.1±0.3
20:4, n-6a>b'c 8.0±0.3 2.6±0.8 5.2±0.5
20:5, n-3 0.2±0.2 O.liO.O -
22:6, n-3a'c 12.4±1.5 10.8±1.5 4.2±0.7
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=8 per
dietary group. Superscript characters denote significant differences (0.001< p < 0.05) between
individual fatty acid species within each phospholipid fraction. a control vs n-3 PUFA,
b control vs n-6 PUFA, c n-3 PUFA vs n-6 PUFA.
The n-6 PUFA diet increased the proportion of 18:2, n-6 in all fractions compared to
control, approximately doubling it in PE and PI. However, in all fractions bar PC,
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there was a paradoxical decrease in 20:4, n-6; of the order of 20-25% in PI and PE. Of
the n-3 fatty acids, 20:5, n-3 was not detected in relation to the n-6 PUFA diet and
22:6, n-3 was less than half that of control except in PI where it was slightly higher.
A noticeable effect of the n-3 PUFA diet was the fall in the n-6:n-3 ratios which
reached 8-fold in PI (Table 5.13). Significant changes in the double bond index,
however, were restricted to PC and PE, where this parameter rose. In relation to the
n-6 PUFA diet, the n-6:n-3 ratios rose 2 to 3-fold but the double bond index fell
significantly in PC, PE and PS.
Table 5.13 Phospholipid fraction n-6:n-3 ratios and double bond indices (DBI) in hearts
isolatedfrom rats fed experimental diets.
Phospholipid fraction,
n-6:n-3 ratio and DBI Control
Diet

















PI n-6:n-3 ratioa'b>c 37.3±4.3 4.7±0.3 64.0±8.1
DBI 154±9 164±6 128±6
PS n-6:n-3 ratioa»b>c 1.7±0.3 0.7±0.1 5.2±1.0
DBIb 174±14 169±10 144±8
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters denote
significant differences (0.001< p< 0.05) between parameters for individual
phospholipid fractions. a control vs n-3 PUFA, b control vs n-6 PUFA,
c n-3 PUFA vs n-6 PUFA.
5.3.8 Correlations: LV responses and cardiac fatty acid composition
In each dietary group, it was possible to identify and select the responses of hearts for
which fractionated phospholipid fatty acid data were available (n=8 per group). Thus,
baseline and maximum peak LVP could be regressed against the values for individual
PUFA in 10%fat diets and the heart 95
fatty acid species, n-6:n-3 ratios and double bond indices, singly and in multiple
combinations, for each phospholipid fraction (see section 2.9). No significant
correlations were found.
5.4 Results: chemical denervation study
§
5.4.1 Dietary PUFA and LVP: denervated hearts
In contrast to the findings in the absence of chemical denervation (see Table 5.2),
baseline peak LVP was not influenced by diet in the denervated hearts (Table 5.14).
The lack of difference was related to higher pressures in the n-3 PUFA dietary group.
Table 5.14 Peak LVP (mm Hg) prior to noradrenaline infusion, in the presence of timolol
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Figure 5.4 Response of peak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pm), in the presence of timolol
(10 pM), of hearts isolated from
chemically denervated rats fed
experimental diets: n-3 PUFA and
n-6 PUFA.
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In both dietary groups, peak LVP fell slightly from baseline with the first dose of
noradrenaline (n-3 PUFA: 80±5 to 73±6 mm Hg, n-6 PUFA: 84±5 to 81±5 mm Hg,
both N.S.). Overall, hearts from the n-3 PUFA group showed attenuated responses to
ai-adrenoceptor stimulation (p< 0.05, ANOVA-RM, Fig. 5.4). Secondary analysis
identified significant differences at higher concentrations of agonist (p< 0.05, t test).
5.4.2 Dietary PUFA and LVdP.dt"' : denervated hearts
LVdP.dt-! was similar in the two dietary groups. In response to oq-adrenoceptor
stimulation, dP.dt~lmax and dP.dboth increased significantly (p< 0.001,
ANOVA) but neither was altered in relation to diet (ANOVA-RM, N.S., Table 5.15).
Table 5.15 LVdP.dt(mm Hg.secr*) at baseline and in response to noradrenaline
(0.1-2.4 pM) in the presence of timolol (10 pM) in hearts isolated from chemically
denervated ratsfed experimental diets.
Noradrenaline Diet
concentration n-3 PUFA n-6 PUFA
dP-dt ^max dP-dt ^min dP-dt"1^ dP-dt"1^
Baseline 3473±102 2200±141 3627±122 2460±157
0.10 pM 3000±177 1893±174 3427±184 2400±167
0.19 pM 4053±176 2907±166 4160±101 3320±211
0.52 pM 4453±187 3373±179 4573±129 3813±210
1.22 pM 4533±153 3653±180 4733±153 4013±209
2.37 pM 4467±149 3653±195 4667±160 3907±206
Values: mean ± s.e.m., n=15 per dietary group. There were no significant differences in
relation to diet.
5.4.3 Dietary PUFA and heart rate: denervated hearts
At baseline, hearts from the n-6 PUFA group had a faster heart rate but not
significantly so (Table 5.16). There was again a trend to initial bradycardia but this was
also not significant. Heart rates during a\ -adrenoceptor stimulation tended to be lower
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in relation to the n-3 PUFA diet but there was no statistically significant difference
between the groups (ANOVA-RM, N.S.).
Table 5.16 Rates (bpm) at rest and in response to noradrenaline (0.1-2.4 pM) in the
presence of timolol (10 pM) of hearts isolated from chemically denervated rats fed
experimental diets.
Noradrenaline Diet
concentration n-3 PUFA n-6 PUFA
Baseline 252±9 269±9
0.10 pM 232±8 254±9
0.19 pM 225±5 241±7
0.52 pM 234±4 250±7
1.22 pM 244±6 254±6
2.37 pM 252±5 266±6
Values: mean ± s.e.m., n=15 per dietary group. There were no
significant differences between the groups.
5 4.4 Dietary PUFA: coronary flow and lactate production: denervated hearts
The hearts of animals fed the n-3 and n-6 PUFA diets did not differ in terms of
coronary flow or lactate production (Table 5.17).
Table 5.17 Resting coronary flow (ml.min'Kg wet heart weight'^) and lactate production
(pmol.min'Kg wet heart weight'^) of hearts isolated from chemically denervated rats fed
experimental diets.
Diet Flow Lactate
n-3 PUFA 11.2±0.36 0.62±0.4
n-6 PUFA 12.3±0.48 0.67±0.4
Values: mean ± s.e.m., n=15 per dietary group. There were no
significant differences between the groups.
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5.4.5 Noradrenaline content: denervated hearts
Cardiac noradrenaline content did not differ in relation to the n-3 PUFA and n-6
PUFA diets (Table 5.18). In relation to 6-hydroxy-dopamine treatment, cardiac
noradrenaline was significantly reduced (to < 0.6%) regardless of diet.
Table 5.18 Cardiac noradrenaline content (nmol.g wet heart weight'^) in hearts isolated
from ratsfed experimental diets: effect ofdenervation with 6-hydroxy-dopamine.
Diet Normal Denervated
n-3 PUFA 7.61±1.43a 0.04±0.03a
n-6 PUFA 7.56±1.28b 0.05±0.04b
Values: mean ± s.e.m., n=8 per dietary group. a>b p< 0.001
There were no significant differences in relation to diet.
5.4.6 Body and heart weights: denervated animals.
In this experiment, both the final body weights and the wet heart weights were
significantly greater for rats fed the n-3 PUFA diet. The initial body weights were
identical (Table 5.19).
Table 5.19 Final body weights (g) and wet heart weights (g) of chemically denervated rats
fed experimental diets.
Diet Initial body weight Final body weight Heart weight
n-3 PUFA 163±3 383±8a 1.2±0.0b
n-6 PUFA 163±3 347±8a 1.0±0.0b
Values: mean ± s.e.m., n=15 per dietary group. a>b p< 0.05.
5.4.7 Fatty acid composition of adipose tissue: denervated animals
In adipose tissue, the proportion of 18:2, n-6 varied 2-fold with respect to diet but
20:4, n-6 was not altered (Table 5.20). Fatty acids of the n-3 series were not detected
(< 0.1%) in relation to the n-6 PUFA diet.
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Table 5.20 Fatty acid composition of adipose tissue from chemically denervated rats fed
experimental diets.
Diet
Fatty acid species n-3 PUFA n-6 PUFA
18:2, n-6 14.2±0.7a 25.9±1.5a
20:4, n-6 0.4±0.0 0.4±0.0
20:5, n-3 1.3±0.1 -
22:6, n-3 1.9±0.2 .
Values (mean ± s.e.m.) represent the percentage weight of total
fatty acid species, n=8 per dietary group. a p< 0.0001.
5.4.8 Fatty acid composition of cardiac total and fractionated phospholipid
The amount of total phospholipid and the distribution of the individual phospholipid
fractions was not affected by diet (Table 5.21).
Table 5.21 Total phospholipid and phospholipid fractions in hearts isolated from
chemically denervated ratsfed experimental diets.
Phospholipid Diet






Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet
heart weight"^, n=8 per dietary group. There were no
significant differences between the groups.
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The analysis of total and fractionated phospholipid fatty acid composition revealed
many statistically significant differences in relation to diet. In total phospholipid, the
proportion of 18:2, n-6 was the same with respect to the two PUFA diets but there
was a 2-fold differences in the level of 20:4, n-6 (Table 5.22). Of the n-3 series, 20:5,
n-3 was not detected (< 0.1%) in relation to the n-6 PUFA diet which was associated
with a total phospholipid 22:6, n-3 content 30% of that brought about by the n-3
PUFA diet. There was a 6-fold difference in the n-6:n-3 ratios and the double bond
index was significantly greater for the n-3 PUFA group.
Table 5.22 Fatty acid composition, including the n-6:n-3 ratio and double bond index
(DBI), of total phospholipid in hearts isolated from chemically denervated rats fed
experimental diets.
Fatty acid species,
n-6:n-3 ratio and DBI
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 24.7±0.6 25.4±0.5
20:4, n-6 11.0±0.2a 20.1±0.1a
20:5, n-3 1.7±0.1 -
22:6, n-3 18.4±0.4b 5.1±0.2b
n-6:n-3 ratio 1.6±0.1c 9.2±0.5C
DBI 234±3d 210±ld
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids
represent the percentage weight of total fatty acid species. Superscript
characters denote significant differences (p< 0.001) between individual
fatty acid species and parameters.
The fatty acid composition of fractionated phospholipid revealed that 18:2, n-6 was
unaltered with respect to diet, apart from in PE where it was slightly increased by n-6
PUFA (Table 5.23). The proportion of 20:4, n-6 varied up to 2-fold in PC, PE and PS
but the difference was smaller in PI. Again, 20:5, n-3 was only detected in relation to
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the n-3 PUFA diet which brought about 3 to 6 times greater levels of 22:6, n-3 than
the n-6 PUFA diet.
Table 5.23 Fatty acid composition of phospholipid fractions in hearts isolated from
chemically denervated ratsfed experimental diets.
Phospholipid fraction and Diet
fatty acid species n-3 PUFA n-6 PUFA
PC 18:2, n-6 16.0±0.8 15.2±0.5
20:4, n-6 14.0±0.4a 22.9±0.6a
20:5, n-3 2.0±0.1 -
22:6, n-3 9.0±0.7b 1.5±0.2b
PE 18:2, n-6 7.2±0.3C 9.0±0.3C
20:4, n-6 9.9±0.2d 21.3±0.6d
20:5, n-3 2.1±0.1 -
22:6, n-3 32.0±1.0e 9.9±0.4e
PI 18:2, n-6 7.0±0.1 6.8±0.3
20:4, n-6 24.8±0.9S 27.8±0.9§
20:5, n-3 1.0±0.2 -
22:6, n-3 2.9±0.3h 0.4±0.1h
PS 18:2, n-6 2.9±0.2 2.8±0.2
20:4, n-6 2.5±0.2i 5.2*0.4*
20:5, n-3 0.1±0.1 -
22:6, n-3 19.4±1.8J 6.1±l.oi
Values (mean ± s.e.m.) represent the percentage weight of total fatty
acid species, n=8 per dietary group. Superscript characters denote
significant differences (0.0001< p< 0.05) between individual fatty acid
species within fractions in relation to diet.
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There were striking variations in the n-6:n-3 ratio, ranging from 8-fold in PE to
11-fold in PI (Table 5.24). The double bond indices were higher in all fractions in
relation to the n-3 PUFA diet, though not significantly so in PI.
Table 5.24 Phospholipidfraction n-6:n-3 ratios and double bond indices in hearts isolated
from chemically denervated ratsfed experimental diets.
Phospholipid fraction, Diet
n-6:n-3 ratio and DBI n-3 PUFA n-6 PUFA
PC n-6:n-3 ratio 2.3±0.1a 23.8±3.3a
DBI 178±5b 162±4b
PE n-6:n-3 ratio 0.5±0.0C 4.1±0.2C
DBI 282±5d 238±3d
PI n-6:n-3 ratio 6.0±0.5e 67.0±7.6e
DBI 159±5 146±5
PS n-6:n-3 ratio 0.4±0.0f 4.0±0.4f
DBI 172±9§ 142±10g
Values: mean ± s.e.m., n=8 per dietary group. Superscript
characters denote significant differences (0.0001< p< 0.05)
between parameters for individual phospholipid fractions.
5.4.9 Changes in phospholipid fatty acid composition in relation to denervation
We compared the effects of the PUFA diets on cardiac fractionated phospholipid fatty
acid composition in the first study with the effects in the second (denervation) study.
Analysis of variance (section 2.8) confirmed that there was no significant variation in
the fatty acid composition of PC and PI between the studies. Variance in PE arose
from the smaller fall in 22:6, n-3 in the second study in relation to the n-6 PUFA diet
(9.9±0.4 vs 6.3±0.9). However, these differences were not of great magnitude. More
interesting was variation in the effects of the n-3 PUFA diet in PS whereby the
proportion of 22:6, n-3 in the second study was considerably greater than in the first
(19.4±1.8 vs 10.8±1.5). The remaining fatty acid species in PE and PS did not vary.
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There was no significant variation in the n-6:n-3 ratios between the two studies and
the double bond index only varied in PI, where it was greater in relation to n-6 PUFA
following denervation (146±5 vs 128±6).
5.4.10 Correlation of LV responses with cardiac fatty acid composition
As in the preceding experiment, no correlation could be identified between the LV
responses and the values for individual fatty acid species, n-6:n-3 ratios and double
bond indices, singly or in multiple combinations, in the different phospholipid fractions.
5.5 Discussion
§
The first of these two studies demonstrated that a 10% fat calorie diet rich in n-3
PUFA (30% of fat calories), compared to a relatively saturated control diet (10% fat
calories, P/S ratio 0.3), was associated with the attenuation of peak LVP responses to
noradrenaline in the isolated retrogradely perfused rat heart. The responses were
obtained in the presence of timolol and were previously shown to be abolished by
prazosin in this model, thus we infer that they were mediated by the a\ -adrenoceptor.
A 10% fat calorie diet rich in n-6 PUFA (-50% of fat calories, almost all 18:2, n-6)
had no statistically significant effect, but peak LVP responses were slightly enhanced
compared to control. Comparison of peak LVP for the two PUFA diets confirmed that
they differed significantly. There were small increases in LVdP.dt"! in response to
a \-adrenoceptor stimulation but these were not influenced by diet. Neither heart rate
nor baseline coronary flow was influenced by diet. Compared to the control diet, both
PUFA diets brought about widespread statistically significant changes in phospholipid
fatty acid composition.
Subsequently, the n-3 and n-6 PUFA diets, which had differed the most in terms of
LVP responses in the first study, were compared again in the context of chemical
denervation. The difference in baseline peak LVP between the n-3 and n-6 PUFA diets
disappeared when animals were denervated, but the separation of responses to
noradrenaline was maintained. This suggests that, in this experimental model, dietary
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n-3 PUFA may normally be associated with a reduction in spontaneous noradrenaline
release. As in the first study, LVdP.dt"!, heart rate and coronary flow did not differ
between the two PUFA groups. Following chemical denervation, the distribution of
individual fatty acid species within the phospholipid fractions for the n-3 and n-6
PUFA diets was very similar to that of the previous study with the exception of the
22:6, n-3 component in PS. We are not aware of any evidence to suggest that the
metabolism ofPS in relation to the sympathetic nervous system is distinct from that of
the other three phospholipid fractions analysed.
Although we agree with the contention of Reibel et al. [1988] that dietary fish oil
can reduce a j -adrenoceptor mediated cardiac inotropy, we disagree with respect to
the parameter(s) affected. These authors reported that fish oil decreased increments in
LVdP.dt-l^, (to phenylephrine in the presence of propranolol), but we could not
demonstrate any change in either LVdP.dt"lwax; or LVdP.dt~^min with respect to
diet. The changes we observed were confined to peak LVP, a parameter not reported
in this other study. The attenuation of peak LVP by dietary n-3 PUFA in our study is
consistent with the decreases in resting tension, and tension responses to Ca?+,
described for papillary muscles isolated from rats fed an n-3 PUFA diet [McLennan et
al., 1987], These findings, and ours, contrast with the lack of effects of n-3 PUFA in
swine, where cardiac parameters at rest and during rapid atrial pacing were unaltered
in animals fed mackerel oil as opposed to saturated fat [Hartog et al, 1987a, Hartog
etal., 1987A].
There was no significant effect of the 10% fat calorie n-6 PUFA diet. Dietary n-6
PUFA in 30-35% fat calorie diets has been reported to improve the relationship
between LV work and filling pressure [de Deckere and ten Hoor, 1980] and to
enhance LV contractile force [Hoffman et al., 1982] in the isolated rat heart.
(Increased baseline coronary flow with n-6 PUFA was also reported in these studies
but the effect was not apparent in the working heart [de Deckere and ten Hoor, 1980]
or at one year [Hoffman et al., 1982].) Conversely, in the study referred to above
[McLennan et al., 1987], the tension responses of rat papillary muscles were reduced
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following dietary n-6 PUFA. Adding to these inconsistencies, another investigation
from this group, using a similar n-6 PUFA diet, found no effect on either resting or
stimulated LV ejection fraction in marmosets [Charnock et al., 1987], Thus, the
effects of different n-6 PUFA diets on cardiac parameters in different experimental
models are not easy to interpret.
The mechanism underlying the effects of dietary n-3 PUFA in our two studies
remains unclear. Flowever, the changes in fractionated phospholipid fatty acid
composition in relation to the n-3 PUFA diet suggest certain possibilities. The changes
in the PI fraction were extensive; the proportion of22:6, n-3 was up to 30-fold greater
than with either of the other two diets and the proportion of 20:4, n-6 was
substantially (50%) decreased compared to control. With a lower dose of n-3 PUFA in
a 40% fat calorie diet we have previously found 20:4, n-6 to be tightly conserved in PI
(Chapters 3 and 4). Ifwe can assume that the fatty acid composition ofPI reflects that
of PIP2, the source of the second messengers inositol-fra-phosphate and
diacylglycerol, then oq-adrenoceptor signalling may have been affected in terms of
second messenger composition and release. This is unlikely to be the sole explanation
for the effects of n-3 PUFA as no correlation could be found between the fatty acid
composition ofPI and the cardiac responses. The substantially lower levels of 20:4, n-
6 and significantly higher double bond indices in PC and PE, as mentioned before,
carry implications for prostanoid synthesis and cell membrane-linked events.
Enrichment of the diet with n-6 PUFA had no significant effect on peak LVP
responses compared to control despite 18:2, n-6 accounting for almost all the dietary
fat calories. The explanation for the lack of effect may lie in the relatively limited
changes the n-6 PUFA diet produced in fractionated phospholipid. Levels of 18:2, n-6
altered little; differences in 18:2, n-6 between the two PUFA diets were only seen in
PE, and 20:4, n-6 was either unchanged or decreased compared to the control diet.
Interestingly, the double bond index always fell in relation to dietary n-6 PUFA.
EDRF is released from coronary arteries [Collins et al., 1986, Nyborg, 1990,
Lamontagne et al., 1992] and the endocardium [Shah et al., 1991] and can reduce
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myocardial contractility. Enhancement of the actions ofEDRF by n-3 PUFA might be
relevant to our observations and this is discussed in detail in Chapter 9.
In summary, a high dose of dietary n-3 PUFA (3.0% dietary calories in a 10% fat
calorie diet) was associated with the attenuation of peak LVP responses to
ai-adrenoceptor stimulation in the isolated rat heart. Changes in fractionated
phospholipid fatty acid composition suggested certain possible mechanisms in the n-3
PUFA effect. The amount of n-3 PUFA administered was very large indeed and it
remains to be seen whether a realistic dose might have similar consequences. In the
following chapter, the effects of dietary PUFA on the heart are pursued in the context
of semisynthetic diets relevant to man.
Chapter 6
Polyunsaturatedfatty acids in




In Chapter 5 we demonstrated that the responses of peak LVP to oq-adrenoceptor
stimulation in the isolated rat heart could be attenuated by dietary n-3 PUFA
compared to a control relatively saturated diet. Dietary n-6 PUFA did not exert this
effect. For these studies we used diets deriving 10% of dietary calories from fat in an
attempt to reproduce published findings [Reibel et at, 1988] without the shortcomings
of their design. Such diets are of limited relevance to man. The two PUFA diets are
too rich in their respective PUFA series and all three diets are too low in fat. Having
identified responses which were susceptible to dietary influence in our experimental
model, we wished to pursue the possible effects of the diets described in Chapters 3
and 4; diets which represent what is, or might be, consumed by man. Accordingly, we
examined the effects of dietary PUFA in 40% fat calorie diets on the responses to
ai-adrenoceptor stimulation in the isolated rat heart. As before, the control diet had a
P/S ratio of 0.3 with an adequate n-6 essential fatty acid intake. Supplementation of
the control diet with 0.4% dietary calories fish oil provided the n-3 PUFA diet and the
n-6 PUFA diet had a P/S ratio of2.0.
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6.2 Methods
§
Thirty-six Sprague-Dawley rats were separated at random into three groups and
commenced on semisynthetic experimental diets deriving 40% of total dietary calories
from fat. Briefly, 24 animals received a control diet of P/S ratio 0.3, and 12 of these
received a daily oral supplement of n-3 PUFA (0.4% total dietary calories). A third
group of 12 animals received an n-6 PUFA diet of P/S ratio 2.0. The control and n-6
PUFA groups received a daily oral dose of olive oil which was retained from their
daily dietary fat intake (see section 2.2.4). At the end of the eight week feeding period,
hearts were perfused (section 2.6.3) and the responses of the isolated hearts to
noradrenaline 0.1-2.4 pM in the presence of timolol 10 pM were recorded according
to the protocol described in section 2.6.4. No experimental exclusions were indicated.
6.3 Results
§
6.3.1 Dietary PUFA and LVP
At baseline, in the absence of noradrenaline but in the presence of timolol, peak LVP
was lower for the two PUFA groups but neither differed significantly from control
(Table 6.1).
Table 6.1 Peak LVP (mm Hg) prior to noradrenaline infusion, in the presence oftimolol





Values: mean ± s.e.m., n=12 per dietary group.
There were no significant differences between the
groups.
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The response of peak LVP to oq-adrenoceptor stimulation in hearts from the n-3
PUFA group tended to be less than that of the control group but the difference was
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Figure 6.1 Response ofpeak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence of timolol
(10 pM), in hearts isolatedfrom rats
fed experimental diets: n-3 PUFA.
In contrast, the responses for the n-6 PUFA dietary group were significantly
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figure 6.2 Response ofpeak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence oftimolol
(10 pM), in hearts isolatedfrom rats
fed experimental diets: n-6 PUFA.
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Secondary analysis revealed significant differences between the n-6 PUFA and control
groups at higher concentrations of noradrenaline. The responses for the n-6 PUFA
group tended to diverge from those of the n-3 group (p = 0.06, ANOVA-RM).
6.3.2 Dietary PUFA and LVdP.dt"1
Neither 6PA\r^max nor dP.dt"1^ were altered at baseline with respect to diet. Both
parameters increased significantly (p< 0.001, ANOVA) in response to
a i-adrenoceptor stimulation but there were no significant differences (ANOVA-RM)
between the three dietary groups (Tables 6.2 and 6.3).
Table 6.2 LVdP.dt'^max (mm Hg.sec'^) at baseline and in response to noradrenaline





n-3 PUFA n-6 PUFA
Baseline 3008±250 2850±121 3083±149
0.10 pM 3083±249 3000±118 3200±232
0.19 pM 3583±278 3417±158 3833±280
0.52 pM 3983±237 3817±215 4150±209
1.22 pM 4300±252 4267±236 4217±210
2.37 pM 4333±280 4300±303 4083±236
Values: mean ± s.e.m., n=12 per dietary group. There were no significant differences in
relation to diet.
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Table 6.3 LVdP.dt ^min (mm Hg.sec"^) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence oftimolol (10 pM), in hearts isolatedfrom ratsfed
experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 2167±153 2050±100 2250±128
0.10 pM 2250±167 2100±101 2258±152
0.19 pM 2717±194 2383±134 2683±202
0.52 pM 3283±215 2983±127 3133±144
1.22 pM 3650±222 3333±164 3283±158
2.37 pM 3567±248 3233±218 3250±197
Values: mean ± s.e.m.,
relation to diet.
n=12 per dietary group. There were no significant differences in
>.3 Dietary PUFA and heart rate
Table 6.4 Heart rate (bpm) at baseline and in response to noradrenaline (0.1-2.4 pM), in
the presence oftimolol (10 pM), in hearts isolatedfrom ratsfed experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 309±8a 316±8 331±6a
0.10 pM 296±8 304±8 312±7
0.19 pM 287±8 293±8 291±7
0.52 pM 286±6 292±8 292±9
1.22 pM 286±7 292±6 293±9
2.37 pM 293±8 296±7 303±9
Values: mean ± s.e.m., n=12 per dietary group. a p< 0.05.
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At baseline, the heart rate of the n-6 PUFA group was significantly greater than that of
the control group, but not than that of the n-3 PUFA group. This difference was no
longer apparent at the lowest concentration of agonist, and the dose response
relationships for the three groups did not vary with respect to diet (Table 6.4). Heart
rates were generally slower, but did not alter significantly, during a j-adrenoceptor
stimulation.
6.3.4 Dietary PUFA: coronary flow and lactate production
In this study, coronary flow was assessed at baseline, twice during a \ -adrenoceptor
stimulation (at noradrenaline concentrations 0.19 pM and 2.37 pM) and on recovery 3
minutes post-noradrenaline infusion (Table 6.5). At none of these points did the three
dietary groups differ significantly from one another. Coronary flow did decrease in all
three groups with increasing concentrations of noradrenaline.




n-3 PUFA n-6 PUFA
Baseline 10.6±0.5 11.8±0.6 11.4±0.4
0.19 pM 9.2±0.3 8.7±0.4 7.9±0.6
2.37 pM 8.4±0.6 8.1±0.4 7.7±0.5
Recoveryt 9.6±0.5 9.5±0.4 9.1±0.8
Values: mean ± s.e.m., n=12 per dietary group. There were no significant differences
in relation to diet. T 3 minutes post-noradrenaline infusion.
Baseline lactate production was not influenced by diet (Table 6.6).
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Table 6.6 Production oflactate (pmol.min'Kg wet heart weight'1) by hearts isolatedfrom





Values: mean ± s.e.m., n=12 per dietary group.
There were no significant differences between the
groups.
6.3.5 Dietary PUFA: body and heart weights
Rats fed the n-3 PUFA diet were heavier, and those fed the n-6 PUFA diet lighter,
than control, but neither significantly so (Table 6.7).
Table 6.7 Final body weights (g) and heart weights (g) ofratsfed experimental diets.
Diet Body weight Heart weight
Control 332±13 1.00±0.04
n-3 PUFA 352±14 1.08±0.03
n-6 PUFA 318±8 0.97±0.02
Values: mean ± s.e.m., n=12 per dietary group. There were no
significant differences between the groups.
6.3.6 Fatty acid composition of adipose tissue
The proportion of 18:2, n-6 did not alter in relation to n-3 PUFA supplementation but
the small percentage of adipose 20:4, n-6 was decreased (Table 6.8). Only in the n-3
PUFA group was 22:6, n-3 detectable in adipose tissue; 20:5, n-3 was not apparent for
any of the diets. The P/S ratio 2.0 n-6 PUFA diet more than doubled the proportion of
18:2, n-6 and was associated with a small but significant increase in 20:4, n-6.
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Table 6.8 Fatty acid composition ofadipose tissue from ratsfed experimental diets.
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Fatty acid species Control
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 13.7±0.2a 13.4±0.1b 31.3±0.3a'b
20:4, n-6 0.2±0.0c'd 0.1±0.0c>e 0.3±0.0d'e
20:5, n-3 - - -
22:6, n-3 - O.liO.O -
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=8
per dietary group. Superscript characters denote significant differences
(0.05< p< 0.001) between individual fatty acid species in relation to diet.
6.3.7 Fatty acid composition of cardiac total and fractionated phospholipid
The distribution of the individual phospholipid fractions and the amount of total
phospholipid were unaffected by diet (Table 6.9).





n-3 PUFA n-6 PUFA
PC 5081±161 4832±158 5236±250
PE 3287±200 3430±123 3233±228
PI 470±11 484±12 474±13
PS 265±22 266±19 277±21
Total 11233±272 11611±275 11531±256
Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet heart weight"!, n=8 per
dietary group. There were no significant differences between the groups.
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The fatty acid composition of both total and fractionated phospholipid revealed a
number of statistically significant changes. In total phospholipid (Table 6.10), the n-3
PUFA supplement did not alter 18:2, n-6 compared to the control diet but there was a
25% fall in 20:4, n-6. Only in relation to dietary n-3 PUFA was 20:5, n-3 detected and
22:6, n-3 was nearly doubled. The n-6:n-3 ratio was more than halved and the double
bond index increased significantly. With the P/S ratio 2.0 n-6 PUFA diet, there was a
small increase in 18:2, n-6 but 20:4, n-6 did not change. The proportion of 22:6, n-3
fell slightly with dietary n-6 PUFA and there was a 50% rise in the n-6:n-3 ratio but
the double bond index did not differ significantly from control.
table 6.10 Fatty acid composition oftotal phospholipid, including the n-6:n-3 ratio and
double bond index (DBI), in hearts isolatedfrom ratsfed experimental diets.
Fatty acid species.
n-6:n-3 ratio and DBI Control
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 19.6±0.4a 19.7±0.4b 23.0±0.6a'b
20:4, n-6 24.0±0.4C 18.7±0.5c>d 23.4±0.3d
20:5, n-3 - 0.3±0.0 -
22:6, n-3 9.5±0.3 17.2±0.6 7.5±0.3
n-6:n-3 ratio 4.3±0.1e 2.0±0.1e>f 6.1±0.3f
DBI 228±2§ 243±2§>h 223±2h
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids represent the
percentage weight of total fatty acid species. Superscript characters denote significant
differences (p< 0.0005) between individual fatty acid species in relation to diet.
Examining the fatty acid composition of the phospholipid fractions (Table 6.11),
supplementation of the diet with n-3 PUFA left 18:2, n-6 unaltered but 20:4, n-6
decreased in all fractions. The decrease was limited in PI and PS but substantial in PC
and PE. With regard to the n-3 fatty acid species, 20:5, n-3 was only detected in PC
and PE with n-3 PUFA supplementation and was not apparent in PI and PS with any
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of the diets. The proportion of 22:6, n-3 rose more than 50% in PE and PS and more
than doubled in PC and PI. In relation to the n-6 PUFA diet, there were modest
increases in 18:2, n-6 in all fractions but 20:4, n-6 was unaltered compared to the
control diet. As mentioned, 20:5, n-3 was not detected following the n-6 PUFA diet
and 22:6, n-3 showed small decreases.
Table 6.11 Fatty acid composition ofphospholipidfractions in hearts isolatedfrom rats fed
experimental diets.
Phospholipid fractions and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6b>c 8.3±0.5 9.1±0.6 11.5±0.7
20:4, n-6a'c 29.3±0.6 23.8±0.7 29.4±0.6
20:5, n-3 - 0.3±0.1 -
22:6, n-3a»b'c 3.9±0.7 8.9±0.6 2.7±0.2
PE 18:2, n-6b'c 4.9±0.2 4.8±0.4 6.8±0.5
20:4, n-6a>c 24.5±0.5 17.9±0.9 23.3±0.6
20:5, n-3 - 0.3±0.1 -
22:6, n-3a>b'c 18.9±0.5 29.8±2.2 16.6±0.9
PI 18:2, n-6b'c 4.2±0.2 4.1±0.2 6.9±0.2
20:4, n-6a 36.9±0.6 34.9±0.5 35.7±0.4
20:5, n-3 - - -
22:6, n-3a'b'c 1.2±0.1 2.7±0.1 0.8±0.1
PS 18:2, n-6c 2.3±0.3 2.1±0.1 3.4±0.5
20:4, n-6a 7.1±0.6 4.9±0.3 5.8±0.6
20:5, n-3 - - -
22:6, n-3a'c 12.9±1.3 20.6±1.6 10.7±0.8
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=8 per
dietary group. Superscript characters denote significant differences (0.0005< p< 0.05) between
individual fatty acid species within phospholipid fractions. a control vs n-3 PUFA, b control vs
n-6 PUFA, c n-3 PUFA vs n-6 PUFA
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The n-6:n-3 ratios fell at least twofold with dietary n-3 PUFA which increased the
double bond index significantly in PC and PE but not in PI and PS (Table 6.12) The
most prominent effect of the P/S 2.0 n-6 PUFA diet was an increase in the n-6:n-3
ratio; up by a third in PC, PE and PS and by more than half in PI. However, the double
bond index did not differ significantly from control following dietary n-6 PUFA.
Table 6.12 Phospholipidfraction n-6:n-3 ratios and double bond indices (DBI) in hearts
isolatedfrom rats fed experimental diets.
Phospholipid fraction, Diet
n-6:n-3 ratio and DBI Control n-3 PUFA n-6 PUFA
PC n-6:n-3 ratioa>b>c 7.8±0.5 3.0±0.2 12.4±0.8
DBIa>c 186±2 194±3 184±2
PE n-6:n-3 ratioa>b>c 1.7±0.1 0.9±0.2 2.3±0.2
DBIa'c 272±4 292±5 268±4
PI n-6:n-3 ratioa>b>c 22.7±1.3 9.8±0.3 35.0±2.0
DBI 183±3 183±3 179±2
PS n-6:n-3 ratio3'c 1.6±0.2 0.5±0.0 2.0±0.1
DBI 175±11 183±12 167±10
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters denote
significant differences (0.001< p< 0.05) between parameters for individual
phospholipid fractions. a control vs n-3 PUFA, " control vs n-6 PUFA, c n-3
PUFA vs n-6 PUFA
6.3.8 Correlations: LV responses with fatty acid composition
The correlation of individual fatty acid species, n-6:n-3 ratios and double bond indices,
singly and in multiple combinations, in each phospholipid fraction with the changes in
LVP failed to reveal any significant relationships.
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6.4 Discussion
§
This study demonstrated once more that the responses of the isolated rat heart to
a i -adrenoceptor stimulation can be influenced by dietary PUFA. However, the
findings are in marked contrast to those of Chapter 5 where a 10% fat diet rich in n-3
PUFA, but not a diet rich in n-6 PUFA, significantly attenuated peak LVP responses
to noradrenaline in the presence of timolol. With the 40% fat diets, supplementation of
a relatively saturated (P/S ratio 0.3) control diet with a small amount of n-3 PUFA
(0.4% dietary calories) tended to reduce peak LVP responses but the effect was not
significant. Conversely, an n-6 PUFA diet (P/S ratio 2.0) did significantly attenuate
peak LVP responses. LVdP.dt"^wax:, LVdP.dt"^^ and coronary flow were not
affected by diet, either prior to or during a\-adrenoceptor stimulation. Both 40% fat
PUFA diets brought about numerous significant changes in phospholipid fatty acid
composition.
With regard to the effects of dietary n-6 PUFA, the difference between the 10%
and 40% studies is remarkable. Whereas the peak LVP responses of the 10% and 40%
fat control groups are superimposable at 0.19-1.22 pM (see Figs. 5.2 and 6.2), the
significant effect of n-6 PUFA in the current study is opposite in direction to the
previous trend. The reason for these contrasting results is unclear but there were
several differences in the effects of the two n-6 PUFA diets on phospholipid fatty acid
composition. In total phospholipid, at 40% fat, 18:2, n-6 was higher in relation to the
n-6 PUFA diet than control or n-3 PUFA diets (Table 6.10) but this was not the case
at 10% fat where the n-3 and n-6 PUFA diets did not differ (Table 5.11). But it is the
disparity in the effects of the two PUFA diets on 20:4, n-6 that is most striking. At
10% fat there was an unexpected decrease in 20:4, n-6 with n-6 PUFA whereas at
40% fat this fatty acid species remained unchanged by n-6 PUFA, as we commonly
find. This observation extends to fractionated phospholipid fatty acid composition
where paradoxical falls in 20:4, n-6 in PE, PI and PS were seen with the 10% fat n-6
PUFA diet (Table 5.12). This did not occur at 40% fat (Table 6.11).
PUFA in 40%fat diets and the heart 119
In the present study, the small dose of n-3 PUFA (0.4% dietary calories) had no
significant effect on the responses of the isolated heart in contrast to what was found
with a higher dose (7.5% dietary calories) in a lower fat diet. The differences in tissue
fatty acid composition in response to these two n-3 PUFA diets are extensive. In total
and fractionated phospholipid (Tables 5.11, 5.12 and 6.10, 6.11) supplementation of
the 40% fat diet with 0.4% total calories n-3 PUFA affected 20:4, n-6 to a lesser
extent than was the case for the 10% fat n-3 PUFA diet. Higher levels of 22:6, n-3 for
all three 40% fat diets meant that the relative increases in this fatty acid species
brought about by the n-3 PUFA supplement were smaller. Interestingly, although the
associated decreases in the n-6:n-3 ratio were curtailed, relative increases in the double
bond index were similar (Tables 5.13 and 6.12). Comparison of the 10% and 40% fat
diets is however complicated by the fact that the amount of fat, and not the
composition, differed between the two control diets. As a result, there was less 22:6,
n-3 in the cardiac phospholipids of rats fed the control 10% fat diet.
These differences between the effects on phospholipid fatty acid composition of
the 10% and 40% fat diets may in some way account for the differences in their effects
on peak LVP. However, the difficulty in interpreting these data is the lack of statistical
support for a cause and effect relationship; we were unable to correlate fatty acid
composition, n-6:n-3 ratio or double bond index with LVP. Indeed, this remained true
when the data for the 10% fat and 40% fat experiments was pooled.
The effect of n-6 PUFA on the responses of the isolated heart in the present study
contrasts again with reports of increased cardiac work and contractility following
dietary n-6 PUFA [de Deckere and ten Hoor, 1980, Hoffman et al., 1982], Although
peak LVP is not an index of contractility, we found no effect on LVdP.dt'l. The
findings of the present study are now consistent with the attenuation of rat papillary
muscle tension responses in relation to an n-6 PUFA diet [McLennan et al., 1987],
Once more, there was no effect ofn-6 PUFA on coronary flow.
The mechanism underlying the effect of dietary n-6 PUFA in our study is unclear.
Increases in phospholipid 18:2, n-6 following dietary n-6 PUFA did not lead to
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increases in the prostanoid precursor 20:4, n-6 but a simple and attractive proposition
is that myocardial prostanoid release was affected in our study. This possibility is
examined in the following chapter.
In summary, a 40% fat calorie diet with an increased proportion of n-6 PUFA (P/S
ratio 2.0), compared to a control relatively saturated diet (40% fat, P/S ratio 0.3), was
associated with the attenuation of peak LVP responses to a \ -adrenoceptor stimulation
in the isolated rat heart. A similar trend which was not significant was seen with a
small dietary supplement of n-3 PUFA as might be taken by man. In Chapter 7, the
influence of the cyclooxygenase inhibitor flurbiprofen on the effects of dietary PUFA is
investigated.
Chapter 7
The role ofprostanoids in the effect of
dietary polyunsaturatedfatty acids on the heart
7.1 Introduction
§
In Chapter 6, we demonstrated that an n-6 PUFA diet (40% fat calories, P/S ratio 2.0)
was associated with the attenuation of LVP responses to oq-adrenoceptor stimulation
in the isolated rat heart. A small dietary supplement of n-3 PUFA (0.4% dietary
calories) produced a similar trend but this was not significant. Cardiac fractionated
phospholipid fatty acid composition demonstrated many significant changes in relation
to both of the PUFA diets but the mechanism underlying their effects on cardiac
responses remains unclear. We thought it possible that increased release of series 2
prostanoids in relation to dietary n-6 PUFA might account for our findings.
The aim of the present study was to examine the influence of the cyclooxygenase
inhibitor flurbiprofen on the effects of the n-6 PUFA diet. For two reasons,
flurbiprofen was administered parenterally to the animals at the end of the dietary
feeding period, as opposed to being infused during the experiments. First, we felt that
it was ofmore interest to look at the effects of "chronic" cyclooxygenase inhibition in
relation to the effects of diet on LV responses. Second, this strategy allowed us to
assess any effect of the administration of flurbiprofen on phospholipid fatty acid
composition.
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7.2 Methods
§
Forty-eight Sprague-Dawley rats were randomly separated into three groups of 16 and
fed the 40% fat calorie semisynthetic experimental diets for eight weeks. The control
relatively saturated diet (P/S ratio 0.3) was fed to 32 animals, 16 of which received a
small daily oral supplement of fish oil (0.4% dietary calories) by gavage. The remaining
16 animals received an n-6 PUFA diet of P/S ratio 2.0. The control and n-6 PUFA
groups received control oral doses of olive oil which was retained from their dietary fat
intake (see section 2.2.4). From 48 hours prior to sacrifice, twelve rats from each
group received flurbiprofen in a dose of 2 mg.kg"! intraperitoneally twice daily, such
that each treated animal received five doses (total dose 10 mg.kg"*). The four
untreated rats in each group were controls for the effect of flurbiprofen. On the day of
perfusion, hearts were excised (section 2.6.3) and perfused according to the protocol
of section 2.6.4. The effect of flurbiprofen on cardiac prostanoid release was assessed
by measuring coronary venous levels of 6-oxo-PGF^, the breakdown product of
prostacyclin (section 2.7.6). Timed samples of coronary effluent were collected for 6
hearts in each flurbiprofen-treated dietary group and for the 4 hearts from the control
untreated animals in each dietary group. The samples were immediately frozen for
subsequent assay. Subsequently, the responses of the hearts isolated from flurbiprofen-
treated animals to noradrenaline 0.1-2.4 pM in the presence of 10 pM timolol were
recorded. One heart from each group of 12 was excluded from further analysis.
7.3 Results
§
7.3.1 Dietary PUFA and LVP
Baseline peak LVP, in the absence of noradrenaline but in the presence of timolol, did
not vary with respect to diet (Table 7.1).
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Table 7.1 Baseline peak LVP (mm Hg), prior to noradrenaline infusion, in the presence of





Values: mean ± s.e.m., n=ll per dietary group.
There were no significant differences between the
groups.
Despite a tendency to attenuation, the response of peak LVP to a \ -adrenoceptor
stimulation in hearts from the n-3 PUFA group did not differ significantly from that of










-a- n-3 PUFA JANOVA-RM
(both n= 11)
Figure 7.1 Response ofpeak LVP
(mm Hg) to noradrenaline (0.1-
2.4 pM), in the presence oftimolol
(10 pM), ofhearts isolatedfrom
flurbiprofen-treated ratsfed
experimental diets: n-3 PUFA.
10 "7 10 -® 10 "5
[noradrenaline] M
In contrast to the study of Chapter 6, the LVP responses of hearts from the n-6 PUFA
group also did not differ significantly from control (N.S., ANOVA-RM), displaying
only a slight tendency to attenuation at the highest doses of noradrenaline from control
(Fig. 7.2).
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Figure 7.2 Response ofpeak LVP
(mm Hg) to noradrenaline (0.1-
120' JLV
pressure
2.4 pM), in the presence oftimolol








When the two PUFA groups were compared to one another, there was a non¬
significant tendency to attenuation in the n-3 PUFA group (p=0.07, ANOVA-RM).
7.3.2 Dietary PUFA and LVdP.dt"!
Both LVdP.dt"lmax: (Table 7.2) and LVdP.dt~lw/w (Table 7.3) increased significantly
in response to noradrenaline (p< 0.001, ANOVA), but neither varied with respect to
diet (N.S., ANOVA-RM).
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Table 7.2 LVdP.dt'^max (mm Hg.sec'^) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence oftimolol (10 pM), in hearts isolatedfromflurbiprofen-treated
ratsfed experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 2364±101 2409±1.3 2945±230
0.10 pM 2491±130 2509±101 3050±300
0.19 pM 3018±170 2645±140 3136±250
0.52 pM 3455±180 3164±190 3345±220
1.22 pM 3900±210 3764±210 3682±240
2.37 pM 4064±280 4000±260 3855±300
Values: mean ± s.e.m., n=
relation to diet.
11 per dietary group. There were no significant differences in
Table 7.3 LVdP.dt'^min (mm Hg.sec'^) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence oftimolol (10 pM), in hearts isolatedfrom flurbiprofen-treated
ratsfed experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 1618±38 1700±49 1718±38
0.10 pM 1682±50 1691±55 1764±85
0.19 pM 2100±150 1845±110 2173±130
0.52 pM 2700±100 2400±170 2609±140
1.22 pM 3182±160 2955±160 2900±170
2.37 pM 3236±180 3109±170 2900±210
Values: mean ± s.e.m., n=ll per dietary group. There were no significant differences in
relation to diet.
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7.3.3 Dietary PUFA and heart rate
Baseline heart rates did not differ in relation to diet. With a \ -adrenoceptor stimulation,
the heart rates for the n-3 PUFA group tended to be lower, and the heart rates for the
n-6 PUFA group higher, than control (Table 7.4). Neither PUFA group differed from
the control group. Comparison of the two PUFA groups confirmed that the heart rates
were significantly higher in the n-6 PUFA group (p< 0.05, ANOVA-RM). Secondary
analysis revealed significant differences between the two PUFA groups at the
maximum doses of noradrenaline (p< 0.05, t test).
Table 7.4 Heart rates (bpm) at baseline and in response to noradrenaline
(0.1-2.4 pM), in the presence oftimolol (10 pM), in hearts isolatedfromflurbiprofen-treated
ratsfed experimental diets.
Noradrenaline Diet
concentration Control n-3 PUFA n-6 PUFA
Baseline 303±6 296±9 302±7
0.10 (J.M 294±5 282±8 294±5
0.19 pM 287±5 270±6 290±5
0.52 pM 289±5 279±6 296±5
1.22 pM 285±8 278±6a 300±4a
2.37 pM 284±9 279±6b 300±3b
Values: mean ± s.e.m., n=l 1 per dietary group. a>b p< 0.05
7.3.4 Dietary PUFA: coronary flow and lactate production
Baseline coronary flow and lactate production were comparable for the three dietary
groups (Table 7.5).
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Table 7.5 Baseline coronaryflow (ml.min'^.g wet heart weight'^) and lactate production




n-3 PUFA 11.6±0.5 0.17±0.05
n-6 PUFA 11.3±0.2 0.17±0.06
Values: mean ± s.e.m., n=ll per dietary group. There were no
significant differences between the groups.
7.3.5 Production of 6-oxo-PGFia
Coronary venous levels of 6-oxo-PGFia, whether following, or in the absence of,
treatment with flurbiprofen, did not vary with respect to diet (Table 7.6). The
flurbiprofen regimen led to significant decreases of approximately 75% in the
production of 6-ojco-PGFja.
Table 7.6 Coronary venous 6-oxo-PGFja (ng.min'Kg wet heart weight'^) in hearts ofrats









Values: mean ± s.e.m., n=4 (untreated) and n=6 (treated). Superscript characters
denote significant differences a"c p< 0.01.
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7.3.6 Body and heart weights
The final body weights of the n-3 PUFA group were significantly heavier than those of
the n-6 PUFA group but neither differed from control; initial weights had not differed
(Table 7.7). Heart weights were similar in the three groups.
Table 7.7 Initial andfinal body weights (g) and heart weights (g) offlurbiprofen-treated
rats fed experimental diets.
Diet Initial weight Final weight Heart weight
Control 130±2 384±4 1.17±0.02
n-3 PUFA 131±6 395±10a 1.18±0.02
n-6 PUFA 125±5 358±9a 1.15±0.03
Values: mean ± s.e.m., n=ll per dietary group. a p< 0.05.
7.3.7 Fatty acid composition of cardiac total and fractionated phospholipid
The amount of total phospholipid and the distribution of the individual fractions was
unaffected by diet (Table 7.8).
Table 7.8 Total phospholipid andphospholipidfractions in hearts isolatedfrom




n-3 PUFA n-6 PUFA
PC 4237±320 4059±230 4295±330
PE 2890±269 2487±228 2829±299
PI 467±17 477±18 461±23
PS 202±14 218±13 229±19
Total 10906±329 10276±234 11289±451
Values (mean ± s.e.m.) are expressed as pg fatty acids.g wet weight'1, n=8 per
dietary group. There were no significant differences between the groups.
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The fatty acid composition of total and fractionated phospholipid revealed numerous
statistically significant changes with respect to diet. In total phospholipid,
supplementation of the diet with n-3 PUFA did not affect 18:2, n-6 compared to
control but 20:4, n-6 was significantly reduced (Table 7.9). Of the n-3 species, 20:5,
n-3 was only detected following dietary n-3 PUFA which substantially increased the
level of 22:6, n-3 and nearly halved the n-6:n-3 ratio and tended to increase the double
bond index. In relation to dietary n-6 PUFA, 18:2, n-6 showed a modest increase
compared to control but 20:4, n-6 fell slightly. The n-3 fatty acid species 20:5, n-3 and
22:6, n-3 were similar to control following the n-6 PUFA diet which raised the n-6:n-3
ratio approximately 50% but did not alter the double bond index.
Table 7.9 Fatty acid composition oftotal phospholipid, including the n-6:n-3 ratio and
double bond index (DBI), in hearts isolatedfrom flurbiprofen-treated ratsfed experimental
diets.
Fatty acid species,
n-6:n-3 ratio and DBI Control
Diet
n-3 PUFA n-6 PUFA
18:2, n-6 16.0±0.3a 16.3±0.8b 19.1±0.7a>b
20:4, n-6 26.6±0.4c'd 22.3±0.7c>e 24.6±0.5d>e
20:5, n-3 - 0.3±0.1 -
22:6, n-3 8.4±0.2f 13.7±1.2f>g 7.5±l.lS
n-6:n-3 ratio 4.6±0.2h'i 2.9±0.6hJ 6.2±0.6iJ
DBI 223±2 233±4 223±2
Values: mean ± s.e.m., n=8 per dietary group. Data for fatty acids represent the
percentage weight of total fatty acid species. Superscript characters denote significant
differences (0.001< p< 0.05) between individual fatty acid species and parameters in
relation to diet.
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In fractionated phospholipid (Table 7.10), dietary supplementation with n-3 PUFA did
not affect 18:2, n-6 compared to control in any fraction. The fall in 20:4, n-6 seen in
total phospholipid in relation to n-3 PUFA occurred to a large extent in PE and PC
with a small decrease in PS; 20:4, n-6 in PI was not altered.
Table 7.10 Fatty acid composition offractionatedphospholipid in hearts isolatedfrom
Jlurbiprofen-treated ratsfed experimental diets.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6b>c 5.7±0.3 5.7±0.2 8.4±0.5
20:4, n-6a>c 34.7±0.4 30.3±0.3 33.8±0.4
20:5, n-3 - 0.2±0.1 -
22:6, n-3a'b'c 3.5±0.2 7.9±0.3 2.7±0.1
PE 18:2, n-6b'c 4.0±0.1 3.8±0.1 5.9±0.2
20:4, n-6a>b'c 27.9±0.4 20.2±0.4 25.5±0.5
20:5, n-3 - 0.3±0.0 -
22:6, n-3a'b'c 19.5±0.4 31.3±0.4 15.3±0.4
PI 18:2, n-6b'c 3.7±0.1 3.6±0.2 6.7±0.2
20:4, n-6 37.8±0.5 36.1±0.8 36.8±0.6
20:5, n-3 - - -
22:6, n-3a'b'c 1.8±0.1 3.5±0.2 1.3±0.1
PS 18:2, n-6b'c 1.6±0.1 1.6±0.1 2.4±0.2
20:4, n-6a'b'c 8.2±0.li 6.6±0.2 7.7±0.1
20:5, n-3 - - -
22:6, n-3a'b'c 15.9±0.7 22.1±0.8 12.2±0.8
Values are mean ± s.e.m. and represent the percentage weight of total fatty acid species, n=8 per
dietary group. Superscript characters denote significant differences (0.001< p< 0.05) between
individual fatty acid species within phospholipid fractions in relation to diet. a Control vs n-3 PUFA,
b control vs n-6 PUFA, c n-3 PUFA vs n-6 PUFA
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With dietary n-3 PUFA, 20:5, n-3 was found in PC and PE, where it was not detected
(< 0.1%) in relation to the other diets, but not in PI and PS where this fatty acid
species was undetectable regardless of diet. Increases in 22:6, n-3 following n-3 PUFA
ranged from 25% in PS to greater than 100% in PC and PI. In relation to the n-6
PUFA diet, 18:2, n-6 increased in all fractions but 20:4, n-6 was either unaltered (PC
and PI) or actually decreased (PE and PS). Of the n-3 fatty acid species, 20:5, n-3 was
not detectable following dietary n-6 PUFA and 22:6, n-3 fell by approximately 25%
compared to control.
The n-3 PUFA supplement halved the n-6:n-3 ratio in all fractions and significantly
increased the double bond index in PC and PE, but not in PI and PS (Table 7.11). In
response to n-6 PUFA, the n-6:n-3 ratios rose by 50% but the double bond index did
not change, except in PE where it fell significantly.
Table 7.11 Fractionatedphospholipid n-6:n-3 ratios and double bond indices (DBI) in
hearts isolatedfrom flurbiprofen-treated ratsfed experimental diets.
Phospholipid fraction, Diet
n-6:n-3 ratio and DBI Control n-3 PUFA n-6 PUFA
PC n-6:n-3 ratioa>b>c 9.0±0.4 3.6±0.1 12.8±0.7
DBIa'c 195±1 205±1 195±1
PE n-6:n-3 ratioa'b>c 1.8±0,0 0.8±0.0 2.6±0.1
DBIa'b'c 289±2 307±1 280±3
PI n-6:n-3 ratioa>b>c 15.3±0.7 7.8±0.4 23.6±1.9
DBI 190±3 194±4 190±2
PS n-6:n-3 ratioa>b>c 1.2*0.1 0.5±0.0 2.0±0.2
DBI 200±6 204±7 198±6
Values: mean ± s.e.m., n=ll per dietary group. Superscript characters denote
significant differences (0.001< p< 0.05) between parameters for individual
phospholipid fractions. a Control vs n-3 PUFA, " control vs n-6 PUFA,
c n-3 PUFA vs n-6 PUFA
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7.3.8 Effect of flurbiprofen on phospholipid fractions and fatty acid composition
Comparison of the above phospholipid results with those presented in Chapter 6,
where identical diets were administered to animals which were not treated with
flurbiprofen, confirmed that the amount of total phospholipid and the proportions of
the individual phospholipid fractions did not change in relation to flurbiprofen. In the
phospholipid fractions, analysis of variance revealed that levels of 18:2, n-6 in PC and
PI were significantly lower for all three diets following flurbiprofen. Regarding 20:4,
n-6, this fatty acid species rose significantly in PC and PE and to a lesser extent in PS,
but not in PI. Changes in 22:6, n-3 in relation to flurbiprofen were limited but the
increases for all three diets in PI were significant. Although the n-6:n-3 ratio in PC, PE
and PS did not alter significantly between the two studies, the double bond indices
increased in these three fractions, regardless of diet, following flurbiprofen. In PI, the
n-6:n-3 ratio was significantly decreased in PI following flurbiprofen, strikingly so for
the control and n-6 PUFA dietary groups where it fell by a third, and the double bond
index tended to increase, particularly in relation to the n-6 PUFA diet.
7.3.9 Correlation between LVP responses and fatty acid composition
Regression of peak LVP responses against the fractionated phospholipid fatty acid,
n-6:n-3 ratio and double bond index data, singly and in multiple combinations, failed to
reveal any significant correlations.
7.4 Discussion
§
We found that an n-6 PUFA diet (40% fat calories, P/S ratio 2.0) had no effect on
peak LVP responses to a \ -adrenoceptor stimulation in hearts isolated from rats
treated with parenteral flurbiprofen for the preceding 48 hours. Dietary
supplementation with n-3 PUFA was associated with a non-significant trend to
attenuation of peak LVP. Neither the n-6 nor the n-3 PUFA diet affected
LVdP.dt-lmm, LVdP.dt"^/w, or heart rate compared to control, though heart rates
were higher in the n-6 PUFA group compared to the n-3 PUFA group. The
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flurbiprofen regimen did not abolish cardiac prostanoid release in the three dietary
groups, as reflected by coronary venous levels of 6-oxo-VGF\a but did lead to a 75%
reduction in release. Both PUFA diets brought about significant changes in cardiac
fractionated phospholipid fatty acid composition.
The findings for n-6 PUFA are clearly in contrast to those of Chapter 6. In the
absence of flurbiprofen, an identical n-6 PUFA diet was associated with significant
attenuation of the peak LVP response to oq-adrenoceptor stimulation. Interestingly,
the overall effects of a small dose of n-3 PUFA were similar in the two studies; a non¬
significant trend to attenuation of peak LVP responses which does not appear to be
susceptible to the added influence of flurbiprofen. There was no tendency in the
presence of flurbiprofen for baseline peak LVP to be lower with n-3 PUFA.
As was discussed in Chapter 6, the mechanism underlying the effects of dietary n-6
PUFA on responses in the isolated heart remains unclear. In the present study, the
effect of n-6 PUFA on peak LVP was virtually removed by pre-treating the animals
with a cyclooxygenase inhibitor. On the basis of similar evidence, it has previously
been concluded that enhanced prostanoid release must have some role in n-6 PUFA
dietary effects [Hoffman et al., 1982, McLennan et al., 1987], However, whether with
or without flurbiprofen, we found baseline prostacyclin release to be unaltered by diet
(see Table 7.6). The possibility remains that dietary PUFA might influence prostanoid
release in relation to a \ -adrenoceptor stimulation. We measured coronary venous
6-oxo-PGFia prior to commencing noradrenaline and not during the dose response
relationship. Accordingly, we have not excluded the enhancement by dietary n-6 PUFA
of prostanoid release in association with a\ -adrenoceptor stimulation, a mechanism
consistent with our data. We are not aware of evidence to either support or contest
this theory.
The administration of flurbiprofen was also associated with differences in
phospholipid fatty acid composition. Levels of 18:2, n-6 were lower, and levels of
20:4, n-6 higher, in relation to flurbiprofen treatment but the degree of change was the
same regardless of diet. In contrast to other fractions, the n-6:n-3 ratios in PI appeared
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susceptible to the use of flurbiprofen but the ratio for the control and n-6 PUFA diets
fell to the same extent, a third, between studies. Thus, the effects of dietary n-6 PUFA
are not readily explained by changes in phospholipid fatty acid composition. Once
more, no correlations were found between the change in cardiac responses and the
change in phospholipid fatty acid composition with respect to diet.
Flurbiprofen did not alter the overall effect of dietary n-3 PUFA in these studies,
although any tendency to lower baseline peak LVP disappeared. In both the present
and the previous chapter, a non-significant trend to attenuation of LVP was found.
This is of the same nature as the significant effect of a considerably higher dose of n-3
PUFA (Chapter 5). Others have found the effects of a similarly extreme n-3 PUFA diet
to be resistant to combined cyclooxygenase/lipoxygenase inhibition (Reibel et al.,
1988). It would appear that the effects of dietary n-3 PUFA on the responses to
aJ-adrenoceptor stimulation in the heart are not mediated by some alteration in
prostanoid release.
In summary, the previously documented effects of dietary n-6 PUFA on the
responses of the isolated rat heart to a \ -adrenoceptor stimulation were found to be
almost entirely removed by pre-treatment of the animals with parenteral flurbiprofen.
However, baseline cardiac prostacyclin release, either with or without flurbiprofen
treatment, was unaffected by diet. It remains possible that stimulated, rather than
baseline prostacyclin release was influenced by dietary n-6 PUFA. The overall effects
of n-3 PUFA, albeit not significant, were the same regardless of flurbiprofen treatment.
In the following chapter, the discrepancy between the effects of dietary n-6 PUFA
in 40% fat diets in the heart and vasculature is pursued further by examining the effect




phospholipidfatty acid composition in heart and aorta
8.1 Introduction
§
In Chapters 4,6, and 7, we used identical dietary regimens supplying 40% of total
calories from fat. The control diet was relatively rich in saturated fat with a P/S ratio
of 0.3, representing the fat intake of middle-aged Scottish men. The n-3 PUFA diet
was the control diet supplemented with 0.4% dietary calories fish oil. The n-6 PUFA
diet had a P/S ratio of 2.0, achieved by increasing the proportion of 18:2, n-6 at the
expense of saturated fatty acids.
The n-3 PUFA diet was associated with significant attenuation of the responses to
a J-adrenoceptor stimulation in the isolated resistance artery (Chapter 4) but effects of
a similar nature in the heart were not significant (Chapters 6 and 7). Conversely, for
the n-6 PUFA diet the effect in the heart was significant (Chapter 6) but not that in the
resistance artery.
Analysis of the fatty acid composition of the resistance arteries was not possible
but the different effects of diet on vascular and cardiac responses persuaded us to
attempt a comparison between the three 40% fat diets in terms of their influence on
fractionated phospholipid fatty acid composition in the heart and aorta.
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8.2 Methods
§
Twenty-four Sprague-Dawley rats were randomly separated into three groups of 8
before commencing the 40% fat calorie semisynthetic diets. Two groups were fed the
control P/S ratio 0.3 diet and one of these, the n-3 PUFA group, received fish oil daily
by gavage. The third group received the n-6 PUFA P/S ratio 2.0 diet. The control and
n-6 PUFA groups received daily control oral doses of olive oil, which had been
retained from their dietary fat intake. At the end of the feeding period, hearts were
excised and placed in ice-cold buffer (section 2.6.2) until beating stopped. The hearts
were then trimmed of atria and great vessels, opened, blotted, weighed and placed in
Nunc tubes under liquid nitrogen. Aortas were dissected free from arch to iliac
bifurcation and flushed through with ice-cold 0.9% saline before being gently cleaned
free of the adjacent inferior vena cava and adherent adipose tissue under 0.9% saline in
a petri dish. Aortas were then blotted and frozen in an identical manner to the hearts.




8.3.1 Body and heart weights
Neither final body weights nor heart weights varied with respect to diet (Table 8.1).
Table 8.1 Final body weights (g)and heart weights (g) ofratsfed experimental diets.
Diet Body weight Heart weight
Control 379±17 0.9±0.0
n-3 PUFA 383±9 1.1±0.1
n-6 PUFA 368±9 1.1±0.1
Values: mean ± s.e.m., n=8 per dietary group. There were no
significant differences in relation to diet.
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8.3.2 Fatty acid composition of cardiac tissue fractionated phospholipid
As before, the amount of total phospholipid and the distribution of the individual
phospholipid fractions in cardiac tissue did not differ with respect to diet (Table 8.2).
Table 8.2 Phospholipidfractions and total phospholipid in the hearts ofratsfed
experimental diets.
Phospholipid Diet
fraction Control n-3 PUFA n-6 PUFA
PC 4164±669 4062±423 4098±779
PE 2533±652 2627±629 2275±596
PI 441±58 436±38 445±61
PS 261±64 217±47 218±45
Total 10788±1093 10723±1008 11056±1184
Values (mean ± s.e.m.) are expressed as pg.g fatty acids.g wet
weight"1, n=8 per dietary group. There were no significant
differences in relation to diet.
The fatty acid composition of cardiac fractionated phospholipid demonstrated many
statistically significant differences with respect to diet (Table 8.3). The n-3 PUFA diet
was associated with small increases in 18:2, n-6 in all fractions but PE. The proportion
of 20:4, n-6 was decreased in all fractions following n-3 PUFA but only to a small
extent in PI. Of the n-3 fatty acid species, 20:5, n-3 was detected in PC, PI and PS, but
not in PI, and only in relation to the n-3 PUFA diet. Levels of 22:6, n-3 rose 50% in
PE and PI and were doubled in PC with n-3 PUFA supplementation but were little
altered in PS. Following the n-6 PUFA diet, 18:2, n-6 rose in all fractions, being
doubled in PI, but 20:4, n-6 fell in all fractions. The n-3 fatty acid species 20:5, n-3
was not detected (< 0.1%) in relation to the n-6 PUFA diet and levels of 22:6, n-3
decreased by approximately 25%.
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Table 8.3 Fatty acid composition ofphospholipidfractions in the hearts ofratsfed
experimental diets.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6a'b>c 5.3±0.4 7.5±0.4 9.2±0.4
20:4, n-6a'b'c 35.2±0.4 27.9±0.5 33.2±0.5
20:5, n-3 - 0.3±0.0 -
22:6, n-3a'b'c 3.8±0.2 7.8±0.3 2.5±0.1
PE 18:2, n-6b>c> 3.5±0.2 3.7±0.1 6.0±0.2
20:4, n-6a'b'c 27.9±0.6 20.3±0.5 25.6±0.6
20:5, n-3 - 0.3±0.0 -
22:6, n-3a>b'c 20.9±0.6 30.7±0.5 14.6±0.5
PI 18:2, n-6a'b'c 3.5±0.1 4.2±0.1 7.0±0.1
20:4, n-6a'b 38.1±0.7 34.4±0.5 35.8±0.5
20:5, n-3 - - -
22:6, n-3a'b'c 1.8±0.0 3.5±0.1 1.2±0.0
PS 18:2, n-6a>b'c 2.0±0.1 2.7±0.2 3.6±0.2
20:4, n-6a'c 9.0±0.3 6.8±0.4 8.5±0.2
20:5, n-3 - 0.2±0.1 -
22:6, n-3b'c 16.1±0.8 18.8±1.1 11.1±0.5
Values (mean ± s.e.m.) represent the percentage weight of total fatty acids within each
phospholipid fraction, n=8 per dietary group. Superscript characters denote significant
differences (0.001< p< 0.05) between individual fatty acid species within different
phospholipid fractions in relation to diet. a Control vs n-3 PUFA, b Control vs n-6 PUFA,
c n-3 PUFA vs n-6 PUFA
In response to the n-3 PUFA diet, the n-6:n-3 ratios were halved in PC, PE and PI but
fell less in PS, and only in PE was the double bond index significantly increased (Table
8.4). Following n-6 PUFA, the n-6:n-3 ratios rose by 70-75% and the double bond
index fell in PC and PE; it did not change in PI and PS.
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Table 8.4 Phospholipidfraction n-6:n-3 ratios and double bond indices (DBI) in the hearts
ofratsfed experimental diets.
Phospholipid fraction, Diet
n-6:n-3 ratio and DBI Control n-3 PUFA n-6 PUFA
PC n-6:n-3 ratioa>b'c 8.1±0.4 3.6±0.2 13.9±0.6
DBIb>c 199±1 199±2 192±1
PE n-6:n-3 ratioa>b>c 1.6±0.1 0.8±0.0 2.7±0.1
DBIa'b>c 289±2 301±1 271±1
PI n-6:n-3 ratioa>b>c 14.2±0.4 7.5±0.2 25.3±1.0
DBI 193±2 190±2 186±2
PS n-6:n-3 ratiob>c 1.3±0.1 0.9±0.2 2.3±0.1
DBI 205±6 199±6 193±3
Values: mean ± s.e.m., n=8 per dietary group. Superscript characters denote significant
differences (0.000K p< 0.05) between parameters for individual phospholipid fractions in
relation to diet. a Control vs n-3 PUFA, b Control vs n-6 PUFA, c n-3 PUFA vs n-6 PUFA
8.3.3 Fatty acid composition of aortic tissue fractionated phospholipid
It was necessary to pool the tissue from 4 of the 8 aortas from each dietary group in
order to have sufficient for fractionated phospholipid analysis. Mean values (effective
n=2) for the phospholipid fractions, and the proportion each fraction represented (of
PC+PE+PI+PS), are given in Table 8.5. Diet did not affect the relative amounts of the
individual phospholipid fractions.
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Table 8.5 Phospholipidfractions in the aortas ofratsfed experimental diets.
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Phospholipid Diets
fraction Control n-3 PUFA n-6 PUFA
PC 738 (49%) 831 (48%) 764 (52%)
PE 509 (34%) 472 (32%) 519 (31%)
PI 127 (8%) 124 (9%) 145 (8%)
PS 139 (9%) 143 (11%) 167 (9%)
Values are means and are expressed as pg fatty acids.g wet weight"1, n=2 results
per dietary group. In parentheses is the proportion each fraction represented as a
percentage of E(PC+PE+PI+PS).
We did not attempt to analyse total phospholipid fatty acid composition in the aortas
because of the small amounts of tissue available, but focused on fractionated
phospholipid. Means and errors derived from the results for pooled tissue are shown in
Table 8 .6. With an effective sample size of 2, we felt that statistical comparison of the
dietary groups was not appropriate. The following is a qualitative interpretation. In
relation to the n-3 PUFA supplement, 18:2, n-6 increased slightly and 20:4, n-6 fell in
PC and PE. Of the n-3 fatty acid species, small proportions of 20:5, n-3 were found in
all fractions and there were 25% increases in 22:6, n-3. With the n-6 PUFA diet, 18:2,
n-6 increased in all fractions but 20:4, n-6 altered little, even falling slightly in PE.
Following n-6 PUFA, 20:5, n-3 was not detected (< 0.1%) and 22:6, n-3 fell in PC,
PE and PS, though not in PI.
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Table 8.6 Fatty acid composition ofphospholipidfractions in aortic tissue from ratsfed
experimental diets.
Phospholipid fraction and Diet
fatty acid species Control n-3 PUFA n-6 PUFA
PC 18:2, n-6 8.1±0.2 10.2±1.2 13.9±0.5
20:4, n-6 21.8±0.4 16.1±0.7 22.0±0.2
20:5, n-3 - 0.5±0.1 -
22:6, n-3 1.3±0.1 2.5±0.6 0.9±0.1
PE 18:2, n-6 3.1±0.2 4.1±1.0 6.7±0.4
20:4, n-6 38.8±0.2 33.4±2.3 36.5±0.2
20:5, n-3 - 1.1±0.2 -
22:6, n-3 5.5±0.1 10.2±1.8 4.0±0.2
PI 18:2, n-6 2.2±0.4 3.0±0.7 4.4±0.4
20:4, n-6 38.2±2.3 35.0±1.7 37.6±0.6
20:5, n-3 - 0.3±0.0 -
22:6, n-3 0.4±0.0 0.9±0.2 0.3±0.0
PS 18:2, n-6 2.5±0.2 3.4±0.1 4.2±0.5
20:4, n-6 12.2±0.2 10.7±0.5 13.0±0.1
20:5, n-3 - 0.1±0.1 -
22:6, n-3 3.3±0.5 5.5±1.6 2.2±0.2
Values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=2 results
per dietary group.
The n-6:n-3 ratios and DBI values for the aortic phospholipid fractions are given in
Table 8.7. Again, statistical comparison was not performed because of the sample size.
Profound changes in n-6:n-3 ratio occurred with both PUFA diets, particularly in the
PI fraction. The DBI was less affected by diet but tended to be unaltered or decreased
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with n-3 PUFA. There was no consistent effect of n-6 PUFA which increased the
in PC and decreased it in PE.
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DBI
Table 8.7 Phospholipidfraction n-6:n-3 ratios and double bond indices (DBI) in aortic
tissue from ratsfed experimental diets.
Phospholipid fraction,
n-6:n-3 ratio and DBI Control
Diet

































Values: mean ± s.e.m., n=2 results per dietary group.
8.3.4 Aortic versus cardiac phospholipid fatty acid composition
The small sample sizes for the aortic fractionated phospholipid fatty acid composition
results precluded statistical comparison with the cardiac results. However, to assist
interpretation, Table 8.8 lists the aortic data from Table 8.6 together with the 95%
confidence intervals for the respective cardiac data. Generally, levels of 18:2, n-6 were
of a similar order in the two tissues. The proportion of20:4, n-6, although similar in PI
and PS, was substantially lower in aortic PC and increased in PE. The small proportion
of 20:5, n-3 was more evident in aortic tissue and was detected in PI. Regarding 22:6,
n-3, this fatty acid species was lower in all fractions, substantially so in PE, PI and PS.
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Table 8.8 Fatty acid composition ofphospholipidfractions in aortic tissue, and (95%
confidence intervals) for cardiac tissue results, from ratsfed experimental diets.
Phospholipid Diet
fraction and Control n-3 PUFA n-6 PUFA
fatty acid species Aortic Cardiac Aortic Cardiac Aortic Cardiac
PC 18:2, n-6 8.1±0.2 (4.4-6.2) 10.2±1.2 (6.7-8.4) 13.9±0.5 (8.2-10.3)
20:4, n-6 21.8±0.4 (34.3-36.1) 16.1±0.7 (26.7-29.0) 22.0±0.2 (32.0-34.4)
20:5, n-3 ll:lllllllllllli (-) 0.5±0.1 (0.2-0.4) (-)
22:6, n-3 1.3±0.1 (3.4-4.3) 2.5±0.6 (7.1-8.5) 0.9±0.1 (2.2-2.8)
PE 18:2, n-6 3.1±0.2 (3.1-4.0) 4.1±1.0 (3.4-4.0) 6.7±0.4 (5.6-6.5)











PI 18:2, n-6 2.2±0.4 (3.3-3.8) 3.0±0.7 (3.9-4.4) 4.4±0.4 (6.7-7.3)
20:4, n-6 38.2±2.3 (36.4-39.7) I 35.0±1.7 (33.3-35.4) 37.6±0.6 (34.6-37.1)
20:5, n-3 (-) 0.3±0.0 (-) M (-)
22:6, n-3 0.4±0.0 (1.7-1.9) 0.9±0.2 (3.2-3.8) 0.3±0.0 (1.1-1.3)
PS 18:2, n-6 2.5±0.2 (1.9-2.2) 3.4±0.1 (2.3-3.1) 4.2±0.5 (3.2-4.0)









Aortic values (mean ± s.e.m.) represent the percentage weight of total fatty acid species, n=2 per
dietary group. In parentheses are the 95% confidence intervals (n=8) for the cardiac fractionated
phospholipid content of the same fatty acid species. Shading identifies aortic results (mean) falling
within the cardiac 95% CI range.
In the same manner, Table 8.9 displays the n-6:n-3 ratios and DBI values for aortic
tissue together with the 95% confidence interval for the cardiac fractionated
phospholipid results. The aortic phospholipid n-6:n-3 ratios were all higher, strikingly
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so in PI. Interestingly, the DBI values for aortic tissue phospholipids agreed quite
closely with the cardiac values in the PI fraction where they were the same for the n-6
PUFA diet.
Table 8.9 Phospholipidfraction n-6:n-3 ratios and double bond indices (DBI) in aortic
tissue, and (95% confidence interval) for cardiac tissue results, from ratsfed experimental
diets.
Phospholipid Diet
fraction, n-6:n-3 Control n-3 PUFA n-6 PUFA
ratio and DBI Aortic Cardiac Aortic Cardiac Aortic Cardiac
PC n-6:n-3 ratio 20.1±0.4 (7.2-9.0) 8.3±1.9 (3.2-3.9) 34.7±1.1 (12.4-15.3)
DBI 145±1 (197-200) 136±4 (195-203) 151±2 (189-195)
PE n-6:n-3 ratio 7.8±0.1 (1.4-1.8) 3.3±0.6 (0.7-0.8) 11.6±0.3 (2.4-3.0)
DBI 264±1 (285-293) 267±3 (298-304) 255±2 (268-274)
PI n-6:n-3 ratio 71.8±9.5 (13.1-15.2) 24.0±4.5 (6.9-8.0) 111.5±16.0 (23.1-27.6)
DBI 182±7 (187-198) 176±3 (187-194) 183±1 (181-190)
PS n-6:n-3 ratio 6.2±0.6 (1.0-1.5) 3.1±0.7 (0.5-1.3) 10.6±0.7 (2.0-2.6)
DBI 146±8 (191-219) 146±12 (184-214) 146±0.5 (187-200)
Aortic values: mean ± s.e.m., n=2 results per dietary group. In parentheses are the 95% confidence
intervals (n=8) for the cardiac fractionated phospholipid analyses. Shading identifies aortic results
(mean) falling within the cardiac 95% CI range.
8.4 Discussion
§
Widespread changes in the fractionated phospholipid fatty acid composition of aortic
and cardiac tissue were seen in relation to dietary PUFA. Although limited statistically
by the small effective sample size for the aortic results, there were clearly quite
remarkable differences in the fatty acid composition of the two tissues. Levels of 18:2,
n-6 were comparable but 20:4, n-6 was increased in aortic PE and strikingly decreased
in aortic PC. There tended to be more 20:5, n-3 in the aortic phospholipid fractions
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including in PI, where 20:5, n-3 is usually not detected in the heart. Conversely, levels
of 22:6, n-3 were lower in all the aortic fractions, irrespective of diet. These
differences were reflected in the n-6:n-3 ratios which were higher in aortic tissue.
Also, generally lower DBI values in aortic tissue were further evidence of a lesser
degree of incorporation of the longer chain unsaturated fatty acid species.
Published data regarding the influence of diet on the fatty acid composition of
vascular and cardiac tissue are sparse. In marmosets, long term feeding with
approximately 17% fat calorie diets rich in n-6 PUFA, n-3 PUFA or saturated fat was
shown to have a number of small effects on aortic versus cardiac total phospholipid
fatty acid composition [Charnock et al., 1992], Aortic 18:2, n-6 levels were 30%
lower than cardiac levels in relation to n-6 PUFA and saturated fat, and aortic 22:6,
n-3 was 60% lower than cardiac following n-3 PUFA. Otherwise, the fatty acid
composition of the heart and aorta were remarkably similar. The diets used by
Charnock et al. are obviously different from our 40% fat calorie diets but there are
clearly considerable differences between the rat and the marmoset with respect to the
fatty acid composition of aortic and cardiac tissue and the influence of diet.
In summary, although the present study was limited by the small effective sample
size of the aortic data, we found potentially important differences in the fractionated






The aim of these studies was to examine the effect of dietary PUFA on vascular and
cardiac responses to a j-adrenoceptor stimulation. With the exception of one series of
experiments (Chapter 5), semisynthetic diets deriving 40% of total dietary calories
from fat were used in order to represent what is, or could be, consumed by man.
In the perfused hind-quarters (Chapter 3) and isolated resistance artery (Chapter
4), a small dietary supplement of n-3 PUFA significantly attenuated responses to
a i-adrenoceptor stimulation. Dietary n-6 PUFA did not exert this effect, although
there was a trend to attenuation in the resistance artery. Neither n-3 PUFA nor n-6
PUFA had any effect on the relaxation to acetylcholine of resistance arteries
constricted to 60% of their maximum response. In these vascular studies, the fatty acid
composition of the target tissue could not be determined, therefore the influence of the
diets in this respect was monitored in cardiac tissue. The fatty acid composition of
cardiac fractionated phospholipid revealed widespread changes, which were more
extensive following dietary n-3 PUFA, in relation to diet.
Diets deriving 10% of total calories from fat, thus of limited relevance to man,
were used in an attempt to corroborate published results [Reibel et al., 1988] and to
establish the parameter(s) susceptible to dietary influence in the isolated rat heart
during a\-adrenoceptor stimulation (Chapter 5). Baseline and stimulated peak LVP
responses were attenuated by a relatively high dose of n-3 PUFA (3.5% of total
dietary calories). An n-6 PUFA enriched diet did not exert this effect, indeed, a small
Discussion 147
trend to enhancement of peak LVP was observed. Other cardiac parameters in this
model; LVdP.dt"!, heart rate and coronary flow, were unaffected by diet. Following a
6-hydroxy-dopamine regimen which has been shown to ablate sympathetic nerve
endings [Allely, 1983], and which reduced cardiac noradrenaline content to < 0.6% of
control levels in our experiments, the effect of the n-3 PUFA diet on baseline peak
LVP disappeared. The attenuation of responses to a\-adrenoceptor stimulation was
maintained.
When we investigated the effects of the 40% fat calorie diets relevant to man on
responses in the isolated heart (Chapter 6), the results differed to those found with the
10% fat calorie diets (Chapter 5). Dietary n-6 PUFA now brought about the significant
attenuation of peak LVP responses to a j -adrenoceptor stimulation whereas a small
n-3 PUFA dietary supplement did not. The effect of n-3 PUFA was curtailed to a non¬
significant trend to attenuation. Subsequently, the attenuatory effect of n-6 PUFA was
shown to be removed by treating the animals with parenteral flurbiprofen (Chapter 7).
The trend seen with n-3 PUFA remained. Baseline coronary venous 6-oxo-PGF^a
concentrations, reflecting prostacyclin release, were reduced 75% by flurbiprofen but
were not influenced by diet. In neither of these consecutive studies could fractionated
phospholipid fatty acid composition, which was altered by diet and further affected in
relation to flurbiprofen treatment, be correlated with peak LVP.
Generally, the changes in phospholipid fatty acid composition following the
administration of n-3 PUFA were most evident in PC and PE where 18:2, n-6 and
20:4, n-6 were reduced and 20:5, n-3 and 22:6, n-3 increased. In association with
these changes, the n-6:n-3 ratios fell and the double bond indices rose. In contrast, the
effects of dietary n-6 PUFA were essentially limited to modest increases in 18:2, n-6
and in the n-6:n-3 ratio; levels of 20:4, n-6 and the double bond index were either
unaltered or fell. In relation to the 40% fat calorie diets, PI, and to some extent PS,
proved relatively resistant to the influence of diet. This was particularly true of 20:4,
n-6 in PI which was tightly conserved.
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In view of the differences between the effects of the 40% fat calorie diets in the
vascular preparations and the isolated heart, a further study was performed to examine
the changes in phospholipid fatty acid composition in the aorta and heart following
these diets. Although this study was limited by the need to pool aortic tissue in order
to have sufficient for analysis, striking differences were apparent in fatty acid
composition between the two tissues. Aortic PC incorporated less 20:4, n-6, and
aortic PE more, than the heart. Noticeably, all aortic fractions contained more 20:5,
n-3, but less 22:6, n-3, than the heart. Levels of 18:2, n-6 were broadly similar. Further
evidence of lesser incorporation of long chain unsaturated fatty acid species in the
aorta compared to the heart were higher n-6:n-3 ratios and lower double bond indices.
9.2 Limitations to the studies
§
The difficulty in measuring the fatty acid composition of vascular fractionated
phospholipid was confirmed in Chapter 8. Despite removing the entire aorta, the tissue
from 4 animals was required for a single analysis. Nevertheless, it is clear that the fatty
acid composition of vascular tissue is inadequately reflected by that of cardiac tissue.
The usefulness of the fatty acid data presented in Chapters 3 and 4 is limited to
verifying that the diets administered were capable of inducing significant changes in
phospholipid fatty acid composition after 8 weeks feeding.
In the isolated heart studies, there were no direct relationships between peak LVP,
which was altered by diet, and cardiac phospholipid fatty acid composition.
Accordingly, the discussion of potential mechanisms in the effects observed must draw
on the experimental data of other investigators, and is therefore speculative.
It has become widely recognised that dietary n-3 PUFA can influence vascular
reactivity by enhancing endothelium-dependent relaxation [Shimokawa et al., 1987,
Yin et al, 1988, Yin et al., 1991], The studies of Chapter 4 do not fully address these
possibilities, referred to in greater detail below (section 9.3). Likewise, effects of n-3
PUFA on the coronary arterial endothelium, and possibly the endocardium, may have
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contributed to the effects on peak LVP shown in Chapter 5. This is discussed in
section 9.4.
The physiological relevance of observations made in the retrogradely perfused
isolated heart is limited. In the light of the effects on peak LVP, and lack of effects on
LVdP.dt"! and heart rate, it would be potentially rewarding to pursue the effects of
dietary PUFA further in the working heart so that a more comprehensive study of
effects on contractility could be performed.
Perfusing the hind-quarters and the isolated heart with crystalloid buffer obviously
removed any potential interaction with blood elements. While this simplifies the
interpretation of the phenomena observed, it would be interesting to investigate dietary
effects in blood perfused systems in view of, for example, the increased erythrocyte
deformability and decreased whole blood viscosity reported in relation to n-3 PUFA
[Terano etal., 1983, Cartwright etal., 1985, Rogers etal., 1987],
9.3 Dietary PUFA and vascular responses
§
The significant effects of dietary n-3 PUFA on responses to a \ -adrenoceptor
stimulation in the perfused hind-quarters and isolated resistance artery (Chapters 3 and
4) may have been indirect. It has been proposed that similar effects of n-3 PUFA in
other studies were due to a decrease in the synthesis and release of vasoconstrictor
prostanoids, PGEf? and TXA2 [Lockette et al., 1982, Yin et al., 1991], However,
these prostanoids constitute a very small fraction (approximately 2%) of the
prostanoids released by rat vascular tissue. The vasoconstrictor PGF2a is released
following vasoconstriction induced by KC1 but not in response to noradrenaline, unlike
the vasodilators PGI2 and PGE2 [Pipili and Poyser, 1981], Indeed, despite the
changes in aortic phospholipid fatty acid composition it induced (increased 20:5, n-3
and reduced PC 20:4, n-6), the n-3 PUFA supplement may have led to increased
release of vasodilator prostanoids in relation to a \-adrenoceptor stimulation. It is
usually assumed that PGI2 is simply replaced by PGI3, an equiactive vasodilator,
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following dietary n-3 PUFA [Fischer and Weber, 1984], However, it has been shown
in man that n-3 PUFA can increase PGI3 synthesis without compromising PGPj [von
Schacky et al., 1985b] and, recently, that n-3 PUFA can produce a paradoxical
increase in vascular PGI2 synthesis [de Caterina et al., 1990], Thus a net gain in
vasodilator prostanoid release, rather than a loss, can occur with n-3 PUFA. Dietary
n-6 PUFA did not exert significant effects in these studies and the trend to attenuation
of contraction in the resistance artery is unexplained. Despite the lack of influence of
the n-6 PUFA diet on aortic phospholipid 20:4, n-6 content, the results of Chapters 6
and 7 suggest that a prostacyclin-related mechanism was responsible. Further studies
with cyclooxygenase inhibitors are necessary to clarify these issues with regard to both
n-3 and n-6 PUFA.
The possibility that dietary n-3 PUFA was associated with enhanced endothelium-
dependent relaxation in the vascular studies was raised (Chapters 3 and 4). Tonic
release ofEDRF may be important [Malta et al., 1986, Martin et al., 1986, Bullock et
al., 1986] but appreciable effects on baseline relaxation state in our studies seem
unlikely in view of the normalisation results in the isolated resistance artery. EDRF is
released by noradrenaline, but probably through endothelial 012-adrenoceptor
activation [Cocks and Angus, 1983, Miller et al., 1984, Bullock et al., 1986] and the
012-adrenoceptor antagonists rauwolscine and yohimbine were present in our studies.
Difficult to exclude, particularly in the resistance artery where the n-3 PUFA effect
was evident at higher levels of active tension, is enhanced release ofEDRF in response
to vascular stress [Hutcheson and Griffith, 1991, Lamontagne et al., 1992], This could
have contributed to our findings. Lastly, it appears that dietary n-3 PUFA in higher
doses may enhance vascular relaxation by an endothelium independent mechanism
[Malis etal., 1991],
These possibilities could be addressed by including the use of L-arginine analogues
or methylene blue, and de-endothelialised vessels, in future resistance artery studies.
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9.4 Dietary PUFA and cardiac responses
§
A relatively high dose of n-3 PUFA (3.0% total dietary calories) in a 10% fat calorie
diet reduced peak LVP at baseline and during a \ -adrenoceptor stimulation in the
isolated heart (Chapter 5). The baseline effect was not present in chemically
denervated animals, suggesting that spontaneous noradrenaline release is normally
attenuated by dietary n-3 PUFA in this particular model. The changes in cardiac
fractionated phospholipid fatty acid composition associated with the 10% fat calorie
n-3 PUFA diet were profound. There were substantial reductions in 20:4, n-6 which
extended to the PI fraction, usually resistant to dietary influence. Although there was
no correlation between fatty acid composition and peak LVP, it is possible that this
diet exerted direct effects, discussed fully in section 9.5, on a\-adrenoceptor function.
Alternatively, cardiac prostanoid synthesis, considered below, may have been affected
by the reductions in 20:4, n-6.
The potential effects of n-3 PUFA on EDRF and the endocardium should be
considered. EDRF is released from the coronary arteries [Collins et al., 1986,
Shimokawa et al., 1989, Nyborg, 1990, Kelm et al, 1991, Lamontagne et al., 1992]
and the endocardium [Shah et al., 1991], If the actions of EDRF, which can reduce
contractility, were enhanced by n-3 PUFA, this might have contributed to the
attenuation of peak LVP. However, in isolated papillary muscles, EDRF reduces peak
tension by accelerating relaxation and shortening the duration of contraction [Shah et
al., 1991, Henderson et al., 1992], Translated to the isolated heart, an increase in
LVdP.dt'^/fl would be anticipated and we did not find any effect of diet on
LVdP.dfl. Conversely, if dietary n-3 PUFA attenuated the tonic effect of the
endocardium, which is an increase in contractility [Brutsaert et al., 1988, Brutsaert
1989] possibly mediated by the putative transmitter "endocardin" [Smith et al., 1991],
LVdP.dt-ljni/i and perhaps LVdP.dt"^^ would be expected to decrease. To
investigate combined effects of n-3 PUFA on both EDRF and the endocardium,
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further experimental studies, using inhibitors ofEDRF and endocardial disruption, are
required.
Compared to the 10% fat calorie diets, the effects on the isolated heart of the 40%
fat calorie diets relevant to man were quite different (Chapters 6 and 7). The n-6
PUFA diet (P/S ratio 2.0) significantly attenuated peak LVP responses to
a \ -adrenoceptor stimulation whereas the n-3 PUFA supplement was associated with a
non-significant trend to attenuation. The changes in fractionated phospholipid fatty
acid composition following these diets were less striking than for the 10% fat diets
which may account for the lesser n-3 PUFA effect. The n-6 PUFA effect was
unexplained. Again, there were no significant correlations between fatty acid
composition and peak LVP. Following parenteral flurbiprofen, a cyclooxygenase
inhibitor, which reduced baseline PGI2 release by 75%, the n-6 PUFA effect on peak
LVP was no longer apparent. The n-3 PUFA trend remained, indicating that the effect
of n-3 PUFA on cardiac responses is independent of prostanoid synthesis and release.
Baseline PGI2 release (PGI2 is the principal prostanoid released from the isolated the
rat heart [de Deckere et al., 1977]) was not influenced by diet but the results suggest
that prostanoid release during a \ -adrenoceptor stimulation, which we did not
measure, differed for the n-6 PUFA group. Unfortunately, the inotropic actions of
prostanoids are controversial. In the isolated rat heart and atrium, PGI2 has been
shown to be a positive inotrope and to shorten the contraction/relaxation cycle
[Shaffer and Malik, 1984, Metsae-Ketelae 1981], In contrast, studies in rat
cardiomyocytes have revealed negatively inotropic effects ofPGI2 and PGE2 [Auclair
et al., 1988] and biphasic effects of PGI2; positively inotropic at low concentrations
and negatively inotropic at higher concentrations [Das et al., 1983], In the guinea-pig
heart, positively inotropic actions of PGI2 were abolished by the dihydropyridine
calcium channel antagonist, nifedipine [Fassina et al., 1983], which supports the
finding that PGI2 increased the inward Ca^+ current in guinea pig cardiomyocytes
[Alloatti et al., 1991], It is clear that the attenuation of peak LVP by dietary n-6
PUFA was a prostanoid-related phenomenon, but as the inotropic actions of PGI2
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remain uncertain, we cannot deduce whether prostanoid synthesis was enhanced or
depressed by this diet. Further studies measuring prostanoid release during
a J-adrenoceptor stimulation in our model are necessary to clarify this issue.
9.5 Dietary PUFA, membrane enzyme function and signalling
§
By means of steady state fluorescence polarization, both n-3 and n-6 PUFA have been
shown to increase membrane fluidity in the sarcoplasmic reticulum [Abeywardena et
al., 1984] and platelets [Hornstra and Rand, 1986] of diet-fed rats. Also, a 5% fat diet
(P/S ratio 1.0), as opposed to a fat-deficient diet, led to greater membrane
unsaturation associated with a lower gel-liquid phase transition temperature [King et
al., 1977], Alterations in the biophysical properties of the cell membrane, as would be
expected with the experimental diets used in our studies, may affect the function of
membrane-bound enzymes, such as protein kinase C, ATPases and phospholipases.
The activation of protein kinase C is thought to be facilitated by membrane
unsaturation, which, by widening phospholipid head-group spacing, allows deeper
seating of the enzyme in the membrane and encourages conformational change [Epand
and Lester, 1990], Studies in erythrocyte ghosts from rats fed n-6 PUFA diets revealed
decreased Na+/K+ ATPase activity [Bloj et al., 1973] and increased Ca^+/Mg2+
ATPase activity [Holmes et al., 1983], but these effects may not be straightforward or
applicable to other tissues and subcellular fractions. The study ofHolmes et al. [1983]
found also that n-6 essential fatty acid deficiency enhanced the activity ofNa+/K+ and
Ca2+/Mg2+ ATPases while others report that sarcoplasmic reticulum ATPase activity
is unaffected by changes in membrane saturation [Abeywardena et al., 1984], Effects
ofPUFA on phospholipase function are interesting because changes in membrane fatty
acid composition affect both the environment and the substrate of the enzyme. Dietary
n-6 PUFA increased the hydrolysis of PC and PE in rat cardiac membranes [Leonardi
et al., 1987] and incubation of rat cardiomyocytes with n-6 PUFA increased the
activity of phospholipase A [Nalbone et al., 1990], Likewise, phospholipase A2
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activity was enhanced in gastric tissue [Grataroli et al., 1988] and renal cortical
mitochondria [Malis et al., 1990] from rats fed n-3 PUFA rather than saturated fat.
Recent evidence suggests that cell signalling may be susceptible to n-3 PUFA. The
generation of inositol-tm-phosphate (IP3) was found depressed in platelets from
rabbits fed n-3 PUFA as opposed to n-6 or n-9 PUFA [Medini et al., 1990],
Incubation of rabbit platelets with 20:5, n-3 reduced the production of IP, IP2 and
IP3, reflected by the incorporation of ^H-inositol, in response to a thromboxane
analogue although there was no detectable increase in platelet phospholipid 20:5, n-3
content [Chetty et al., 1989], These authors proposed that minute changes in
membrane fatty acid composition were sufficient to affect signal transduction and that
20:5, n-3 might attenuate the activity of phospholipase C. Remarkably, these findings
are consistent with the results of cell culture studies where extreme fluctuations in
fatty acid composition are induced by incubation with PUFA. Vascular smooth muscle
cell IP3 synthesis in response to low density lipoprotein was reduced by culture in
medium containing 20:5, n-3 [Locher et al., 1988, Locher et al., 1989] and the
addition of 22:6, n-3 to rat cardiomyocyte culture medium caused a decrease in
phospholipid ^H-inositol incorporation [Bordoni et al., 1990],
From the above reports, it appears that dietary PUFA, particularly n-6 PUFA, can
enhance phospholipase A2 activity. This would be expected to result in increased
prostanoid synthesis where levels of 20:4, n-6 are maintained. On the other hand, n-3
PUFA seem able to compromise the PI signalling pathway regardless of the extent of
change in phospholipid n-3 content.
If fluctuations in cell membrane fatty acid composition affect the processes
discussed above, then we may speculate that other membrane-linked phenomena, such
as a1-adrenoceptor affinity and receptor/G protein coupling, may be susceptible to the
influence of diet. The affinity of p-adrenoceptors for the non-selective antagonist
dihydroalprenolol was reduced by n-6 PUFA, as was basal, noradrenaline- and
fluoride-stimulated adenylate cyclase activity [Wince and Rutledge, 1981], These
results indicate that receptor and enzyme function, but not G protein function, was
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affected by n-6 PUFA in these studies. The potential effects of diet on oq-
adrenoceptor affinity await investigation.
9.6 Conclusions
§
In relation to 40% fat calorie diets, which we contend are relevant to man, a small
amount of n-3 PUFA significantly attenuated vascular responses, and tended to
attenuate cardiac responses, to a \ -adrenoceptor stimulation. The precise roles of a
number of potential mechanisms, suggested by fractionated phospholipid fatty acid
data, in this n-3 PUFA effect remain to be clarified. In contrast, dietary n-6 PUFA did
not influence vascular responses but attenuated cardiac responses to a j-adrenoceptor
stimulation. This effect of n-6 PUFA was dependent upon prostanoid synthesis. The
influence of n-3 PUFA on vascular responses may help to explain the putative BP
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1.1 40% fat calorie diets




fat mixture 370 g
salt mixture 46 g
vitamin mixture 8 g
1.2 10% fat calorie diets




fat mixture 92 g
salt mixture 19 g
vitamin mixture 4 g
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Appendix 2
Semisynthetic diets: fat mixtures
§
2.1 40% fat calorie diets
The fat mixtures for the P/S 0.3 (40% fat calories) and P/S 2.0 diets were composed of
the following (2 kg batch).
P/S 0.3 beef dripping 1485 g
olive oil 270 g
safflower oil 245 g
</-a-tocopherol 574 mg
P/S 2.0 beef dripping 261 g
olive oil 472 g
corn oil 1267 g
d-a-tocopherol 50 mg
2.2 10% fat calorie diets
The fat mixtures for the P/S 0.3 (10% fat calories), n-3 PUFA enriched and n-6 PUFA
enriched diets were composed of the following (1 kg batch).
P/S 0.3 beef dripping 743 g
olive oil 135 g
safflower oil 122 g
i/-a-tocopherol 1.5 g
n-3 PUFA fish oil (MaxEPA) 725 g
safflower oil 275 g




Semisynthetic diets: salt mixture
§
The dietary salt mixture for all the diets was prepared from the following salts.
calcium carbonate (CaC03) 1007 g
copper chloride (CUCI2.2H2O) 2.35 g
ferric citrate (CgHsOyFe.SI^O) 21.95 g
magnesium hydrogen phosphate (MgHP04-3H20 478 g
manganese sulphate (MnS04) 33.9 g
trisodium citrate (C6H507Na3) 355.5 g
potassium bicarbonate (KHCO3) 359.5 g
potassium chloride (KC1) 175 g
potassium dihydrogen phosphate (KH2PO4) 237.5 g
potassium iodate (KIO3) 0.035 g
zinc chloride (ZnChj) 6.25 g
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Appendix 4
Semisynthetic diets: vitamin mixture
§
The dietary vitamin mixture for all the diets was prepared from the following
compounds.
calcium pantothenic acid 7.5 g
choline chloride 375 g
folic acid 0.375 g
firmed silica 75 g
menadione 0.375 g
myoinositol 37.5 g
nicotinic acid 7.5 g
sucrose 991 g
vitamin A (retinol acetate) 0.558 g
vitamin Bj (thiamine hydrochloride) 2.25 g
vitamin B2 (riboflavin) 2.25 g
vitamin 65 (pyridoxine hydrochloride) 0.75 g
vitamin B12 (cyanocobalamin) 0.008 g
vitamin D2 (calciferol) 0.14 g
vitamin H (d-biotin) 0.075 g
